{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "6c696411-61e5-4685-9783-9340e764ed96",
   "metadata": {},
   "outputs": [],
   "source": [
    "from rouge_score import rouge_scorer\n",
    "import llm2geneset\n",
    "import json\n",
    "import openai\n",
    "import numpy as np\n",
    "import random\n",
    "import pandas as pd\n",
    "\n",
    "aclient = openai.AsyncClient()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4bb1cfab-c1ff-4aa1-a23e-a51137250619",
   "metadata": {},
   "source": [
    "# ROUGE metric example"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "d32908f9-a87f-4e16-bcf3-e6154fb7b929",
   "metadata": {},
   "outputs": [],
   "source": [
    "#rouge1 : unigram\n",
    "#rouge2 : bigram\n",
    "#rougeL : longest common subsequence \n",
    "scorer = rouge_scorer.RougeScorer(['rouge1','rouge2', 'rougeL'], use_stemmer=True)\n",
    "scores = scorer.score('The quick brown fox jumps over the lazy dog',\n",
    "                      'The quick brown dog jumps on the log.')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "0c4b8843-1f38-4b53-b688-5f9fcd035ca2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'rouge1': Score(precision=0.75, recall=0.6666666666666666, fmeasure=0.7058823529411765),\n",
       " 'rouge2': Score(precision=0.2857142857142857, recall=0.25, fmeasure=0.26666666666666666),\n",
       " 'rougeL': Score(precision=0.625, recall=0.5555555555555556, fmeasure=0.5882352941176471)}"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "scores"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2d1e37b4-58be-41a1-92af-4a9de34c76ad",
   "metadata": {},
   "source": [
    "# Test "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "351e065f-6492-4fbe-b051-3dd96139e2cf",
   "metadata": {},
   "outputs": [],
   "source": [
    "lib_names = [\"KEGG_2021_Human\", \n",
    "             \"Reactome_2022\", \n",
    "             \"WikiPathway_2023_Human\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "87defc31-c817-4c09-880f-ad8c28bc065c",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████| 1/1 [00:09<00:00,  9.30s/it]\n",
      "100%|█████████████████████████████████████████████| 1/1 [00:11<00:00, 11.40s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: Signal Transduction and Transcriptional Regulation\n",
      "LLM self-assessed confidence: 0.85\n",
      "\n",
      "Critical Analysis:\n",
      "\n",
      "1. Signal Transduction: This protein system includes numerous components involved in signal transduction. For instance, the presence of multiple G proteins (e.g., GNG, GNA subunits), MAP kinases (e.g., MAPK1, MAPK3, MAPK10), and adenylate cyclases (ADCY subunits) highlights intricate signaling networks. These proteins play pivotal roles in transducing extracellular signals into intracellular responses. Such pathways often commence with a receptor-ligand interaction leading to G protein activation, subsequent modulation of adenylate cyclase or phospholipase pathways (as indicated by PLCB2, PLCB3, PLCB4), and eventual phosphorylation cascades involving MAP kinases and AKT.\n",
      "\n",
      "2. Transcriptional Regulation: Several transcription factors and transcription-associated proteins (e.g., CREB1, CREB3L1, TBP, TAFs, GTFs) are prominent in this system, emphasizing the regulation of gene expression. CREB proteins are particularly noted for their role in responding to signaling events, often becoming phosphorylated and then modulating the transcription of target genes. TATA-binding proteins (TBP), alongside various transcription-associated factors (TAFs and GTFs), form the backbone of the transcriptional machinery necessary for RNA polymerase II-driven transcription.\n",
      "\n",
      "3. Collagen and Structural Protein Interaction: The inclusion of collagen types (e.g., COL1A1, COL1A2, COL4A1) suggests interactions with the extracellular matrix, affecting cellular adhesion, migration, and signal modulation. These interactions may play secondary, supportive roles in signal mediation, and possibly in tissue integrity and repair processes.\n",
      "\n",
      "4. Growth Factor and Cytokine Signaling: Proteins such as VEGFA, VEGFB, TGFB1, and TGFB2 suggest roles in growth factor signaling, angiogenesis, and cellular proliferation. These factors often initiate signaling cascades that converge on transcriptional regulation and extracellular matrix interaction, further ensuring cellular responses to environmental stimuli.\n",
      "\n",
      "The integration of signaling and transcriptional regulation indicates that the principal process governing this protein system is the conversion of extracellular signals into cellular responses through intricate pathways. The MAPK and PI3K/AKT pathways, along with cyclic AMP-mediated pathways, act concertedly to modulate transcriptional responses, thereby orchestrating cell fate decisions ranging from proliferation to differentiation.\n",
      "\n",
      "In summary, the overlapping roles of signal transduction components and transcriptional regulators underscore a coherent system dedicated to translating external signals into precise genetic responses, influencing a broad spectrum of cellular activities.\n",
      "\n",
      "Confidence Score Rationale: The majority of the proteins present are significantly involved in signal transduction and transcriptional regulation. Given the extensive cross-talk between these pathways and their comprehensive representation in this protein set, the confidence level of the assigned process name is relatively high. However, the diversity of involved proteins and some less represented pathways necessitate a slight reduction in absolute confidence.\n",
      "\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████| 1/1 [00:04<00:00,  4.13s/it]\n",
      "100%|█████████████████████████████████████████████| 1/1 [00:07<00:00,  7.96s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: Signal Transduction and Xenobiotic Metabolism Interaction Network\n",
      "LLM self-assessed confidence: 0.89\n",
      "\n",
      "The provided protein system prominently features proteins involved in signal transduction pathways and xenobiotic metabolism. The key interacting components can be categorized into several critical groups:\n",
      "\n",
      "1. **Receptor Tyrosine Kinases and Associated Signaling Pathways**: Proteins such as ALK, MET, ERBB2, and EGFR are receptor tyrosine kinases that play vital roles in cell signaling. These receptors activate downstream signaling cascades critical for cell growth, differentiation, and survival. For example, MET can activate the MAPK and PI3K pathways, essential for signal transduction. Additionally, linker proteins like GRB2 and SOS1/SOS2 act as adaptors in these pathways.\n",
      "\n",
      "2. **PI3K/AKT/mTOR Pathway**: The PI3K/AKT pathway is represented comprehensively, with several catalytic subunits (PIK3CA, PIK3CB, PIK3CD) and regulatory subunits (PIK3R1, PIK3R2, PIK3R3) of phosphoinositide 3-kinases being prominent. The downstream effectors such as AKT1, AKT2, and AKT3 are also present. PDPK1 is involved in the phosphorylation and activation of AKT. The PI3K/AKT pathway is integral to cellular proliferation, growth, and survival.\n",
      "\n",
      "3. **MAPK/ERK Pathway**: This system includes pivotal members of the MAPK/ERK pathway such as RAF1, BRAF, MAP2K1/2, and MAPK1/3. These proteins contribute to signal transduction from cell surface receptors to the nucleus, influencing gene expression, cellular proliferation, and survival.\n",
      "\n",
      "4. **Cell Cycle Regulation and Tumor Suppressors**: Cyclin-dependent kinases (CDK4, CDK6) and their regulators (CCND1, CDKN1A, CDKN2A) interact to control cell cycle progression. Proteins like TP53 and RB1 are crucial tumor suppressors that regulate the cell cycle and apoptosis.\n",
      "\n",
      "5. **Xenobiotic Metabolism**: The presence of multiple UDP-glucuronosyltransferases (UGT1A1, UGT2B10, UGT1A8, etc.) and aldehyde dehydrogenases (ALDH2, ALDH7A1) highlights the importance of xenobiotic metabolism. UGTs are responsible for the glucuronidation of various endogenous and exogenous compounds, facilitating their excretion. ALDH enzymes are involved in oxidizing aldehydes to their corresponding acids during phase I metabolism, crucial for detoxification.\n",
      "\n",
      "6. **JAK/STAT Pathway**: Proteins such as JAK3 and STAT3, STAT5A, and STAT5B are essential for cytokine signaling, impacting processes like proliferation, differentiation, and immune response.\n",
      "\n",
      "In summary, this system encompasses interacting proteins central to signaling networks (such as PI3K/AKT/mTOR, MAPK/ERK, and JAK/STAT pathways) and metabolic processes pertinent to cellular homeostasis and response to cellular stress or xenobiotic exposure. The interplay between signal transduction and metabolic processes highlights critical regulatory nodes and feedback mechanisms, essential for maintaining cellular equilibrium and adaptation to external cues.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████| 1/1 [00:05<00:00,  5.99s/it]\n",
      "100%|█████████████████████████████████████████████| 1/1 [00:07<00:00,  7.07s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: Immune System Regulation and Signal Transduction\n",
      "LLM self-assessed confidence: 0.90\n",
      "\n",
      "This system of proteins primarily involves components critical to immune cell function, signal transduction, and ion transport processes. These proteins fall into several interconnected clusters based on their primary roles and interactions.\n",
      "\n",
      "1. **T-cell and B-cell Activation and Signaling:**\n",
      "   - **CD3E, CD4, CD8A/B, CD19, CD40, CD40LG, ZAP70, ICOS, PRKCA/B/G, JAK3:** These proteins are involved in the activation, differentiation, and signal transduction in T-cells and B-cells, essential for adaptive immune responses. CD proteins, ZAP70, and JAK3 are crucial in T-cell receptor signaling, while CD19, CD40, and CD40LG are pivotal in B-cell receptor signaling and interactions.\n",
      "\n",
      "2. **Cytokine Signaling and Regulation:**\n",
      "   - **IL7R, IL2RG:** These receptors are part of the cytokine receptor family crucial for lymphocyte development and function. The interaction of these receptors with JAK3 further emphasizes their role in immune responses.\n",
      "\n",
      "3. **Class II MHC Expression and Antigen Presentation:**\n",
      "   - **CIITA, RFXAP, RFXANK, RFX5:** This set of proteins regulates the transcription of MHC class II genes, essential for antigen presentation to helper T-cells, a critical step in initiating an adaptive immune response.\n",
      "\n",
      "4. **Signal Transduction Pathways:**\n",
      "   - **ADCY1-9, GNAS, PRKA subunits (CAMP, PRKACG, PRKACA), PLCB1-4, BTK:** These proteins are involved in adenylate cyclase and phospholipase C signaling pathways, mediating various cellular responses through secondary messengers like cAMP and IP3/DAG.\n",
      "\n",
      "5. **Ion Transport and Homeostasis:**\n",
      "   - **ATP1A/B subunits (ATP1A1-4, ATP1B1-4), ATP2B1-4, SLC12A2, SLC4A2, KCNMA1, ORAI1:** These ion transporters and channels regulate ion homeostasis, fundamental for maintaining cellular functions, particularly in excitable cells like neurons and muscle cells, and are also involved in cellular signaling.\n",
      "\n",
      "6. **Calcium Signaling and Binding:**\n",
      "   - **CALM1-6, ITPR1-3, CAMK2, CALML3-5:** These proteins are involved in calcium signaling, critical for various cellular processes, including muscle contraction, neurotransmitter release, and regulation of gene expression.\n",
      "\n",
      "7. **Miscellaneous Immune-related Proteins:**\n",
      "   - **ADA, AICDA, UNG, CST1-6:** These proteins participate in various aspects of immune cell function, such as adenosine deaminase in lymphocyte proliferation and activation-induced cytidine deaminase in class switch recombination and somatic hypermutation in B-cells.\n",
      "\n",
      "In summary, the proteins in this set are predominantly involved in the regulation and signaling processes of the immune system. They significantly contribute to T and B cell activation, antigen presentation, cytokine signaling, and ion transport processes, collectively ensuring a robust adaptive immune response and cellular communication.\n",
      "\n",
      "The confidence in naming this biological process is high, given the large proportion of genes involved in immune-related functions.\n",
      "\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████| 1/1 [00:04<00:00,  4.70s/it]\n",
      "100%|█████████████████████████████████████████████| 1/1 [00:10<00:00, 10.98s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: Immune Response Regulation and Signal Transduction\n",
      "LLM self-assessed confidence: 0.95\n",
      "\n",
      "The system of interacting proteins given consists mostly of components critical for immune response regulation, signal transduction pathways, and cellular responses to external stimuli. Here's a breakdown of the key roles these proteins play and their interplay:\n",
      "\n",
      "1. **Cytokine Signaling and JAK-STAT Pathway**: Proteins such as JAK1, JAK2, IFNGR1, IFNGR2, and STAT proteins (STAT1, STAT3) play central roles in cytokine signaling, with JAK-STAT pathways being critical for mediating responses to various cytokines, including interferons (e.g., IFNG). These pathways regulate gene expression related to immune responses, cell survival, and proliferation.\n",
      "\n",
      "2. **T-cell Receptor Signaling**: T-cell surface proteins like CD3G, CD3E, CD3D, CD4, and CD28 are crucial for T-cell receptor (TCR) signaling. This signaling is essential for T-cell activation and differentiation, involving kinases such as ZAP70, LCK, and adaptor molecules like LAT. These components work together to transmit activation signals from the TCR to intracellular signaling cascades.\n",
      "\n",
      "3. **NF-κB Signaling Pathway**: Proteins such as RELA, NFKBIA, NFKB1, NFKBIE, IKBKG, and IKBKB are essential elements of the NF-κB signaling pathway. NF-κB transcription factors are activated in response to stimuli such as cytokines and stress, leading to the transcription of genes involved in inflammation, immune response, and cell survival.\n",
      "\n",
      "4. **PI3K-AKT Signaling Pathway**: PI3Ks (PIK3R3, PIK3R1, PIK3CA, PIK3CB, PIK3CD) in conjunction with AKT isoforms (AKT1, AKT2, AKT3) form a critical signaling axis. The PI3K-AKT pathway plays a crucial role in cell survival, metabolism, and proliferation. It is also heavily involved in TCR signaling and lymphocyte proliferation.\n",
      "\n",
      "5. **Apoptosis Regulation**: Caspases (CASP3, CASP8, CASP9) and BID are key for the execution of apoptosis, a vital process for maintaining immune homeostasis and eliminating infected or damaged cells. Their regulation ensures proper immune cell turnover and response termination.\n",
      "\n",
      "6. **MAPK Signaling Pathways**: Proteins involved in MAPK signaling (MAP2K1, MAP2K2, MAP2K3, MAP2K6, MAPK1, MAPK2, MAPK3, MAPK11, MAPK12, MAPK13, MAPK14) are crucial for transmitting signals from the cell surface to the nucleus, affecting gene expression in response to various stimuli including cytokines and stress.\n",
      "\n",
      "7. **Antigen Presentation and Processing**: HLA class I (HLA-A, HLA-B, HLA-C, HLA-E, HLA-F) and class II molecules (HLA-DRB1, HLA-DRA, HLA-DQA1, HLA-DQA2, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-DMA, HLA-DOB, HLA-DPB1, HLA-DQB1) play critical roles in the immune system’s ability to present antigens and initiate adaptive immune responses. These molecules are essential for the interaction between antigen-presenting cells and T-cells.\n",
      "\n",
      "8. **Integration of Signals for Immune Response Regulation**: Other proteins like CD40, CD40LG, CD86, TRAF6, and signaling adaptors (MYD88, TICAM1, TICAM2, TIRAP) are involved in signal integration and amplification, critical for mounting appropriate immune responses. These proteins mediate interactions between immune cells and propagate activation signals leading to robust immune responses.\n",
      "\n",
      "The majority of the proteins within this system are engaged in interconnected pathways essential for detecting, processing, and responding to antigens, making up an intricate network crucial for immune surveillance, response, and regulation.\n",
      "\n",
      "To summarize, this system of interacting proteins is predominantly involved in immune response regulation and signal transduction.\n",
      "\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████| 1/1 [00:05<00:00,  5.06s/it]\n",
      "100%|█████████████████████████████████████████████| 1/1 [00:08<00:00,  8.71s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "**Name: Regulation of Cell Growth, Apoptosis, and Signaling via TGF-beta Pathway**\n",
      "\n",
      "**LLM self-assessed confidence: 0.86**\n",
      "\n",
      "1. **TGF-beta Signaling:** TGFB1, TGFB2, and TGFB3 are prominent members of the Transforming Growth Factor-Beta (TGF-beta) family, critical for cellular growth, differentiation, and apoptosis. TGFBR1 and TGFBR2 are their receptors that initiate the downstream signaling cascade. SMAD4, a central mediator in the TGF-beta pathway, interacts with receptor-regulated SMADs to transduce the signal to the nucleus, affecting gene expression.\n",
      "\n",
      "2. **Cell Cycle Regulation and Apoptosis:** Proteins such as TP53, CDKN1A, CDKN1B, CDKN2A, and RB1 are central to cell cycle regulation and apoptosis. TP53, known as the \"guardian of the genome,\" regulates cell cycle arrest and apoptosis in response to DNA damage. The cyclin-dependent kinase inhibitors CDKN1A (p21), CDKN1B (p27), and CDKN2A (p16) inhibit cell cycle progression, preventing unregulated cell growth. BCL2L1, BAD, BAX, and BAK1 are involved in the intrinsic apoptosis pathway.\n",
      "\n",
      "3. **Cell Growth and Proliferation:** The MAPK/ERK pathway, involving proteins like MAPK1 (ERK2), MAPK3 (ERK1), MAP2K1 (MEK1), and MAP2K2 (MEK2), is crucial for cell proliferation, differentiation, and survival. PIK3CA, PIK3CB, PIK3CD, PIK3R1, PIK3R2, and PIK3R3 are key components of the PI3K/AKT pathway, essential for cell growth, survival, and metabolism. AKT1, AKT2, and AKT3 further propagate these signaling cascades.\n",
      "\n",
      "4. **Transcriptional Regulation:** MYC, E2F1, E2F2, and E2F3 are transcription factors controlling the expression of genes needed for cell cycle progression and DNA replication. CDK4 and CDK6 are involved in the regulation of the cell cycle by phosphorylating RB1, leading to the release and activation of E2F transcription factors.\n",
      "\n",
      "5. **DNA Damage Response and Repair:** GADD45A, GADD45B, and GADD45G are involved in the maintenance of genomic stability through DNA repair mechanisms. TP53 and MDM2 play roles in the DNA damage response, with TP53 activating repair genes and MDM2 regulating TP53 levels.\n",
      "\n",
      "This system of interacting proteins heavily revolves around regulation of cellular growth, apoptosis, signal transduction via the TGF-beta pathway, and maintenance of genomic stability. Their functions are intricately linked, ensuring proper cellular responses to various stimuli.\n",
      "\n",
      "Overall, these proteins collectively ensure proper cell cycle control, response to DNA damage, and cellular signaling, with a significant focus on TGF-beta mediated regulation.\n",
      "\n",
      "**Confidence Rationale:** The majority of proteins in this set are either directly involved in TGF-beta signaling or in related processes such as cell cycle regulation, apoptosis, and cellular proliferation. While there are some proteins related to specific metabolic functions not directly central to TGF-beta signaling, their roles are complementary, hence the high confidence score.\n",
      "\n",
      "**LLM self-assessed confidence: 0.86**\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████| 1/1 [00:03<00:00,  3.77s/it]\n",
      "100%|█████████████████████████████████████████████| 1/1 [00:07<00:00,  7.07s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: Olfactory signal transduction and mitochondrial bioenergetics\n",
      "LLM self-assessed confidence: 0.85\n",
      "\n",
      "The system of interacting proteins provided encompasses two major biological processes: olfactory signal transduction and mitochondrial bioenergetics. \n",
      "\n",
      "1. **Olfactory Signal Transduction:**\n",
      "   A significant portion of the proteins in this system are olfactory receptors (ORs), which include OR52B6, OR5D14, OR1Q1, and many others. These receptors are critical for the detection of odor molecules and play a substantial role in the initiation of olfactory signal transduction. Upon ligand binding, these receptors activate downstream G-proteins such as GNAQ and GNG13. These G-proteins then modulate the activity of various intracellular effectors, including adenylate cyclases like ADCY3, which catalyze the production of cyclic AMP (cAMP) from ATP. The rise in cAMP levels activates cyclic nucleotide-gated ion channels (such as CNGA2 and CNGA4), leading to an influx of ions and generation of an action potential that is transmitted to the brain for odor perception.\n",
      "\n",
      "2. **Mitochondrial Bioenergetics:**\n",
      "   Another prominent subset of the proteins is involved in mitochondrial function and energy production. This includes NADH:ubiquinone oxidoreductase subunits such as NDUFA1, NDUFS5, and NDUFV1, which form parts of Complex I in the electron transport chain (ETC). In addition, components of other ETC complexes such as COX4I1 (Complex IV), SDHC (Complex II), and ATP synthase subunits (ATP5F1C, ATP5MC3) are also represented. These proteins are integral to the process of oxidative phosphorylation (OXPHOS), where electrons are transferred through the ETC, leading to the generation of ATP, the cell’s primary energy currency.\n",
      "\n",
      "Interestingly, the presence of regulatory factors like CREBBP and EP300 suggests the modulation of gene expression connected to both olfactory function and mitochondrial operations, potentially indicating interactions that link these two biological domains.\n",
      "\n",
      "To summarize, the proteins in this system are predominantly centered around two synergistic processes: the transduction of olfactory signals and the bioenergetic activities within the mitochondria, emphasizing the complex interplay between sensory perception and cellular energy metabolism. \n",
      "\n",
      "Given the high proportion of proteins dedicated to these processes, the detailed name “Olfactory signal transduction and mitochondrial bioenergetics” accurately captures the essence of this protein interaction network.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████| 1/1 [00:04<00:00,  4.41s/it]\n",
      "100%|█████████████████████████████████████████████| 1/1 [00:06<00:00,  6.54s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: Pancreatic differentiation and function\n",
      "LLM self-assessed confidence: 0.95\n",
      "\n",
      "1. **Transcription Factors**:\n",
      "   - **PDX1, RFX6, NEUROG3, ONECUT1, MAFA, HNF4A, BHLHA15, PAX4, NR5A2, HNF1A, NEUROD1, HNF1B, PAX6, HHEX, NKX6-1, MNX1, FOXA2, NKX2-2**: These transcription factors play crucial roles in the development, differentiation, and maturation of pancreatic tissues, particularly pancreatic beta cells. For instance, PDX1 and NKX6-1 are essential for beta-cell maturation and function, while NEUROG3 is vital for endocrine cell specification.\n",
      "\n",
      "2. **Hormones and Secretory Proteins**:\n",
      "   - **INS (Insulin)** and **IAPP (Islet Amyloid Polypeptide)**: Both of these are critical for glucose homeostasis. Insulin manages blood glucose levels by promoting cellular glucose uptake, whereas IAPP regulates the action of insulin and plays a role in beta-cell health and amyloid formation in diabetes.\n",
      "\n",
      "3. **Metabolic Enzymes**:\n",
      "   - **GCK (Glucokinase), PKLR (Pyruvate Kinase), XDH (Xanthine Dehydrogenase), CYP2A7, CYP2A6, CYP1A2**: Enzymes such as GCK and PKLR are essential for glucose metabolism, playing a role in glycolysis and gluconeogenesis. Enzymes like CYP2A7 and CYP2A6 are involved in drug metabolism and the metabolism of steroid hormones.\n",
      "\n",
      "4. **Transporters**:\n",
      "   - **SLC2A2 (GLUT2)**: Key transporter responsible for glucose uptake in pancreatic beta cells, hepatocytes, and other tissues, crucial for glucose sensing.\n",
      "\n",
      "5. **Developmental Genes**:\n",
      "   - **HES1**: Involved in maintaining the undifferentiated state of neural and pancreatic progenitor cells.\n",
      "\n",
      "6. **Others**:\n",
      "   - **NAT1, NAT2**: These are involved in the N-acetylation process, a phase II metabolic reaction important for drug metabolism and possibly influencing beta-cell function.\n",
      "   - **FOXA3** and **HNF4G**: Contribute to the regulation of insulin gene transcription and maintenance of glucose homeostasis.\n",
      "\n",
      "The identified proteins predominantly contribute to processes underpinning the differentiation of pancreatic tissues, the development of functional pancreatic cells, and the regulation of glucose metabolism. This concerted action highlights the pivotal role of these proteins in establishing and maintaining pancreatic functionality essential for metabolism and homeostasis. Additionally, many of these proteins interact synergistically to ensure effective glucose regulation and beta-cell function, emphasizing the integrated nature of these biological processes.\n",
      "\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████| 1/1 [00:03<00:00,  3.04s/it]\n",
      "100%|█████████████████████████████████████████████| 1/1 [00:06<00:00,  6.31s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: DNA Repair Mechanisms and Glycosylation Pathways\n",
      "LLM self-assessed confidence: 0.89\n",
      "\n",
      "1. **DNA Repair Mechanisms**: A significant subset of the proteins, including POLD1, POLB, XRCC1, OGG1, SMUG1, UNG, NEIL3, NEIL2, POLL, POLH, NEIL1, POLD2, POLD4, POLE, POLE2, POLE3, POLE4, and APEX1, are directly involved in various DNA repair pathways. For example, POLD1 (DNA polymerase delta catalytic subunit) and POLE (DNA polymerase epsilon catalytic subunit) are involved in DNA synthesis and repair. XRCC1 interacts with DNA ligase III (LIG3) and DNA polymerase β (POLB) in the base excision repair (BER) pathway. Proteins such as OGG1 and UNG are essential for glycosylase activities that initiate BER by recognizing and removing damaged bases.\n",
      "\n",
      "2. **Glycosylation Pathways**: Another important group of proteins involves enzymes essential for glycosylation, such as MGAT2, MGAT1, MGAT4A, MGAT4B, MGAT4C, MGAT4D, MAN1A1, MAN1A2, MAN1C1, MAN2A1, MAN2A2, ALG1, ALG2, ALG3, ALG9, ALG12, ALG13, and ALG14. These proteins are vital for processing glycoproteins in the endoplasmic reticulum and Golgi apparatus. MGAT enzymes, for example, are involved in the complex N-glycan synthesis, and ALG enzymes participate in various steps of the dolichol-linked oligosaccharide biosynthesis. \n",
      "\n",
      "3. **Synergistic and Antagonistic Effects**: DNA repair and glycosylation pathways, while seemingly distinct, have interconnected roles in maintaining cellular functionality. Proper DNA repair ensures genomic stability, which is crucial for the accurate synthesis of proteins that will undergo glycosylation. Glycosylation, in turn, is essential for the correct folding and function of many proteins involved in DNA repair. \n",
      "\n",
      "4. **Functional Integration**: The interplay between these proteins suggests a coordinated effort to maintain cellular integrity and functionality. For instance, PCNA (Proliferating Cell Nuclear Antigen) acts as a scaffold in DNA replication and repair, interacting with several DNA repair proteins and influencing glycosylation pathways by regulating protein interactions.\n",
      "\n",
      "In summary, the proteins in this system play crucial roles in the cellular processes of DNA repair and glycosylation. These functions are interconnected and essential for maintaining cellular homeostasis, ensuring that any damage to DNA is efficiently repaired, and that proteins are correctly processed and functional.\n",
      "\n",
      "LLM self-assessed confidence: 0.89\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████| 1/1 [00:08<00:00,  8.84s/it]\n",
      "100%|█████████████████████████████████████████████| 1/1 [00:12<00:00, 12.38s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: Signal Transduction and Cellular Proliferation\n",
      "LLM self-assessed confidence: 0.90\n",
      "\n",
      "The system of interacting proteins provided includes a large number of proteins associated with signal transduction pathways and cellular proliferation. Below is a critical analysis of the major groups of proteins and their functional integration within the system:\n",
      "\n",
      "1. **Growth Factors and Receptors:** \n",
      "   - **Fibroblast Growth Factors (FGFs)** and **FGF Receptors (FGFRs):** FGF1, FGF2, FGF4, FGF5, FGF6, FGF7, FGF9, FGF10, FGF16, FGF17, FGF18, FGF19, FGF20, FGF21, FGF22, and their respective receptors (e.g., FGFR2). FGFs play a crucial role in cell proliferation, differentiation, and angiogenesis by activating FGFR-mediated signaling cascades.\n",
      "   - **Transforming Growth Factors (TGFs):** TGFB1, TGFB2, TGFB3, TGFBR1, and TGFBR2. These proteins regulate cell growth, differentiation, and apoptosis, often interacting with the SMAD pathway.\n",
      "   - **Platelet-Derived Growth Factors (PDGFs) and their receptors:** PDGFA, PDGFB, PDGFRA, and PDGFRB. These growth factors are significant in embryonic development, cell proliferation, and angiogenesis.\n",
      "\n",
      "2. **Signal Transduction Pathways:**\n",
      "   - **Mitogen-Activated Protein Kinase (MAPK) Pathway:** Including MAPK1, MAPK3, MAP2K1, MAP2K2, RAF1, ARAF, BRAF. This pathway mediates cellular responses to growth signals, playing roles in proliferation, differentiation, and survival.\n",
      "   - **Phosphoinositide 3-Kinase (PI3K) Pathway:** Including PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PIK3R3, and AKT1, AKT2, AKT3. This pathway is key in regulating cell growth, proliferation, and survival.\n",
      "   - **WNT Signaling Pathway:** Includes multiple WNTs (WNT1, WNT2, WNT3, WNT4, WNT5A, WNT5B, WNT6, WNT7A, WNT7B, WNT8A, WNT8B, WNT9A, WNT9B, WNT10A, WNT10B, WNT11, WNT16) and their receptors (e.g., FZD1, FZD2, FZD3, FZD4, FZD5, FZD6, FZD7, FZD9, FZD10). WNT signaling is essential for regulating cell fate, proliferation, migration, and polarity during development and in adult tissues.\n",
      "\n",
      "3. **Key Intracellular Signaling Mediators:**\n",
      "   - **Calcium Signaling Proteins:** CALM1, CALM2, CALM3, CALML3, CALML4, CALML5, CALML6. Calmodulin proteins are pivotal in calcium signal transduction, affecting various cellular processes like metabolism, memory, and muscle contraction.\n",
      "   - **Cyclins and Cyclin-Dependent Kinases (CDKs):** CCND1, CCNE1, CCNE2, CDK2, CDK4, CDK6. These proteins critically regulate the cell cycle, ensuring proper cell division and proliferation.\n",
      "   - **SMAD Proteins (Smad2, Smad3, Smad4):** These proteins transduce extracellular TGF-beta signals to the nucleus where they activate downstream gene transcription involved in cell proliferation and differentiation.\n",
      "\n",
      "4. **Cellular Proliferation and Survival Regulators:**\n",
      "   - **Transcription Factors:** MYC, TCF7, TCF7L1, TCF7L2, LEF1, E2F1, E2F2, E2F3. These factors control gene expression necessary for cell cycle progression and proliferation.\n",
      "   - **Oncogenes and Tumor Suppressors:** TP53, RB1, CDKN2A, CDKN2B, CDKN1A, CDKN1B. These proteins ensure the fidelity of cell division and control cellular responses to DNA damage.\n",
      "\n",
      "In summary, the proteins in this system are primarily involved in the complex network of intracellular signaling pathways that mediate cell growth, proliferation, survival, and differentiation, with most pathways converging to regulate cellular responses to environmental stimuli. \n",
      "\n",
      "These findings indicate a coordinated interplay of growth factor signaling, intracellular kinase cascades, and transcriptional regulation to ensure proper cellular functions and responses.\n",
      "\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████| 1/1 [00:05<00:00,  5.66s/it]\n",
      "100%|█████████████████████████████████████████████| 1/1 [00:06<00:00,  6.35s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: Cytokine and Growth Factor Signaling\n",
      "LLM self-assessed confidence: 0.95\n",
      "\n",
      "1. The system comprises numerous cytokines including interleukins (IL-1, IL-4, IL-6, IL-17, IL-22, IL-27), interferons (IFNA, IFNB, IFNL), and growth factors (GDF, BMP), indicating a prominent role in immune response and cellular growth regulation. Cytokines are crucial for mediating immune system communication and controlling inflammation, differentiation, and proliferation.\n",
      "\n",
      "2. Tumor necrosis factor receptors (TNFRSF) and their ligands (TNF, TNFSF) suggest involvement in apoptotic signaling and immune system modulation. These proteins are key to inducing cell death and regulating immune cell activation.\n",
      "\n",
      "3. The presence of growth hormone receptor (GHR) and prolactin receptor (PRLR) proteins indicates their role in mediating growth hormone and prolactin signaling, critical for growth, metabolism, and reproductive functions.\n",
      "\n",
      "4. Signaling pathways are further indicated by proteins involved in downstream effectors like PIK3CA, PIK3R1, and RHOA, which participate in intracellular signaling and cytoskeletal reorganization.\n",
      "\n",
      "5. Additionally, proteins involved in receptor-mediated endocytosis and vesicle trafficking (DNM1, DNM2) suggest a role in the recycling and degradation of cell surface receptors, which is an important aspect of receptor signaling attenuation.\n",
      "\n",
      "6. Multiple chemokines (CXCL, CCL) and their receptors (CCR, CXCR) point to chemotactic activities guiding the movement of immune cells towards the site of inflammation or injury, which is essential for an effective immune response.\n",
      "\n",
      "The proteins in this system are heavily skewed towards roles in cytokine and growth factor signaling, primarily influencing immune responses, inflammation, and cellular growth mechanisms through intricate networks of receptor-ligand interactions and downstream signaling pathways. \n",
      "\n",
      "This integrated system plays a pivotal role in maintaining immune homeostasis, tissue growth, and repair mechanisms, highlighting its overall importance in body physiology and pathology.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████| 1/1 [00:07<00:00,  7.91s/it]\n",
      "100%|█████████████████████████████████████████████| 1/1 [00:11<00:00, 11.39s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: IL-17 signaling and MAPK pathway regulation\n",
      "LLM self-assessed confidence: 0.92\n",
      "\n",
      "The proteins in this system exhibit strong functional associations predominantly with the IL-17 signaling pathway and various branches of the MAPK signaling pathway. Here are the key points of analysis:\n",
      "\n",
      "1. **IL-17 Signaling Pathway**:\n",
      "   - **IL17RB, IL17RC, IL17RE, IL17RA, IL25, IL17C, IL17F**: These interleukin receptors and cytokines are central to the IL-17 signaling pathway, crucial for mediating inflammatory responses. IL-17 cytokines bind to their corresponding receptors, activating downstream signaling cascades.\n",
      "   - **TRAF6, NOD1, NOD2, RIPK2, IRAK1, IRAK2**: Important signaling molecules within the IL-17 pathway. NOD1/2 and TRAF6 facilitate immune responses, while RIPK2 and IRAK1/2 are involved in signal transduction.\n",
      "   - **TAB1, TAB2, TAB3**: These adapter proteins collaborate with TAK1 to mediate signaling in response to IL-17 stimulation.\n",
      "\n",
      "2. **MAPK Signaling Pathways**:\n",
      "   - **MAP2K3, MAP2K4, MAP2K6, MAP2K7, MAP2K1, MAP3K7, MAP3K8, MAPK1/3/7/8/9/10/11/14**: These Mitogen-Activated Protein Kinases (MAPKs) and their associated kinases are quintessential components of the MAPK signaling pathways. They regulate various cellular activities including inflammation, cell growth, and apoptosis. \n",
      "   - **RPS6KA1, RPS6KA2, RPS6KA3, RPS6KA5**: Activated downstream by MAPK pathways, these kinases govern the phosphorylation of diverse substrates, impacting translational control and other cellular processes.\n",
      "   - **MAPKAPK2, MAPKAPK3**: MAP kinase-activated protein kinases integrate various stress signals to mediate cytokine production and other responses.\n",
      "\n",
      "3. **Dual Specificity Phosphatases (DUSPs)**:\n",
      "   - **DUSP3, DUSP4, DUSP6, DUSP7**: These phosphatases dephosphorylate MAPKs, hence providing a regulatory feedback to MAPK signaling pathways, crucial for modulating signal duration and intensity.\n",
      "\n",
      "4. **Others**:\n",
      "   - **PPP2CA, PPP2CB, PPP2R1A, PPP2R1B, PPP2R5D**: Components of Protein Phosphatase 2A, which modulates various signaling pathways including MAPK through dephosphorylation processes.\n",
      "   - **GINS1, GINS2, GINS3, GINS4, MCM3, MCM4, MCM5, MCM6, MCM7, CDC45**: These proteins, components of the DNA replication machinery, indicate elements of cell cycle regulation intersecting with the observed signaling pathways.\n",
      "   - **CUL1, SKP1, FBXW11, BTRC**: These proteins are part of the SCF ubiquitin ligase complex, implicated in protein degradation and regulation of signaling pathways.\n",
      "\n",
      "The concerted interaction among IL-17 signaling constituents, MAPK pathway regulators, and key modulators like DUSPs and PP2A suggest a robust network regulating inflammatory responses, cell proliferation, and survival, highlighting the cross-talk between immune signaling and MAPK pathways.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████| 1/1 [00:03<00:00,  3.39s/it]\n",
      "100%|█████████████████████████████████████████████| 1/1 [00:09<00:00,  9.86s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: Microtubule Dynamics and Cytoskeletal Organization\n",
      "LLM self-assessed confidence: 0.95\n",
      "\n",
      "1. The largest proportion of proteins in the system are tubulins (TUBA1A, TUBA1B, TUBA1C, TUBA3D, TUBA3C, TUBA4A, TUBA4B, TUBA8, TUBB, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8, TUBB8B). Tubulins are structural proteins that polymerize to form microtubules, which are key components of the cytoskeleton. Microtubules are involved in maintaining cell shape, enabling intracellular transport, and facilitating cell division by forming the mitotic spindle.\n",
      "\n",
      "2. LIMK1 (LIM domain kinase 1) and PKN1/PKN2 (Protein Kinase N1/N2) are involved in regulating cytoskeletal dynamics. LIMK1 plays a key role in actin cytoskeleton remodeling by phosphorylating and inactivating cofilin. PKN proteins influence microtubule organization and stabilization, and are linked to signaling pathways that mediate cytoskeletal reorganization.\n",
      "\n",
      "3. Proteins from the Charged Multivesicular Body Protein (CHMP) family (CHMP2A, CHMP2B, CHMP4B, CHMP4C, CHMP6, CHMP7, RNF103-CHMP3) are involved in endosomal sorting complexes required for transport (ESCRT) machinery. The ESCRT complex is integral for membrane budding and cytokinesis, processes closely linked to microtubule functions and dynamics.\n",
      "\n",
      "4. HSP90AB1 and HSP90AA1 are heat shock proteins that act as molecular chaperones. They assist in the proper folding of tubulins and other cytokinesis-related proteins, ensuring that microtubule dynamics and cellular structures are correctly assembled and maintained.\n",
      "\n",
      "5. SPAST (Spastin) is a microtubule-severing enzyme, playing an essential role in microtubule dynamics by cutting microtubules into shorter segments, which can then be regulated and utilized efficiently within the cell.\n",
      "\n",
      "6. The presence of proteins like ARHGEF7, which regulates actin cytoskeleton organization through Rho GTPase signaling, complements and interacts with microtubule dynamics to ensure coordinated cytoskeletal rearrangements.\n",
      "\n",
      "7. PLXNA1, PLXNA2, PLXNA3, PLXNA4 (Plexin A family) and associated proteins (SEMA3A, NRP1) are involved in signaling pathways that mediate cytoskeleton organization and interact with microtubule networks to influence cell migration and axon guidance.\n",
      "\n",
      "8. IST1, VPS4A, and VPS72 are involved in endosomal trafficking and have overlapping roles with ESCRT proteins, indirectly affecting microtubular dynamics by ensuring proper sorting and degradation of membrane-bound proteins.\n",
      "\n",
      "In summary, the interacting proteins primarily play roles in the assembly, regulation, and organization of microtubules, which are essential for cell structural integrity, intracellular transport, and cell division. The interplay of these proteins ensures dynamic and responsive cytoskeletal arrangements crucial for various cellular activities.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████| 1/1 [00:02<00:00,  2.44s/it]\n",
      "100%|█████████████████████████████████████████████| 1/1 [00:06<00:00,  6.28s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: Autophagy and Ion Transport\n",
      "LLM self-assessed confidence: 0.80\n",
      "\n",
      "1. **Autophagy-Related Proteins**: Several proteins in this system, such as ATG5, ATG12, ULK1, MAP1LC3A, MAP1LC3B, PGAM5, and FUNDC1, are key components and regulators of the autophagy pathway. ATG5 and ATG12 form a complex crucial for autophagosome formation. ULK1 is a serine/threonine kinase that initiates autophagy in response to nutrient deprivation. MAP1LC3A and MAP1LC3B are essential for membrane expansion and closure during autophagosome biogenesis. FUNDC1 mediates mitophagy, which is important for selective degradation of damaged mitochondria. PGAM5 interacts with FUNDC1 and regulates mitochondrial quality control processes.\n",
      "\n",
      "2. **Ion Transport Proteins**: The SCNN1 family (SCNN1A, SCNN1B, SCNN1G, and SCNN1D) encodes subunits of the epithelial sodium channel (ENaC), which is responsible for sodium reabsorption in epithelial tissues, affecting fluid balance and blood pressure regulation. CALHM1 and CALHM3 are involved in ion transport and may play a role in sensory perception and neural signaling.\n",
      "\n",
      "3. **Kinase-Related Regulatory Proteins**: CSNK2B and CSNK2A2 are subunits of casein kinase II, a serine/threonine protein kinase that participates in various cellular processes by phosphorylating a wide array of substrates. Their involvement can affect both autophagic and ion transport mechanisms indirectly.\n",
      "\n",
      "4. **Signal Transduction Protein**: SRC is a non-receptor tyrosine kinase that participates in numerous cellular processes such as proliferation, differentiation, migration, and survival. It can influence pathways involving both autophagy and ion transport through intricate signaling networks.\n",
      "\n",
      "The proteins in this system can be grouped mainly into those that participate in autophagy and those involved in ion transport. While the proteins under each category show functional synergy within their respective processes, there is a potential for crosstalk between autophagy and ion transport, regulated by kinases and other signaling molecules present in the set.\n",
      "\n",
      "Overall, the interactions of the proteins in this system are most prominently aligned with regulating autophagy processes and managing ion transport mechanisms, contributing to cellular homeostasis.\n",
      "\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████| 1/1 [00:04<00:00,  4.46s/it]\n",
      "100%|█████████████████████████████████████████████| 1/1 [00:11<00:00, 11.55s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: Notch Signaling Pathway and Epigenetic Modulation\n",
      "LLM self-assessed confidence: 0.92\n",
      "\n",
      "This system of interacting proteins primarily revolves around the Notch signaling pathway, which plays an essential role in cell fate determination and differentiation across various tissues. The key components and modulators of this pathway include:\n",
      "\n",
      "1. **Notch receptors and ligands**: NOTCH1, DLL1, DLL4, JAG1, and JAG2 are pivotal in initiating the signaling cascade. These interactions are critical for the receptor-ligand binding process that triggers the subsequent intracellular signaling events.\n",
      "\n",
      "2. **Gamma-secretase complex**: Major components like PSEN1, PSEN2, APH1A, APH1B, and PSENEN are involved in the proteolytic cleavage of Notch receptors, essential for releasing the Notch intracellular domain (NICD) and transactivating target genes.\n",
      "\n",
      "3. **Transcriptional regulatory proteins**: RBPJ (CBF1), MAML1, MAML2, MAML3, and other co-activators such as EP300 and CREBBP mediate the transcriptional activation of Notch target genes. These interactions modulate gene expression crucial for cellular differentiation processes.\n",
      "\n",
      "4. **Epigenetic modifiers**: Multiple HDACs (HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC8, HDAC9, HDAC10, HDAC11), KAT2A, KAT2B, NCOR1, and NCOR2 are involved in chromatin modification, suggesting a significant role of epigenetic modulation in regulating Notch target gene expression.\n",
      "\n",
      "5. **Protein ubiquitination/degradation machinery**: Proteins like FBXW7, a known E3 ubiquitin ligase for NICD, CUL1, SKP1, and RBX1 are essential components of the ubiquitin-proteasome system that regulates the stability and turnover of signaling proteins.\n",
      "\n",
      "6. **Other modulators and adapters**: ARRB1, ARRB2, TLE family members (TLE1, TLE2, TLE3, TLE4), and A1CF indicate diverse roles in modulating the pathway, possibly through transcriptional repression, signal diversification, or stabilization of interactions.\n",
      "\n",
      "Advanced layers of regulation are provided by APOBEC family proteins, such as APOBEC1, APOBEC3C, APOBEC3H, APOBEC3B, which could be indicative of interactions affecting RNA editing and other post-transcriptional modification processes.\n",
      "\n",
      "In summary, this protein system's core functionality is anchored in the Notch signaling pathway, coupled with extensive epigenetic regulation and protein stability control. These processes ensure precise control of cellular outcomes during development by maintaining proper gene expression patterns and timely degradation of signaling intermediates.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████| 1/1 [00:03<00:00,  3.77s/it]\n",
      "100%|█████████████████████████████████████████████| 1/1 [00:12<00:00, 12.21s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: Epidermal Growth Factor Receptor (EGFR) Signaling and Glycosylation \n",
      "LLM self-assessed confidence: 0.91\n",
      "\n",
      "1. **EGFR and its Ligands**: EGFR is a tyrosine kinase receptor that, upon activation by its ligands (e.g., TGFA, EREG, AREG, EGF, BTC, HBEGF), initiates several intracellular downstream signaling cascades. This signaling modulates cellular processes such as proliferation, differentiation, and survival. EGFR activation engages several downstream pathways, such as the PI3K/AKT pathway (PIK3CA, PIK3R1) and SRC kinase pathways.\n",
      "\n",
      "2. **PI3K/AKT Pathway**: The PI3K/AKT signaling pathway is crucial in promoting cell survival and growth in response to extracellular signals. PIK3CA and PIK3R1 are essential components of this pathway and function downstream of EGFR to promote cellular proliferation and prevent apoptosis. This pathway's role is critical in oncogenesis and cancer maintenance.\n",
      "\n",
      "3. **Adaptor and Signaling Proteins**: Proteins like GRB2 and PTPN11 serve as adaptors that bridge receptor tyrosine kinases (like EGFR) with downstream signaling components. GRB2 links EGFR to the Ras signaling pathway, while PTPN11 (also known as SHP-2) acts as a signal transducer to facilitate further downstream signaling.\n",
      "\n",
      "4. **Cytoplasmic Tyrosine Kinases**: SRC family kinases (e.g., SRC, CSK) are non-receptor tyrosine kinases involved in controlling cellular architecture, migration, adhesion, and cell cycle progression. They interact with activated EGFR and contribute to amplifying the signal and transmitting it to various cellular responses.\n",
      "\n",
      "5. **Nucleotide-sugar Transporters**: The SLC35 family of transporters (SLC35A1, SLC35A2, SLC35A3, SLC35B2, SLC35B3, SLC35B4, SLC35C1, SLC35D1, SLC35D2) are involved in the transportation of nucleotide sugars from the cytosol into the Golgi lumen, facilitating glycosylation—a critical post-translational modification for proteins and lipids. This process is integral for proper cell signaling, receptor function, and cellular interactions.\n",
      "\n",
      "6. **Regulation and Modulation**: PAG1 and PIGU proteins are involved in the negative regulation and modulation of EGFR signaling. PAG1 localizes to lipid rafts to moderate signaling via SRC family kinases, while PIGU is part of the glycosylphosphatidylinositol (GPI) anchor transamidase complex, linking proteins to cell membranes.\n",
      "\n",
      "7. **Extracellular Matrix and Interactions**: PXDN (peroxidasin) is an enzyme that plays a role in extracellular matrix formation and stabilization. This component facilitates proper cellular adhesion, migration, and tissue integrity, contributing indirectly to the overall cellular responses modulated by EGFR signaling.\n",
      "\n",
      "8. **Cross-functional Interdependence**: The integration of EGFR signaling and glycosylation is vital for ensuring proper protein function, impacting cellular growth, differentiation, and pathway interactions. Glycosylation by SLC35 family members affects the activity and stability of receptors and ligand-binding efficacy.\n",
      "\n",
      "Collectively, the proteins in this system represent a highly coordinated network centered on EGFR signaling, with strong ties to glycosylation processes that ensure correct protein modification and function, ultimately influencing cellular behavior and homeostasis.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████| 1/1 [00:04<00:00,  4.28s/it]\n",
      "100%|█████████████████████████████████████████████| 1/1 [00:09<00:00,  9.21s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "**Name:** Fibroblast Growth Factor Signaling and Sulfur Metabolism  \n",
      "**LLM self-assessed confidence:** 0.87\n",
      "\n",
      "Fibroblast growth factor (FGF) signaling:  \n",
      "1. **FGFR1, FGFR3, FRS2, FRS3, GRB2, HRAS, NRAS, SOS1, PTPN11**: These proteins are integral to the FGF signaling pathway. FGFRs (Fibroblast Growth Factor Receptors) bind FGFs (e.g. FGF1, FGF4, FGF6, FGF8, FGF9, FGF10, FGF13, FGF17, FGF20, FGF22, FGF23), leading to receptor dimerization and activation. This stimulates downstream signaling proteins like FRS2/3, GRB2, and SOS1, which further activate RAS proteins (HRAS, NRAS) and ultimately lead to cellular responses such as differentiation, proliferation, and migration.\n",
      "\n",
      "2. FGF proteins: Various FGFs (FGF1, FGF4, FGF6, FGF8, FGF9, FGF10, FGF13, FGF17, FGF20, FGF22, FGF23) are involved in various developmental and physiological processes. These include angiogenesis, wound healing, limb and organ development, and metabolic regulation.\n",
      "\n",
      "Sulfur metabolism-related proteins:  \n",
      "1. **SQOR, MPST, ETHE1, SUOX, ADO, TSTD1, CDO1, CSAD, GOT2, TXN2**: These proteins are involved in various aspects of sulfur metabolism. For example:\n",
      "   - **SQOR (sulfide:quinone oxidoreductase)**: involved in sulfide oxidation.\n",
      "   - **MPST (3-mercaptopyruvate sulfurtransferase)**: involved in hydrogen sulfide production.\n",
      "   - **ETHE1 (ethylmalonic encephalopathy protein 1)**: regulates the catabolism of hydrogen sulfide.\n",
      "   - **SUOX (sulfite oxidase)**: critical for the conversion of sulfite to sulfate.\n",
      "   - **ADO (L-amino acid oxidase)**, **TSTD1 (thiosulfate sulfurtransferase)**, and **CDO1 (cysteine dioxygenase type 1)**: various roles in sulfur amino acid catabolism.\n",
      "   - **CSAD (cysteine sulfinic acid decarboxylase)** and **GOT2 (glutamate oxaloacetate transaminase 2)**: enzymes involved in the metabolism of sulfur-containing amino acids.\n",
      "   - **TXN2 (thioredoxin 2)**: involved in mitochondrial redox signaling and control of the antioxidant defense system.\n",
      "\n",
      "Other proteins:  \n",
      "- **SLC25A10, KL, VSIG2**: These have more niche or accessory roles. For instance, SLC25A10 is involved in dicarboxylate transport and may indirectly support metabolic processes included in sulfur and energy metabolism. KL (Klotho) can act synergistically with certain FGFs (e.g., FGF23) in phosphate and vitamin D metabolism. VSIG2 has limited direct linkage to the aforementioned processes based on the current data.\n",
      "\n",
      "In summary, the proteins within this system primarily function in FGF signaling, which is crucial for various developmental and physiological functions, as well as sulfur metabolism, which is vital for cellular redox balance and amino acid catabolism. The interaction and integration of these processes suggest a complex coordination between growth factor signaling and metabolic pathways critical for cellular function and organismal homeostasis.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████| 1/1 [00:04<00:00,  4.22s/it]\n",
      "100%|█████████████████████████████████████████████| 1/1 [00:11<00:00, 11.03s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: Transcription Regulation and Chromatin Remodeling\n",
      "LLM self-assessed confidence: 0.85\n",
      "\n",
      "1. **Core Transcription Machinery & Regulation**: Several proteins listed, such as POLR2A, POLR2B, POLR2C, POLR2D, POLR2E, POLR2F, POLR2G, POLR2H, POLR2I, POLR2J, and POLR2L are subunits of RNA polymerase II, which is crucial for the transcription of DNA into mRNA. Additionally, transcription factors and general transcription factors (e.g., GTF2H1, GTF2H2, GTF2H3, GTF2H4, GTF2H5, GTF2E1, GTF2E2, GTF2B, GTF2A1, GTF2A2, TBP, TAF1, TAF2, TAF3, TAF4, TAF5, TAF6, TAF7, TAF9, TAF10, TAF11, TAF12, TAF13, TAF15, TAF7L, TAF9B, TAF1L) indicate a significant role in the regulation of gene expression.\n",
      "\n",
      "2. **Chromatin Remodeling and Histone Modification**: Proteins such as H2AC7, H2BC13, H2AX, H1-0, H1-3, H2BC5, H2BC12L, H2AR1, H2AZ1, H2AC19, H2BC21, and H4C15 represent various histones and histone variants. Combined with chromatin remodelers like EP400 and HMGA1/2, they facilitate the remodeling of chromatin structure to regulate access to DNA.\n",
      "\n",
      "3. **Nuclear Pore Complex and Transport**: Multiple nucleoporins (e.g., NUP205, NUP133, NUP160, NUP88, NUP98, NUP153, NUP214, NUP210, NUP107, NUP37, NUP93, NUP58, NUP43, NUP42, NUP35) and other related proteins (e.g., RANGAP1, RAN, RANBP1, XPO1) indicate that the transport of molecules between the nucleus and cytoplasm is tightly regulated in this system. \n",
      "\n",
      "4. **Transcriptional Elongation and Co-activators**: Factors such as CDK9, CDK7, associated with transcription elongation, and other elements like ELONGATOR complex proteins (e.g., ELOA, ELOA2), transcription elongation factors (e.g., SUPT5H, SUPT6H, SUPT16H), contribute significantly to efficient elongation downstream of transcription initiation.\n",
      "\n",
      "5. **DNA Repair and Maintenance**: DNA repair proteins such as XRCC4, XRCC5, XRCC6, ATM, MRE11, and FEN1 suggest that DNA damage response is an intrinsic part of this regulatory network, ensuring genomic stability during transcription.\n",
      "\n",
      "6. **Protein Ubiquitination and Degradation**: Proteins like UBB, UBA52, and RNF103-CHMP3 indicate that ubiquitin-mediated proteolysis mechanisms are operational within this system to control the levels and turnover of other proteins, ensuring proper cellular regulation.\n",
      "\n",
      "In summary, this system of interacting proteins predominantly involves regulatory processes underlying transcription and chromatin remodeling. The repertoire includes essential components of the transcription machinery, chromatin dynamics, nuclear transport, transcriptional elongation, and DNA repair mechanisms, all integrated into a multifaceted regulatory apparatus within the nucleus.\n",
      "\n",
      "Given the substantial representation and coherence of the involved proteins toward these processes, the selected name represents the main functional integration of this system of proteins with a high degree of confidence.\n",
      "\n",
      "---\n",
      "\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████| 1/1 [00:04<00:00,  4.65s/it]\n",
      "100%|█████████████████████████████████████████████| 1/1 [00:08<00:00,  8.05s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: Interferon-mediated antiviral response\n",
      "LLM self-assessed confidence: 0.98\n",
      "\n",
      "This collection of proteins is prominently involved in the interferon-mediated antiviral response, which is crucial for the defense against viral infections. Interferons are cytokines that play key roles in the activation of both innate and adaptive immune responses. Several components of the system, including IFNA5, IFNA7, IFNA21, IFNA6, IFNB1, and various other IFN-α (interferon-alpha) subtypes, directly represent type I interferons, which are pivotal for initiating these responses.\n",
      "\n",
      "1. **Interferon Regulatory Factors (IRFs)**: IRF7, IRF9, IRF3, IRF1, IRF5, IRF4, IRF2, IRF6, and IRF8 are crucial transcription factors involved in the regulation of interferon genes, thus amplifying the immune response against viral pathogens. IRF3 and IRF7 are directly activated by viral infections and translocate to the nucleus, where they initiate the transcription of interferon genes.\n",
      "\n",
      "2. **Signal Transduction (TYK2, JAK1, STAT1, STAT2)**: These proteins are key elements of the interferon signaling pathway. TYK2 and JAK1 are tyrosine kinases that, upon interferon receptor engagement, phosphorylate and activate STAT1 and STAT2. The activated STAT1/STAT2 complex forms the ISGF3 complex with IRF9, which then translocates to the nucleus to activate interferon-stimulated genes (ISGs).\n",
      "\n",
      "3. **Effector Proteins (ISGs)**: The set includes a variety of interferon-stimulated genes, such as ISG15, IFIT1, IFIT2, IFIT3, IFIT5, MX1, MX2, OAS1, OAS2, OAS3, OASL, RSAD2, IFITM1, IFITM2, IFITM3, and BST2. These proteins execute antiviral actions, such as degradation of viral RNA, inhibition of viral replication and propagation, and promotion of apoptosis in infected cells.\n",
      "\n",
      "4. **Proteins Modulating Apoptosis and Cell Cycle (CDKN1A, CDKN1B, CASP9, MDM2, BAD)**: These proteins contribute to cell cycle regulation and apoptosis, ensuring that infected cells are systematically eliminated to prevent the spread of the virus. For example, CASP9 is involved in the initiation of apoptosis, while CDKN1A and CDKN1B are cyclin-dependent kinase inhibitors that induce cell cycle arrest.\n",
      "\n",
      "5. **Protein Degradation and Regulation (USP18, PSMB8, ABCE1, MKRN1, IP6K2)**: These proteins are involved in mechanisms that either degrade viral components or regulate antiviral protein activities. USP18, for instance, is a ubiquitin-specific protease that regulates the stability and activity of proteins critical for antiviral responses.\n",
      "\n",
      "6. **Histocompatibility Complex Proteins (HLA-A, HLA-B, HLA-C, etc.)**: These molecules are involved in antigen presentation, which is essential for the activation of adaptive immune responses by presenting viral peptides to T cells.\n",
      "\n",
      "The proteins in this system integrate to mount and regulate a robust antiviral defense, primarily driven through the actions of interferons and their downstream signaling pathways. This collective action results in a concerted effort to control and eliminate viral infections from the host.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████| 1/1 [00:02<00:00,  2.00s/it]\n",
      "100%|█████████████████████████████████████████████| 1/1 [00:07<00:00,  7.14s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: Proteasome-mediated protein degradation and regulatory function\n",
      "LLM self-assessed confidence: 0.99\n",
      "\n",
      "The predominant biological process performed by this system of interacting proteins is proteasome-mediated protein degradation, coupled with regulation by associated factors. The identified proteins are heavily involved in the formation and function of the proteasome complex, as well as its regulatory components. This system includes:\n",
      "\n",
      "1. **Proteasome subunits**: Multiple proteasomal proteins (e.g., PSMA1-PSMA8, PSMB1-PSMB11, PSMD1-PSMD14, PSMC1-PSMC6) make up the core 20S proteasome and the regulatory 19S complexes. These subunits constitute the machinery responsible for protein degradation, playing essential roles in maintaining protein homeostasis by degrading ubiquitinated proteins.\n",
      "\n",
      "2. **Proteasome regulators and ubiquitin-related factors**: UBA52, UBB, and UBC are involved in ubiquitin-mediated processes, tagging proteins for degradation by the proteasome. PSMF1 acts as a proteasome inhibitor, regulating the proteolytic activity of the proteasome.\n",
      "\n",
      "3. **Regulatory kinases and signaling components**: PRKCA, PRKACB, PRKACG, GSK3B, and CSNK1A1 are kinases involved in signal transduction pathways that can modulate proteasome activity and substrate specificity.\n",
      "\n",
      "4. **Cullin-Ring E3 ligase complex**: CUL1, SKP1, BTRC, and RBX1 are components of the SCF (Skp, Cullin, F-box containing complex), which is an E3 ubiquitin ligase complex that tags proteins for proteasomal degradation. \n",
      "\n",
      "5. **Transcription factor regulation and signaling**: GLI2 and SUFU are components of the Hedgehog signaling pathway. These proteins have roles signaling and transcriptional regulation and are also targeted for degradation by the proteasome, emphasizing the feedback mechanisms regulating protein levels.\n",
      "\n",
      "6. **Nicotinic acetylcholine receptors**: CHRNA3, CHRNA4, CHRNB2, CHRNB4, CHRND, CHRNE, and CHRNG, relate to synaptic communication but are also subject to regulation and degradation via proteasome pathways.\n",
      "\n",
      "The integration of these classes of proteins ensures rigorous cellular control over protein turnover, maintaining proteostasis, regulating signaling pathways, and ensuring rapid degradation of misfolded, damaged, or unneeded proteins. This highly sophisticated system underscores the importance of the proteasome and its regulatory elements in sustaining cellular health and function across various biological contexts.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████| 1/1 [00:04<00:00,  4.77s/it]\n",
      "100%|█████████████████████████████████████████████| 1/1 [00:09<00:00,  9.68s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: Mitochondrial energy metabolism and redox homeostasis\n",
      "LLM self-assessed confidence: 0.88\n",
      "\n",
      "The given set of interacting proteins appears to be predominantly involved in processes associated with mitochondrial energy metabolism and redox homeostasis. Here is a critical analysis of the biological processes performed by this system of interacting proteins:\n",
      "\n",
      "1. **Mitochondrial Oxidative Phosphorylation and Energy Production**: Several proteins in the set are crucial components of the mitochondrial oxidative phosphorylation (OXPHOS) system. The cytochrome c oxidase (COX) subunits, including COX5A, COX5B, COX6A1, COX6B1, COX6C, COX7A2L, COX7B, COX7C, COX8A, COX14, COX19, and COX20, play pivotal roles in electron transfer and the terminal step of the mitochondrial respiratory chain. These proteins are essential for ATP synthesis and energy metabolism within the mitochondria.\n",
      "\n",
      "2. **Redox Homeostasis**: Proteins such as PRDX1, PRDX2, PRDX5, GSR, and TXN2 are involved in maintaining redox homeostasis within the cell. These peroxiredoxins and glutathione reductase proteins play critical roles in detoxifying reactive oxygen species (ROS), thereby protecting the cell from oxidative damage and ensuring proper cellular function.\n",
      "\n",
      "3. **Mitophagy and Protein Quality Control**: Proteins like SESN1, SESN2, and SESN3 are involved in the regulation of mitophagy, a process essential for the degradation of damaged mitochondria and maintenance of mitochondrial quality. Additionally, proteins such as TNRC6A, TNRC6B, and TNRC6C, involved in RNA-induced silencing complexes, may have indirect roles in regulating mitochondrial gene expression and protein turnover.\n",
      "\n",
      "4. **mTOR Signaling and Autophagy**: The mTOR pathway, involving proteins such as MTOR, RPTOR, and LAMTOR complex components (LAMTOR1, LAMTOR2, LAMTOR3, LAMTOR4, LAMTOR5), plays a significant role in the regulation of cellular growth, autophagy, and energy metabolism in response to nutrient and energy status.\n",
      "\n",
      "5. **Amino Acid and Glucose Metabolism**: Proteins such as SLC38A9, which is involved in amino acid transport, and enzymes like GLS2, which is involved in glutamine metabolism, contribute to the metabolic processes linking energy production to the availability of amino acids and glucose.\n",
      "\n",
      "6. **Regulation of Apoptosis**: Some proteins, such as CYCS (cytochrome c), are key players in the intrinsic pathway of apoptosis, linking mitochondrial dysfunction to cell death pathways.\n",
      "\n",
      "The system appears to be extensively involved in coordinating mitochondrial functions with broader cellular metabolic and regulatory networks, integrating energy production, redox maintenance, nutrient sensing, and the response to cellular stress.\n",
      "\n",
      "LLM self-assessed confidence: 0.88\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████| 1/1 [00:03<00:00,  3.72s/it]\n",
      "100%|█████████████████████████████████████████████| 1/1 [00:10<00:00, 10.05s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: Cell Cycle Regulation and DNA Replication\n",
      "LLM self-assessed confidence: 0.98\n",
      "\n",
      "This system of interacting proteins predominantly involves processes linked to cell cycle regulation and DNA replication. Here's the detailed analysis:\n",
      "\n",
      "1. **Cyclins and Cyclin-Dependent Kinases (CDKs)**:\n",
      "   - **CCNA1, CCND1, CCND2, CCND3, CCNE1, CCNE2, CCNB1, CCNH, CCNG2**: These cyclins are key regulators that control the progression through different phases of the cell cycle by activating specific CDKs.\n",
      "   - **CDK1, CDK2, CDK4, CDK6, CDK7**: These CDKs work in conjunction with cyclins to advance the cell cycle through various checkpoints.\n",
      "\n",
      "2. **CDK Inhibitors**:\n",
      "   - **CDKN1A (p21), CDKN1B (p27), CDKN1C (p57), CDKN2A (p16), CDKN2B (p15), CDKN2C (p18), CDKN2D (p19)**: These proteins inhibit CDK activity, providing a crucial regulatory mechanism to halt cell cycle progression in response to cellular stress or DNA damage.\n",
      "\n",
      "3. **Transcription Factors**:\n",
      "   - **E2F1, E2F2, E2F3, TFDP1, TFDP2**: These transcription factors are essential for the transcription of genes required for DNA replication. They play a pivotal role in the G1 to S phase transition.\n",
      "   - **MYC, MYB**: These transcription factors promote the transcription of many genes involved in cell proliferation.\n",
      "\n",
      "4. **Origin Recognition Complex (ORC)**:\n",
      "   - **ORC1, ORC2, ORC3, ORC4, ORC5, ORC6**: This complex is essential for the initiation of DNA replication. It binds to origins of replication and lays the groundwork for the assembly of other components of the pre-replication complex.\n",
      "\n",
      "5. **Minichromosome Maintenance Complex (MCM)**:\n",
      "   - **MCM2, MCM3, MCM4, MCM5, MCM6, MCM7**: These proteins form the MCM complex, which functions as a helicase, unwinding DNA during replication.\n",
      "\n",
      "6. **Replication Protein A (RPA)**:\n",
      "   - **RPA1, RPA2, RPA3**: This complex stabilizes single-stranded DNA intermediates that form during replication and repair processes.\n",
      "\n",
      "7. **Polymerases and Associated Factors**:\n",
      "   - **POLE, POLE2 (Polymerase Epsilon), POLA2 (Polymerase Alpha) and PRIM1, PRIM2 (Primase)**: These proteins are critical components of the DNA synthesis machinery. POLE and POLA2 are involved in the leading and lagging strand synthesis, while PRIM1 and PRIM2 synthesize RNA primers.\n",
      "   - **PCNA**: Proliferating cell nuclear antigen acts as a processivity factor for DNA polymerase.\n",
      "\n",
      "8. **Checkpoint and Damage Response Proteins**:\n",
      "   - **TP53, ATM, MDM2, GADD45A**: These are key players in the DNA damage response, halting cell cycle progression when damage is detected and facilitating repair or apoptosis if the damage is irreparable.\n",
      "\n",
      "9. **Regulatory Kinases and Phosphatases**:\n",
      "   - **CDC25A, WEE1, MYT1**: These enzymes regulate CDK activity through phosphorylation and dephosphorylation events, thus controlling cell cycle transitions.\n",
      "\n",
      "10. **CREB Transcription Factors (CREB1, CREB3, CREB3L1, CREB3L3, CREB3L4)**: These proteins can influence the expression of genes involved in cell growth and division, with some also playing roles in the DNA damage response.\n",
      "\n",
      "This extensive network of proteins intricately manages cell proliferation through coordination of cell cycle progression and ensuring DNA is replicated accurately, emphasizing the tight regulation required to maintain cellular function and genomic integrity. Given the substantial representation of proteins related to these processes, the analysis strongly supports this interpretation.\n",
      "\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████| 1/1 [00:01<00:00,  1.99s/it]\n",
      "100%|█████████████████████████████████████████████| 1/1 [00:07<00:00,  7.34s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: Ubiquitin-Proteasome System Regulation and MAPK Signaling Pathway\n",
      "LLM self-assessed confidence: 0.85\n",
      "\n",
      "The provided protein set can be largely categorized into those involved in the Ubiquitin-Proteasome System (UPS) and those related to the Mitogen-Activated Protein Kinase (MAPK) signaling pathway.\n",
      "\n",
      "1. **Ubiquitin-Proteasome System (UPS):** \n",
      "   - **ELOB, ELOC:** These proteins are subunits of the Elongin B/C complex, which plays a role in the recognition and targeting of proteins for ubiquitination and subsequent proteasomal degradation.\n",
      "   - **RBX1:** An E3 ubiquitin ligase that forms part of the Cullin-RING ligase complexes.\n",
      "   - **CUL2:** A member of the Cullin family, which serves as a scaffold for assembling E3 ubiquitin ligase complexes.\n",
      "   - **NAE1, UBA3:** These are components of the NEDD8-activating enzyme, critical for activating Cullin proteins.\n",
      "   - **ZYG11B:** Associated with cell cycle regulation and ubiquitin-mediated processes.\n",
      "\n",
      "2. **MAPK Signaling Pathway:**\n",
      "   - **BRAF, RAF1:** Both are serine/threonine-specific protein kinases that function in the MAPK/ERK signaling pathway, which regulates cell division, differentiation, and secretion.\n",
      "   - **GRB2, SOS1:** Adaptors and exchange factors that link receptor tyrosine kinases to the Ras signaling pathway, which subsequently activates the MAPK pathway.\n",
      "   - **PTPN11:** A tyrosine phosphatase that modulates signaling downstream of cytokine receptors and affects the MAPK pathway.\n",
      "   - **NF1:** A Ras GTPase-activating protein (GAP) that negatively regulates Ras/MAPK signaling.\n",
      "  \n",
      "3. **Miscellaneous Functions:**\n",
      "   - **CBFB:** Functions as a transcription factor, potentially influencing the expression of genes implicated in the above processes.\n",
      "\n",
      "Overall, the proteins predominantly cluster around two central processes: the ubiquitination and proteasomal degradation of proteins (UPS) and the MAPK signaling pathway. These pathways intersect and influence cellular responses like growth, differentiation, and stress responses, underlining the intricate regulation of cell fate and homeostasis. The interplay of these systems may represent a coordinated network of growth signaling and protein quality control mechanisms.\n",
      "\n",
      "Given that the majority of proteins can be grouped into these two categories, the selected biological process name accurately encapsulates the system's primary functions.\n",
      "\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████| 1/1 [00:02<00:00,  2.68s/it]\n",
      "100%|█████████████████████████████████████████████| 1/1 [00:09<00:00,  9.15s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: Inflammatory Response and Detoxification Dual-Modulation System\n",
      "LLM self-assessed confidence: 0.85\n",
      "\n",
      "The proteins in this system can be grouped into two major functional clusters: inflammatory response regulators and detoxification/metabolic enzymes.\n",
      "\n",
      "1. **Inflammatory Response Regulators:**\n",
      "   - **NF-κB Pathway:** Key proteins like IKBKB, NFKBIA, RELA, NFKB1, NFKB2, and IKBKG (NEMO) play crucial roles in the NF-κB signaling pathway, which regulates the expression of pro-inflammatory genes. Regulatory proteins such as CHUK and MYD88 are also crucial upstream components that modulate this signaling cascade.\n",
      "   - **Toll-Like Receptors (TLRs):** Proteins TLR4, TLR7, and TLR8 are involved in pathogen recognition and activation of innate immune responses. These receptors recognize microbial molecules and, upon activation, signal via adapter proteins like MYD88 and IRAK1 to activate downstream signaling pathways, including NF-κB.\n",
      "   - **Cytokines and Chemokines:** IL6, TNF, IL10, IL1A, and chemokines like CXCL8, CCL3, and CCL4 are involved in mediating and regulating immune responses. They play roles in cell recruitment, inflammation amplification, and modulation of the immune response.\n",
      "   - **Transcription Factors and Kinases:** Proteins like IRF7, IRF1, and IRF5 are transcription factors that modulate the expression of interferons and other cytokines. Kinases like MAPK8, MAPK14, and MAP3K7 are part of the MAP kinase signaling pathways activated during inflammatory responses.\n",
      "\n",
      "2. **Detoxification and Metabolic Enzymes:**\n",
      "   - **Cytochrome P450 Enzymes:** CYP2C8, CYP2C19, CYP3A4, CYP2C9, and CYP1A2 are part of the cytochrome P450 family responsible for the oxidation of various substrates, including metabolic intermediates and xenobiotics, thus playing a crucial role in detoxification.\n",
      "   - **Arachidonic Acid Metabolism:** Enzymes like ALOXE3, ALOX15, and ALOX12B, associated with the metabolism of polyunsaturated fatty acids, are involved in the production of lipid mediators, which can often act as inflammatory mediators.\n",
      "   - **Anti-Oxidative Enzymes:** GPX4 (glutathione peroxidase 4) is an important enzyme in reducing lipid hydroperoxides to their corresponding alcohols, protecting cells from oxidative damage.\n",
      "\n",
      "**Interplay and Integration:**\n",
      "The inflammatory response proteins and detoxification enzymes exhibit a synergistic interplay. Inflammatory responses often lead to increased production of reactive oxygen species (ROS), necessitating the upregulation of detoxification enzymes to mitigate oxidative damage. Conversely, detoxification pathways, by alleviating oxidative stress, can influence inflammation resolution, showing a tight functional integration.\n",
      "\n",
      "In summary, this system of interacting proteins prominently features a dual modulation role, integrating inflammatory responses and detoxification/metabolic processes to maintain cellular homeostasis and protect against pathogenic insults. This interplay highlights the system's complex regulatory nature, ensuring a balanced response to external and internal stressors.\n",
      "\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████| 1/1 [00:03<00:00,  3.59s/it]\n",
      "100%|█████████████████████████████████████████████| 1/1 [00:07<00:00,  7.52s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: MAPK Signaling Pathway and Xenobiotic Metabolism Regulation\n",
      "LLM self-assessed confidence: 0.92\n",
      "\n",
      "1. **MAPK Cascade Components**: A significant subset of the proteins listed, including MAPK10, MAPK1, MAPK12, MAPK14, MAP2K6, MAP2K4, MAP2K1, MAP3K1, MAP3K2, MAP2K7, MAP2K3, MAP3K3, BRAF, RAF1, and ARAF, are components of the Mitogen-Activated Protein Kinase (MAPK) signaling pathway. This pathway is crucial for translating extracellular signals into various intracellular responses. It governs cellular processes such as proliferation, differentiation, and apoptosis. Several kinases within this pathway, like MAPKs and MAP2Ks, are tightly regulated and activated through phosphorylation cascades.\n",
      "\n",
      "2. **Regulatory Proteins and Adapters**: Proteins such as GRB2, RASA3, SOS2, SOS1, ELK1, and RRAS are involved in the regulation of the MAPK pathway. GRB2 acts as an adapter protein, transmitting signals from receptor tyrosine kinases to SOS proteins (SOS1 and SOS2), which in turn activate the RAS proteins (NRAS, HRAS, KRAS, and RRAS). These RAS proteins further propagate the signal to the downstream MAPK cascade.\n",
      "\n",
      "3. **Xenobiotic Metabolism**: CYP3A4, CYP7A1, and xenobiotic nuclear receptors like NR1I3 (CAR), NR1H4 (FXR), NR1I2 (PXR), and VDR (Vitamin D Receptor) are primarily involved in the metabolism and detoxification of foreign substances, including drugs and environmental toxins. CYP3A4 plays a critical role in drug metabolism, while NR1I3 and NR1I2 help regulate the expression of various detoxifying enzymes in response to xenobiotics.\n",
      "\n",
      "4. **Transport Proteins**: Proteins such as ABCB11, ABCC4, SLCO1B1, ABCB1, ABCC2, ABCC3, and SLC51A/SLC51B constitute a major component of the efflux transport system, crucial for the removal of xenobiotics and metabolic byproducts from cells. These transporters are particularly significant in tissues like the liver and intestines where detoxification processes occur.\n",
      "\n",
      "5. **Other Metabolic Enzymes**: BAAT and SULT2A1 are involved in bile acid conjugation and sulfate conjugation, respectively, further pointing towards roles in detoxification and metabolic regulation.\n",
      "\n",
      "To summarize, the primary functional integration within this system centers around the MAPK signaling pathway, which governs essential cellular processes, and the regulation of xenobiotic metabolism, which includes both the biochemical modification and transport of foreign substances. These proteins work synergistically to ensure cellular homeostasis in response to various internal and external stimuli.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████| 1/1 [00:05<00:00,  5.50s/it]\n",
      "100%|█████████████████████████████████████████████| 1/1 [00:10<00:00, 10.78s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: Modulation of Cellular Responses to External Stimuli via Signaling Pathways\n",
      "LLM self-assessed confidence: 0.92\n",
      "\n",
      "The given system of interacting proteins predominantly involves key players in various signaling pathways, contributing to the modulation of cellular responses to external stimuli.\n",
      "\n",
      "1. **MAPK Cascade (MAPK1, MAPK3, MAPK8, MAPK9, MAPK10, MAPK11, MAPK12, MAPK13, MAPK14, MAP2K1, MAP2K2, MAP2K3, MAP2K4, MAP2K6, MAP2K7, MAP3K1, MAP3K7):** These proteins are primarily involved in the MAPK signaling pathway, which relays extracellular signals to the cellular machinery, affecting various cellular activities such as gene expression, mitosis, differentiation, and cell survival/apoptosis.\n",
      "\n",
      "2. **TGF-beta Signaling (TGFBR1, TGFBR2, TGFB1, TGFB2, TGFB3, SMAD2, SMAD3, SMAD4, EP300):** This pathway is crucial for the regulation of cell growth, differentiation, and embryonic development. SMAD proteins transduce extracellular TGF-beta signals to the nucleus where they activate the transcription of target genes.\n",
      "\n",
      "3. **Immune Response Modulation (TLR2, TLR3, TLR4, TIRAP, MYD88, IRF3, IRF7, MAVS, TRAF6, IRAK1, IRAK4, IKBKB, IKBKG, NFKB1, RELA):** Toll-like receptors (TLRs) and adaptor molecules like MYD88 and IRFs play significant roles in recognizing pathogens and initiating innate immune responses. Downstream signaling activates NF-κB, leading to the transcription of genes involved in immune response.\n",
      "\n",
      "4. **Apoptosis and Cell Survival (CASP3, CASP8, CASP9, CYCS, FAS, FADD, BID, BCL2, BAX, APAF1, IKBKB, IKBKG):** These proteins are intrinsic components of the apoptotic machinery and are crucial in regulating programmed cell death, ensuring proper cellular turnover and tissue homeostasis.\n",
      "\n",
      "5. **PI3K/AKT Signaling (PIK3CA, PIK3CB, PIK3CD, PIK3R1, PIK3R2, PIK3R3, AKT1, AKT2, AKT3):** This pathway is essential for controlling cell growth and metabolism. PI3K activation leads to AKT phosphorylation, which subsequently influences various pathways important for survival, proliferation, and metabolism.\n",
      "\n",
      "6. **Interferon Response (IFNA1, IFNA2, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA21, IFNB1, IFNAR1, TYK2, JAK1, JAK2, JAK3, STAT1, STAT2, STAT3, STAT4, STAT5A, STAT5B, STAT6):** The interferon signaling pathway plays a vital role in the defense against viral infections. Interferon-stimulated genes are activated through the JAK-STAT pathway, leading to antiviral responses.\n",
      "\n",
      "This network of proteins demonstrates extensive integration across multiple signaling pathways, showing a cohesive modulatory effect on cellular processes in response to external stimuli, including stress, pathogens, and growth factors.\n",
      "\n",
      "The significant involvement of proteins in these connected pathways and their directed effects on cellular responses form the basis of the proposed name and confidence level.\n",
      "\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████| 1/1 [00:03<00:00,  3.62s/it]\n",
      "100%|█████████████████████████████████████████████| 1/1 [00:06<00:00,  6.01s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: Inflammatory Response and Apoptosis Regulation\n",
      "LLM self-assessed confidence: 0.92\n",
      "\n",
      "This protein interaction network indicates significant involvement in inflammatory response and apoptosis regulation. The analysis reveals a multifaceted interplay between several key processes:\n",
      "\n",
      "1. Inflammation Mediators:\n",
      "- The complement system proteins, including C1QA, C1QB, C1QC, C1R, C1S, C2, C5, and C4B, are essential for the activation of the classical pathway of complement activation, promoting phagocytosis and cell lysis.\n",
      "- TNF and TNFRSF1B (TNF receptor) are crucial in the induction of inflammation, typically activating signaling pathways that lead to the expression of inflammatory cytokines.\n",
      "- TRAF proteins (TRAF1, TRAF2, TRAF3, TRAF6) play vital roles in the signal transduction pathways that mediate inflammation and immunity, often via the activation of NF-κB, a key transcription factor in the inflammatory response.\n",
      "\n",
      "2. Apoptosis Regulation:\n",
      "- The extrinsic and intrinsic pathways of apoptosis are represented by proteins such as CASP3, CASP9, APAF1, BCL2, and BAK1, which are critical in either initiating or executing apoptotic processes.\n",
      "- These apoptotic pathways can be influenced by TNF signaling, linking inflammation and cell death.\n",
      "\n",
      "3. Stress and Cellular Response:\n",
      "- Proteins like GADD45A, NFKBIE, and MAPK signaling proteins (MAP2K4, MAP3K1, MAP3K9, MAPK10, MAPK13) integrate signals from a variety of stress stimuli, such as DNA damage (monitored by proteins like PCNA) and oxidative stress, often leading to transcriptional and post-transcriptional modifications that control cell fate decisions.\n",
      "- CDC42, a small GTPase, and its associated signaling pathways also contribute to the regulation of cell cycle and apoptosis.\n",
      "\n",
      "4. Muscle Contraction and Calcium Handling:\n",
      "- Proteins involved in muscle contraction and calcium handling (RYR1, CASQ1, ATP2A1, TNNC2) could relate to cellular stress responses and mitochondrial pathways affecting apoptosis and immune response via interplay with Ca2+-dependent mechanisms.\n",
      "\n",
      "The comprehensive involvement of these proteins highlights a significant crosstalk between the inflammatory response and the regulation of apoptosis, underlined by their shared pathways and mutual regulatory mechanisms.\n",
      "\n",
      "LLM self-assessed confidence: 0.92\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████| 1/1 [00:05<00:00,  5.14s/it]\n",
      "100%|█████████████████████████████████████████████| 1/1 [00:06<00:00,  6.76s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: Signal Transduction and Cell Proliferation Regulation\n",
      "LLM self-assessed confidence: 0.89\n",
      "\n",
      "1. The proteins in this system prominently contribute to signal transduction pathways, particularly those governing cell proliferation, survival, and differentiation. For instance, proteins like AKT1, MAPK1, and MAPK3 are critical components of the PI3K/AKT and MAPK signaling pathways, which regulate cell growth and proliferation.\n",
      "\n",
      "2. Several proteins in this set are involved in cytokine and growth factor signaling pathways. For example, JAK1, JAK2, and STAT family members (STAT3, STAT5A, STAT5B) are key players in the JAK/STAT signaling pathway, which is crucial for mediating responses to cytokines such as interleukins IL3 and IL5RA. \n",
      "\n",
      "3. Proteins such as GAB1, GAB2, SRC, and the PI3K components (PIK3CA, PIK3R1, PIK3R2, PIK3CD) function in bridging receptor tyrosine kinase signals from the cell surface to downstream signaling pathways. This includes signals from growth factors like HGF (via MET), further emphasizing the system's role in cell growth and proliferation.\n",
      "\n",
      "4. The interaction network also includes proteins involved in integrin signaling, such as ITGB1 (integrin beta-1), which facilitate cell-extracellular matrix interactions and influence cell motility, survival, and differentiation.\n",
      "\n",
      "5. Negative regulators and feedback mechanisms are also present, such as PTEN, which antagonizes PI3K signaling, and proteins involved in dephosphorylation events like PTPN1 and PTPN11, which ensure the termination of signaling events to maintain cellular homeostasis.\n",
      "\n",
      "6. Additional modulators like SOS1, RAP1A, and RAP1B emphasize the fine-tuned regulation of the Ras signaling pathway, critical for controlling cell dynamics and differentiation.\n",
      "\n",
      "This integrated network underscores the coordinated regulation of signal transduction pathways that facilitate cellular responses to environmental cues, ultimately controlling cell proliferation, differentiation, and survival.\n",
      "\n",
      "In summary, the system's proteins synergistically interact to modulate signal transduction and regulate cellular processes essential for growth and proliferation, with a substantial focus on pathways like PI3K/AKT, MAPK, JAK/STAT, and integrin signaling.\n",
      "\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████| 1/1 [00:05<00:00,  5.87s/it]\n",
      "100%|█████████████████████████████████████████████| 1/1 [00:09<00:00,  9.56s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: Apoptotic signaling and regulation\n",
      "LLM self-assessed confidence: 0.93\n",
      "\n",
      "1. Apoptosis, or programmed cell death, is a tightly regulated process involving a specific set of proteins. Central players in this process include caspases (e.g., CASP1, CASP2, CASP3, CASP4, CASP6, CASP7, CASP8, CASP9, CASP10), which are protease enzymes that execute the death program by cleaving specific cellular substrates.\n",
      "\n",
      "2. Death receptors (e.g., TNFRSF10A, TNFRSF10B, TNFRSF10C, TNFRSF10D, TNFRSF1A, TNFRSF1B, TNFRSF25, TNFRSF11B, FAS, TNFRSF6B) initiate the extrinsic pathway of apoptosis. Ligands such as TNF and FASLG bind to these receptors, leading to downstream signaling involving adapter proteins like FADD and TRADD.\n",
      "\n",
      "3. Intrinsic apoptosis is regulated by mitochondrial signals, involving BCL2 family proteins (e.g., BCL2, BCL2L1, BCL2L10, BCL2L11, BCL2L2, BCL2A1, MCL1, BOK, BAX, BAK1, BCL2L2) and apoptotic protease activating factor 1 (APAF1). The balance between pro-apoptotic (e.g., BAX, BAK1) and anti-apoptotic (e.g., BCL2, BCL2L1) members of this family dictates cellular fate.\n",
      "\n",
      "4. Proteins like DIABLO, AIFM1, AIFM2, and ENDOG further facilitate mitochondrial-derived apoptotic signals, leading to the release of cytochrome c (CYCS). Subsequently, CYCS activates APAF1, which forms the apoptosome, a crucial complex for activating initiator caspases such as CASP9.\n",
      "\n",
      "5. Inhibitors of apoptosis proteins (IAPs) like BIRC2, BIRC3, BIRC5, and XIAP function to inhibit caspase activity, thus regulating apoptosis. Proteins like SMAC/DIABLO antagonize IAPs, thereby promoting apoptosis.\n",
      "\n",
      "6. Cell death regulation also involves numerous signaling pathways. For instance, NF-κB (e.g., NFKB1, NFKBIA, IKBKB) and MAPK (e.g., MAPK3, MAPK8, MAPK14) pathways can modulate apoptosis through transcriptional regulation of apoptotic genes.\n",
      "\n",
      "7. Other regulators and modulators include DAXX, TP53, CFLAR, and interacting proteins like TRAF6 and MYD88, which integrate various apoptotic signals.\n",
      "\n",
      "To summarize, the set of proteins shows a robust involvement in the orchestration, modulation, and execution of apoptotic signaling, regulating both intrinsic and extrinsic pathways. The integration of multiple signaling cascades ensures precise control of cell survival and death, reflecting a complex but coherent system aimed at apoptosis regulation. \n",
      "\n",
      "LLM self-assessed confidence: 0.93\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████| 1/1 [00:03<00:00,  3.62s/it]\n",
      "100%|█████████████████████████████████████████████| 1/1 [00:09<00:00,  9.94s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: Lipid and Carbohydrate Metabolism\n",
      "LLM self-assessed confidence: 0.82\n",
      "\n",
      "The system of interacting proteins presented above predominantly involves enzymes, transporters, and other proteins that play critical roles in lipid and carbohydrate metabolism. \n",
      "\n",
      "1. **Lipid Metabolism:** \n",
      "   - **ACOT enzymes (ACOT1, ACOT2, ACOT4, ACOT6, ACOT7, ACOT8, ACOT9, ACOT11, ACOT12, ACOT13)**: These are acyl-CoA thioesterases that regulate the levels of acyl-CoA and free fatty acids, essential for lipid metabolism and signal transduction.\n",
      "   - **SCP2, THEM5, AMACR, ACOX2**: Involved in the peroxisomal beta-oxidation of fatty acids, which is crucial for lipid homeostasis and energy production.\n",
      "   - **NPC1, NPC2**: Involved in intracellular cholesterol trafficking and homeostasis. NPC1 and NPC2 mutations can result in Niemann-Pick disease.\n",
      "   - **CYP27A1, DHCR7, EBP**: Play roles in cholesterol biosynthesis and metabolism. CYP27A1 is part of the bile acid synthesis pathway, while DHCR7 and EBP are involved in cholesterol's final biosynthetic steps.\n",
      "\n",
      "2. **Carbohydrate Metabolism:**\n",
      "   - **Glycolytic Enzymes (HK1, LDHA, LDHB)**: Critically involved in glycolysis, the pathway that breaks down glucose to produce energy. \n",
      "   - **Hexose Transporters (SLC2A1, SLC2A3)**: Facilitative glucose transporters important for cellular glucose uptake. SLC2A1 (GLUT1) is widely expressed and crucial for basal glucose uptake, while SLC2A3 (GLUT3) has a high affinity for glucose and is important in neurons.\n",
      "   - **HSD11B1, HSD11B2**: These are involved in the interconversion of active and inactive glucocorticoids and influence glucose metabolism indirectly through their effects on cortisol.\n",
      "   - **NUDT14**: Involved in the metabolism of sugar nucleotides, which are important for glycosylation processes and glycogen metabolism.\n",
      "\n",
      "3. **Transporters and Other Metabolic Enzymes:**\n",
      "   - **SLC1A2, SLC27A2, SLC27A5, SLC16A1, SLC16A3, SLC16A7, SLC4A4**: These transporters play various roles in transporting amino acids, fatty acids, lactate, and bicarbonate, which are crucial for maintaining metabolic homeostasis.\n",
      "   - **CA2, CA4**: Carbonic anhydrases crucial for maintaining pH balance in tissues and influencing metabolic processes.\n",
      "   - **BAAT (Bile acid-CoA:amino acid N-acyltransferase)**: Involved in bile acid conjugation, which is important for lipid digestion and absorption.\n",
      "\n",
      "In summary, the proteins in this set are significantly implicated in both lipid and carbohydrate metabolism. The enzymes and transporters work together to maintain energy production, storage, and homeostasis, ensuring proper metabolic functions within the cell. They interact synergistically to support anabolic and catabolic processes essential for cellular physiology.\n",
      "\n",
      " \n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████| 1/1 [00:04<00:00,  4.89s/it]\n",
      "100%|█████████████████████████████████████████████| 1/1 [00:09<00:00,  9.32s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: Regulation of Hormone Receptors and Xenobiotic Metabolism in Reproductive Health\n",
      "LLM self-assessed confidence: 0.87\n",
      "\n",
      "1. **Regulation of Hormone Receptors**:\n",
      "   - **NR5A1** and **NRIP1** are nuclear receptors involved in the regulation of gene transcription pertinent to reproductive health and steroidogenesis.\n",
      "   - **FSHR**, **LHCGR**, **PRLR**, and **ESR2** are hormone receptors crucial for ovarian function, folliculogenesis, and gonadal development. **PGR** (progesterone receptor) participates in regulating the female reproductive system as well.\n",
      "   - **GJA4** (gap junction alpha-4 protein) and **SYNE2** contribute to cellular communication vital for coordinated ovarian function.\n",
      "\n",
      "2. **Xenobiotic Metabolism**:\n",
      "   - **ABCB1**, **ABCC2**, **ABCC3**, and **SLCO1B1** are transmembrane transport proteins involved in the efflux and uptake of xenobiotics and metabolites across cellular membranes.\n",
      "   - **CYP3A4**, **CYP2C8**, **CYP2D6**, and **CYP19A1** are cytochrome P450 enzymes essential in the metabolism of xenobiotics and endogenous hormones such as estrogens.\n",
      "   - **UGT1A1**, **UGT1A6**, **UGT1A8**, **UGT1A9**, **UGT1A10**, **UGT2B4**, and **UGT2B7** are UDP-glucuronosyltransferases that facilitate glucuronidation reactions, critical for drug metabolism and hormone conjugation.\n",
      "\n",
      "3. **DNA Damage and Repair**:\n",
      "   - **RAD51**, **MSH5**, **ATM**, **MLH1**, and **DMC1** are essential components involved in DNA damage recognition and repair mechanisms particularly during meiosis.\n",
      "\n",
      "4. **Cell Cycle Regulation and Signaling**:\n",
      "   - **CDK4**, **CCND2**, **CDKN1B**, and **AKT1** are integral to cell cycle progression, mitogen-activated signaling pathways, and apoptosis regulation.\n",
      "   - **MTOR** is central to cell growth, proliferation, and survival.\n",
      "\n",
      "5. **Transcription Factors**:\n",
      "   - **TBP** (TATA-binding protein) and **CREB1** (cAMP response element-binding protein 1) play significant roles in transcription regulation.\n",
      "   - **EGR1** functions as a transcriptional regulator, responding to hormonal stimuli.\n",
      "\n",
      "6. **Gamete Interaction and Development**:\n",
      "   - **ZP2** and **ZP3** are zona pellucida glycoproteins critical for sperm binding and fertilization.\n",
      "   - **GDF9**, **DAZL**, and **INHA** are involved in folliculogenesis and gametogenesis.\n",
      "\n",
      "In summary, the proteins in this system are critically involved in regulating hormone receptors important for reproductive health and the metabolic processing of xenobiotics. Additionally, these proteins also play roles in DNA repair, cell cycle regulation, and transcriptional control, which further underscores the complex interplay necessary for maintaining reproductive and cellular health. The substantial proportion of proteins involved in these prominent processes justifies the selected name and confidence score.\n",
      "\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    }
   ],
   "source": [
    "model = \"gpt-4o-2024-05-13\"\n",
    "\n",
    "df_output=pd.DataFrame()\n",
    "\n",
    "for lib_name in lib_names:\n",
    "    with open(\"libs_human/\" + model + \"/\" + lib_name + \".json\") as f:\n",
    "        gen_res = json.load(f)\n",
    "        descr_cleaned = gen_res['descr_cleaned']\n",
    "        curated_genesets = gen_res[\"curated_genesets\"]\n",
    "        lib_size = len(descr_cleaned)\n",
    "\n",
    "        for i in range(10):\n",
    "            # randomly choose 2 gene sets from library\n",
    "            rand_choices = random.sample(range(lib_size), 2)\n",
    "            gt_name = [descr_cleaned[rand_choices[0]], descr_cleaned[rand_choices[1]]]\n",
    "            # combine and shuffle the genes from 2 gene sets\n",
    "            genes = [curated_genesets[rand_choices[0]], curated_genesets[rand_choices[1]]]\n",
    "            genes_combine = set()\n",
    "            for g in genes:\n",
    "                genes_combine.update(set(g))  \n",
    "            genes_combine = list(genes_combine)\n",
    "            random.shuffle(genes_combine)\n",
    "            genes_queries = [[\", \".join(genes_combine)]]\n",
    "            \n",
    "            # use llm2geneset to generate high confidence gene set names\n",
    "            llm2geneset_res = await llm2geneset.get_pathways_from_genes(aclient, \n",
    "                                                                        genes_queries, \n",
    "                                                                        model=\"gpt-4o\", \n",
    "                                                                        n_retry=3, \n",
    "                                                                        use_sysmsg=False)\n",
    "            llm2geneset_names = np.array(llm2geneset_res[0]['parsed_pathways'])[np.array(llm2geneset_res[0]['conf'])=='high']\n",
    "    \n",
    "            # use GSAI to generate geneset name\n",
    "            gsai_res = await llm2geneset.gsai(aclient, genes_queries, model=\"gpt-4o\", n_retry=1)\n",
    "            gsai_name = gsai_res[0]['name']\n",
    "    \n",
    "            gsai_scores=[]\n",
    "            llm2geneset_scores=[]\n",
    "\n",
    "            for ref in gt_name:\n",
    "                gsai_scores.append(scorer.score(ref, gsai_name)['rouge1'].fmeasure)\n",
    "                scores = []\n",
    "                for pred in llm2geneset_names:\n",
    "                    scores.append(scorer.score(ref, pred)['rouge1'].fmeasure)\n",
    "                llm2geneset_scores.append(np.max(scores))\n",
    "\n",
    "            output={\"library\":[lib_name],\n",
    "                    \"gt_name_1\":[gt_name[0]],\n",
    "                    \"gt_name_2\":[gt_name[1]],\n",
    "                    \"gsai_ROUGE1_1\":[gsai_scores[0]],\n",
    "                    \"gsai_ROUGE1_2\":[gsai_scores[1]],\n",
    "                    \"llm2geneset_ROUGE1_1\":[llm2geneset_scores[0]],\n",
    "                    \"llm2geneset_ROUGE1_2\":[llm2geneset_scores[1]]} \n",
    "            df_output = pd.concat([df_output, pd.DataFrame(output)], ignore_index=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "8b5a9780-806c-480f-abc6-3b3323eedcaa",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>library</th>\n",
       "      <th>gt_name_1</th>\n",
       "      <th>gt_name_2</th>\n",
       "      <th>gsai_ROUGE1_1</th>\n",
       "      <th>gsai_ROUGE1_2</th>\n",
       "      <th>llm2geneset_ROUGE1_1</th>\n",
       "      <th>llm2geneset_ROUGE1_2</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>KEGG_2021_Human</td>\n",
       "      <td>Basal transcription factors</td>\n",
       "      <td>Relaxin signaling pathway</td>\n",
       "      <td>0.250000</td>\n",
       "      <td>0.250000</td>\n",
       "      <td>0.400000</td>\n",
       "      <td>0.666667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>KEGG_2021_Human</td>\n",
       "      <td>Non-small cell lung cancer</td>\n",
       "      <td>Ascorbate and aldarate metabolism</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.363636</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>KEGG_2021_Human</td>\n",
       "      <td>Primary immunodeficiency</td>\n",
       "      <td>Salivary secretion</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>KEGG_2021_Human</td>\n",
       "      <td>Viral myocarditis</td>\n",
       "      <td>PD-L1 expression and PD-1 checkpoint pathway i...</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.125000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.153846</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>KEGG_2021_Human</td>\n",
       "      <td>Chronic myeloid leukemia</td>\n",
       "      <td>Pentose and glucuronate interconversions</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.133333</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>KEGG_2021_Human</td>\n",
       "      <td>Huntington disease</td>\n",
       "      <td>Olfactory transduction</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.500000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.400000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>KEGG_2021_Human</td>\n",
       "      <td>Maturity onset diabetes of the young</td>\n",
       "      <td>Caffeine metabolism</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.181818</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>KEGG_2021_Human</td>\n",
       "      <td>Various types of N-glycan biosynthesis</td>\n",
       "      <td>Base excision repair</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.222222</td>\n",
       "      <td>0.666667</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>KEGG_2021_Human</td>\n",
       "      <td>Glioma</td>\n",
       "      <td>Gastric cancer</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>KEGG_2021_Human</td>\n",
       "      <td>Bacterial invasion of epithelial cells</td>\n",
       "      <td>Cytokine-cytokine receptor interaction</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.222222</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.222222</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>Reactome_2022</td>\n",
       "      <td>Unwinding Of DNA</td>\n",
       "      <td>Interleukin-17 Signaling</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.400000</td>\n",
       "      <td>0.400000</td>\n",
       "      <td>0.571429</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Reactome_2022</td>\n",
       "      <td>Sema3A PAK Dependent Axon Repulsion</td>\n",
       "      <td>Sealing Of Nuclear Envelope (NE) By ESCRT-III</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>Reactome_2022</td>\n",
       "      <td>Receptor Mediated Mitophagy</td>\n",
       "      <td>Sensory Perception Of Salty Taste</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>Reactome_2022</td>\n",
       "      <td>Formation Of Editosome</td>\n",
       "      <td>Signaling By NOTCH1</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.222222</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.333333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>Reactome_2022</td>\n",
       "      <td>Transport Of Nucleotide Sugars</td>\n",
       "      <td>GAB1 Signalosome</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>Reactome_2022</td>\n",
       "      <td>FRS-mediated FGFR1 Signaling</td>\n",
       "      <td>Degradation Of Cysteine And Homocysteine</td>\n",
       "      <td>0.181818</td>\n",
       "      <td>0.166667</td>\n",
       "      <td>0.285714</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>Reactome_2022</td>\n",
       "      <td>HIV Life Cycle</td>\n",
       "      <td>DNA Damage/Telomere Stress Induced Senescence</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.333333</td>\n",
       "      <td>0.250000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>Reactome_2022</td>\n",
       "      <td>Interferon Alpha/Beta Signaling</td>\n",
       "      <td>AKT Phosphorylates Targets In Cytosol</td>\n",
       "      <td>0.250000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.666667</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>Reactome_2022</td>\n",
       "      <td>Degradation Of GLI2 By Proteasome</td>\n",
       "      <td>Highly Sodium Permeable Postsynaptic Acetylcho...</td>\n",
       "      <td>0.333333</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.222222</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>Reactome_2022</td>\n",
       "      <td>TP53 Regulates Metabolic Genes</td>\n",
       "      <td>Synthesis Of PIPs At Early Endosome Membrane</td>\n",
       "      <td>0.200000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>WikiPathway_2023_Human</td>\n",
       "      <td>EV Release From Cardiac Cells And Their Functi...</td>\n",
       "      <td>G1 To S Cell Cycle Control</td>\n",
       "      <td>0.266667</td>\n",
       "      <td>0.333333</td>\n",
       "      <td>0.181818</td>\n",
       "      <td>0.615385</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>WikiPathway_2023_Human</td>\n",
       "      <td>Pilocytic Astrocytoma</td>\n",
       "      <td>Hijack Of Ubiquitination By SARS CoV 2</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.133333</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.200000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>WikiPathway_2023_Human</td>\n",
       "      <td>Octadecanoid Formation From Linoleic Acid</td>\n",
       "      <td>miRNA Role In Immune Response In Sepsis</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.142857</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.444444</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>WikiPathway_2023_Human</td>\n",
       "      <td>MAPK Cascade</td>\n",
       "      <td>Drug Induction Of Bile Acid Pathway</td>\n",
       "      <td>0.222222</td>\n",
       "      <td>0.153846</td>\n",
       "      <td>0.400000</td>\n",
       "      <td>0.222222</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>WikiPathway_2023_Human</td>\n",
       "      <td>Hepatitis B Infection</td>\n",
       "      <td>Metabolic Pathways Of Fibroblasts</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.285714</td>\n",
       "      <td>0.250000</td>\n",
       "      <td>0.285714</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>WikiPathway_2023_Human</td>\n",
       "      <td>Oxidative Damage Response</td>\n",
       "      <td>Abnormal Calcium Handling And Its Effects On M...</td>\n",
       "      <td>0.250000</td>\n",
       "      <td>0.125000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.133333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>WikiPathway_2023_Human</td>\n",
       "      <td>Hepatocyte Growth Factor Receptor Signaling</td>\n",
       "      <td>IL 3 Signaling Pathway</td>\n",
       "      <td>0.181818</td>\n",
       "      <td>0.200000</td>\n",
       "      <td>0.250000</td>\n",
       "      <td>0.571429</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>WikiPathway_2023_Human</td>\n",
       "      <td>Monoamine Transport</td>\n",
       "      <td>Apoptosis Modulation And Signaling</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.500000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.400000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>WikiPathway_2023_Human</td>\n",
       "      <td>Lactate Shuttle In Glial Cells</td>\n",
       "      <td>7 Oxo C And 7 Beta HC Pathways</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.166667</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.166667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>WikiPathway_2023_Human</td>\n",
       "      <td>Ovarian Infertility</td>\n",
       "      <td>Codeine And Morphine Metabolism</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.285714</td>\n",
       "      <td>0.400000</td>\n",
       "      <td>0.285714</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                   library                                          gt_name_1  \\\n",
       "0          KEGG_2021_Human                        Basal transcription factors   \n",
       "1          KEGG_2021_Human                         Non-small cell lung cancer   \n",
       "2          KEGG_2021_Human                           Primary immunodeficiency   \n",
       "3          KEGG_2021_Human                                  Viral myocarditis   \n",
       "4          KEGG_2021_Human                           Chronic myeloid leukemia   \n",
       "5          KEGG_2021_Human                                 Huntington disease   \n",
       "6          KEGG_2021_Human               Maturity onset diabetes of the young   \n",
       "7          KEGG_2021_Human             Various types of N-glycan biosynthesis   \n",
       "8          KEGG_2021_Human                                             Glioma   \n",
       "9          KEGG_2021_Human             Bacterial invasion of epithelial cells   \n",
       "10           Reactome_2022                                   Unwinding Of DNA   \n",
       "11           Reactome_2022                Sema3A PAK Dependent Axon Repulsion   \n",
       "12           Reactome_2022                        Receptor Mediated Mitophagy   \n",
       "13           Reactome_2022                             Formation Of Editosome   \n",
       "14           Reactome_2022                     Transport Of Nucleotide Sugars   \n",
       "15           Reactome_2022                       FRS-mediated FGFR1 Signaling   \n",
       "16           Reactome_2022                                     HIV Life Cycle   \n",
       "17           Reactome_2022                    Interferon Alpha/Beta Signaling   \n",
       "18           Reactome_2022                  Degradation Of GLI2 By Proteasome   \n",
       "19           Reactome_2022                     TP53 Regulates Metabolic Genes   \n",
       "20  WikiPathway_2023_Human  EV Release From Cardiac Cells And Their Functi...   \n",
       "21  WikiPathway_2023_Human                              Pilocytic Astrocytoma   \n",
       "22  WikiPathway_2023_Human          Octadecanoid Formation From Linoleic Acid   \n",
       "23  WikiPathway_2023_Human                                       MAPK Cascade   \n",
       "24  WikiPathway_2023_Human                              Hepatitis B Infection   \n",
       "25  WikiPathway_2023_Human                          Oxidative Damage Response   \n",
       "26  WikiPathway_2023_Human        Hepatocyte Growth Factor Receptor Signaling   \n",
       "27  WikiPathway_2023_Human                                Monoamine Transport   \n",
       "28  WikiPathway_2023_Human                     Lactate Shuttle In Glial Cells   \n",
       "29  WikiPathway_2023_Human                                Ovarian Infertility   \n",
       "\n",
       "                                            gt_name_2  gsai_ROUGE1_1  \\\n",
       "0                           Relaxin signaling pathway       0.250000   \n",
       "1                   Ascorbate and aldarate metabolism       0.000000   \n",
       "2                                  Salivary secretion       0.000000   \n",
       "3   PD-L1 expression and PD-1 checkpoint pathway i...       0.000000   \n",
       "4            Pentose and glucuronate interconversions       0.000000   \n",
       "5                              Olfactory transduction       0.000000   \n",
       "6                                 Caffeine metabolism       0.000000   \n",
       "7                                Base excision repair       0.000000   \n",
       "8                                      Gastric cancer       0.000000   \n",
       "9              Cytokine-cytokine receptor interaction       0.000000   \n",
       "10                           Interleukin-17 Signaling       0.000000   \n",
       "11      Sealing Of Nuclear Envelope (NE) By ESCRT-III       0.000000   \n",
       "12                  Sensory Perception Of Salty Taste       0.000000   \n",
       "13                                Signaling By NOTCH1       0.000000   \n",
       "14                                   GAB1 Signalosome       0.000000   \n",
       "15           Degradation Of Cysteine And Homocysteine       0.181818   \n",
       "16      DNA Damage/Telomere Stress Induced Senescence       0.000000   \n",
       "17              AKT Phosphorylates Targets In Cytosol       0.250000   \n",
       "18  Highly Sodium Permeable Postsynaptic Acetylcho...       0.333333   \n",
       "19       Synthesis Of PIPs At Early Endosome Membrane       0.200000   \n",
       "20                         G1 To S Cell Cycle Control       0.266667   \n",
       "21             Hijack Of Ubiquitination By SARS CoV 2       0.000000   \n",
       "22            miRNA Role In Immune Response In Sepsis       0.000000   \n",
       "23                Drug Induction Of Bile Acid Pathway       0.222222   \n",
       "24                  Metabolic Pathways Of Fibroblasts       0.000000   \n",
       "25  Abnormal Calcium Handling And Its Effects On M...       0.250000   \n",
       "26                             IL 3 Signaling Pathway       0.181818   \n",
       "27                 Apoptosis Modulation And Signaling       0.000000   \n",
       "28                     7 Oxo C And 7 Beta HC Pathways       0.000000   \n",
       "29                    Codeine And Morphine Metabolism       0.000000   \n",
       "\n",
       "    gsai_ROUGE1_2  llm2geneset_ROUGE1_1  llm2geneset_ROUGE1_2  \n",
       "0        0.250000              0.400000              0.666667  \n",
       "1        0.363636              0.000000              0.000000  \n",
       "2        0.000000              0.000000              1.000000  \n",
       "3        0.125000              0.000000              0.153846  \n",
       "4        0.133333              0.000000              0.000000  \n",
       "5        0.500000              0.000000              0.400000  \n",
       "6        0.000000              0.181818              0.000000  \n",
       "7        0.222222              0.666667              1.000000  \n",
       "8        0.000000              0.000000              0.000000  \n",
       "9        0.222222              0.000000              0.222222  \n",
       "10       0.400000              0.400000              0.571429  \n",
       "11       0.000000              0.000000              0.000000  \n",
       "12       0.000000              0.000000              0.000000  \n",
       "13       0.222222              0.000000              0.333333  \n",
       "14       0.000000              0.000000              0.000000  \n",
       "15       0.166667              0.285714              0.000000  \n",
       "16       0.000000              0.333333              0.250000  \n",
       "17       0.000000              0.666667              0.000000  \n",
       "18       0.000000              0.222222              0.000000  \n",
       "19       0.000000              0.000000              0.000000  \n",
       "20       0.333333              0.181818              0.615385  \n",
       "21       0.133333              0.000000              0.200000  \n",
       "22       0.142857              0.000000              0.444444  \n",
       "23       0.153846              0.400000              0.222222  \n",
       "24       0.285714              0.250000              0.285714  \n",
       "25       0.125000              0.000000              0.133333  \n",
       "26       0.200000              0.250000              0.571429  \n",
       "27       0.500000              0.000000              0.400000  \n",
       "28       0.166667              0.000000              0.166667  \n",
       "29       0.285714              0.400000              0.285714  "
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_output"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "3a802309-2a7e-49db-bbcb-36825c09dcfa",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_output.to_csv('rouge_scores.tsv', sep=\"\\t\", index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "72c4d2a6-b040-4dda-a60c-0e641179227a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['library', 'gt_name_1', 'gt_name_2', 'gsai_ROUGE1_1', 'gsai_ROUGE1_2',\n",
       "       'llm2geneset_ROUGE1_1', 'llm2geneset_ROUGE1_2'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_output.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "8988107c-34bd-4edf-9825-57d4d0ef3625",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import seaborn as sns\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "\n",
    "# Reshape the DataFrame to long format\n",
    "df_long = pd.melt(df_output, id_vars=['gt_name_1'], value_vars=['gsai_ROUGE1_1', 'llm2geneset_ROUGE1_1'],\n",
    "                  var_name='Metric', value_name='Score')\n",
    "\n",
    "# Create the violin plot\n",
    "plt.figure(figsize=(10, 6))\n",
    "sns.violinplot(x='Metric', y='Score', data=df_long)\n",
    "plt.title('Violin Plot of GSAI_ROUGE1_1 and llm2geneset_ROUGE1_1 Scores')\n",
    "plt.xlabel('Metric')\n",
    "plt.ylabel('Score')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "aca34ee7-6f50-4372-963c-5a456e18c8d7",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAA1oAAAIhCAYAAABXMMsoAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjkuMSwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy/TGe4hAAAACXBIWXMAAA9hAAAPYQGoP6dpAACyHklEQVR4nOzdd1iVdf8H8PfZhz0FQRARF27FnJmj1NRsPmnjyVLrl0/Dp6ynNBtqpTY0R44yR+beKxy4tzlQE0coKoIMQRkyzvz+/sBzkhgCHrg5nPfrus5V3NzjffCsz/kumRBCgIiIiIiIiGxGLnUAIiIiIiKimoaFFhERERERkY2x0CIiIiIiIrIxFlpEREREREQ2xkKLiIiIiIjIxlhoERERERER2RgLLSIiIiIiIhtjoUVERERERGRjLLSIiIiIiIhsjIUW1XjPPPMMnJyckJGRUeI+L7/8MlQqFVJSUrBw4ULIZDJcvXq13NcaO3YsZDJZoW3du3dH9+7dy32ukuzZswcymcx6UygU8Pf3x/PPP4/z589b97t69SpkMhkWLlxY7mucO3cOY8eOrdDf4H527tyJdu3awcXFBTKZDOvXry91/5SUFHzyySdo3bo13N3doVarERQUhGeffRYbN26EyWQqtP/58+fxyiuvoH79+tBqtfD19UXbtm3xzjvvICsrq9hrTJ8+HTKZDM2bNy8xh0wmwzvvvFOu+9q9e/dC/1ZarRZNmzbFV199Bb1eX+wx169fxzvvvIOwsDBotVp4eXmhe/fuWLJkCYQQhfa1PBZWr15d7LneeeedIo9HANDpdJg5cya6desGHx8fqFQq+Pj4oHv37vjpp5+QnZ1d5L6XdHvttdes+yUkJOC9995Dt27d4OnpWeHHHwCsXbsWL774Iho0aAAnJyfUq1cPL7/8MmJjYyt0vsokk8kwduzYUvcp7vn4IK81Jdm1axeGDh2KJk2awMXFBXXq1MFTTz2FEydO2Owa9upBXteKe92tVasWBgwYgOPHjxd7jBACS5cuRc+ePeHl5QWNRoP69evj7bffxvXr14vs37179xJfg9LS0kp8nJ05cwbDhg1DWFgYnJyc4OTkhIYNG+LNN98sks3yHlXS7d6/zaJFi/DCCy+gcePGkMvlqFevXpn/XvdKSkrCp59+ik6dOsHX1xfu7u6IiIjAzz//XOT1uyTXr1/HW2+9hUaNGsHJyQne3t5o0aIF3njjjWL/lkTVhVLqAESVbdiwYVi/fj2WLl2Kt956q8jvMzMzsW7dOjzxxBPw9/dH//79cfjwYQQEBNjk+rNmzbLJef5pwoQJ6NGjB/R6PY4fP47x48dj586d+PPPP1GnTp0HOve5c+cwbtw4dO/evcJvrsURQmDgwIFo1KgRNm7cCBcXFzRu3LjE/Y8cOYInn3wSQgj85z//QceOHeHq6or4+Hhs2rQJzz77LH766ScMGzYMABAdHY0uXbogPDwcn3/+OerVq4e0tDScPn0ay5cvx4cffgh3d/ci15k/fz4AICYmBkePHkWHDh1sdp/r16+PJUuWAABu3ryJX375BZ999hni4+Px888/F9r34MGDeOKJJ+Dq6or//e9/aNmyJTIzM7Fy5Ur8+9//xqZNm7B06VLI5RX/juzmzZt4/PHHcfbsWbz66qsYMWIE/Pz8kJ6ejl27duGjjz7CgQMH8NtvvxU67l//+hc++OCDIuerVauW9f8vXbqEJUuWoHXr1ujXrx+WLVtW4ZzffPMNateujTFjxqB+/fq4fv06JkyYgLZt2+LIkSNo1qxZhc9dk82ePRvp6en473//i6ZNm+LmzZuYPHkyOnbsiG3btqFnz55SR5SMLV7XLK+7BoMB0dHRGDduHLp164ZTp06hYcOG1v3MZjNeeuklrFixAi+++CIWLlwIDw8PnDlzBt999x2WLl2KzZs3o0uXLg90n3766Se88847aNy4Mf773/+iWbNmkMlkOH/+PJYtW4aHHnoIly5dQlhYWKHjtm7dCg8PjyLnu/d977fffkNycjLat28Ps9kMg8FQoYwnTpzAokWLMHjwYHz22WdQqVTYsmUL/vOf/+DIkSPW19+SJCQkoG3btvD09MQHH3yAxo0bIzMzE+fOncPKlSsRFxeH4ODgCmUjqnSCqIYzGo0iMDBQREREFPv72bNnCwBi06ZND3ytL774QlT202r37t0CgFi1alWh7fPmzRMAxFdffSWEEOLKlSsCgFiwYEG5r7Fq1SoBQOzevdsGif+WkJAgAIhvvvnmvvvevn1b+Pv7i9DQUHHjxo1i9zl9+rTYtWuX9efBgwcLFxcXkZWVVez+ZrO5yLZjx44JAKJ///4CgHjjjTeKPRaAePvtt++b+17dunUTzZo1K7TNYDCIhg0bCrVaLfLy8qzbb9++Lfz8/ERISIhITk4ucq5JkyYJAGLixInWbSU9FizefvvtIo/H3r17C5VKJfbu3VvsMWlpaeK3334rtK2s991kMln/3/J3rcjjTwghUlJSimxLTEwUKpVKDBs2rELnrCwAxBdffFHqPsU9HxcsWCAAiCtXrtgsS3F/t+zsbOHv7y8effRRm13HHj3I61pJz7Vff/1VABCff/55oe0TJkwQAMSkSZOKnCs5OVmEhIQIf39/cfv2bev24l4vLG7evFnkcXbgwAEhl8vFgAEDhE6nK/a4lStXisTEROvPlveomzdv3u8uF3o+9+/fX4SEhNz3mOLcunVL6PX6Itstr0/x8fGlHv/5558LACIuLu6+OStbbm5use8jRCVh10Gq8RQKBV599VWcOHECf/75Z5HfL1iwAAEBAejbty+AkrvzzJ8/H61atYJWq4W3tzeeeeaZQl31SvLProOWLkTff/89pkyZgtDQULi6uqJTp044cuRIhe9nx44dAQDXrl0rdb8DBw7g0UcfhZubG5ydndG5c2f8/vvv1t8vXLgQzz//PACgR48e1i4l9+sCdr/zjh07FkFBQQCAjz/+GDKZrNRvlefOnYuUlBR8++23JbYutmzZEj169LD+nJ6eDnd3d7i6uha7f3Hd6ObNmwcAmDRpEjp37ozly5cjNze31Pv6IJRKJVq3bg29Xl+oO+svv/yC1NRUTJo0Cf7+/kWO++ijj9CkSRN89913Ff5m+dixY9i+fTv+7//+D4888kix+/j4+ODf//53hc7/IC1t/+Tn51dkW2BgIIKCgsrUVSgqKgpPPfUUgoKCoNVq0aBBA7z55ptIS0srtJ+lK1VMTAxefPFFeHh4wN/fH0OHDkVmZmahfbOysvDGG2/Ax8cHrq6uePzxx/HXX3892B39B0v3scOHD6Nz587WbpMLFiwAAPz+++9o27YtnJ2d0aJFC2zdurXQ8cX93VxdXdG0adMifzedTocPPvgAtWvXhrOzMx555BGcOHEC9erVK9QlFACSk5Px5ptvIigoCGq1GqGhoRg3bhyMRqN1n/K+th0/fhxPPvkkvL29odVq0aZNG6xcubLQPrm5ufjwww8RGhpqfe1t165dkdbS+52roq9r99OuXTsABV2cLfR6Pb777juEh4fjo48+KnKMv78/Jk6ciJSUFOvrT0VMmDABCoUCP/30E9RqdbH7PP/88wgMDKzQ+W31fPby8oJKpSqyvX379gAKWqxKk56eDrlcXuxjGyia8+jRoxgwYAB8fHyg1WoRFhaG9957r9A+93u/Av7+LLB9+3YMHToUtWrVgrOzM3Q6HQBgxYoV6NSpE1xcXODq6oo+ffogOjq60Dni4uLwwgsvIDAwEBqNBv7+/nj00Udx6tSpUu8z1RwstMghDB06FDKZrEgXhXPnzuGPP/7Aq6++CoVCUeLxEydOxLBhw9CsWTOsXbsW06ZNw5kzZ9CpU6cKjxmZOXMmoqKiMHXqVCxZsgQ5OTno169fkQ93ZXXp0iUAhbty/dPevXvRs2dPZGZmYt68eVi2bBnc3NwwYMAArFixAgDQv39/TJgwwZrx8OHDOHz4MPr37/9A53399dexdu1aAMC7776Lw4cPY926dSWeMyoqCgqFAv369Svz36BTp05ISkrCyy+/jL179yIvL6/U/fPy8qzda5o3b46hQ4ciOzsbq1atKvM1K+LKlSvw9PQs9G9lub8DBgwo9hiZTIYnn3wSt27dqvB4m6ioKADAk08+We5jhRAwGo1FbuIf48YqU1xcHK5du1amboOXL19Gp06dMHv2bGzfvh2ff/45jh49iocffrjYQvW5555Do0aNsGbNGowaNQpLly7F+++/b/29EAJPP/00fvvtN3zwwQdYt24dOnbsaP2CxpaSk5MxZMgQvP7669iwYQNatGiBoUOHYvz48Rg9ejQ++ugjrFmzBq6urnj66adx48aNUs+XmZmJkydPFvm7DRkyBFOnTsWQIUOwYcMGPPfcc3jmmWeKjGe1dB/btm0bPv/8c2zZsgXDhg3DxIkT8cYbbxS5Xlle23bv3o0uXbogIyMDc+bMwYYNG9C6dWsMGjSoUPEzcuRIzJ49GyNGjMDWrVvx22+/4fnnn0d6enq5zlWR17WyuHLlCgCgUaNG1m0nTpzA7du38eSTTxb75Q4ADBgwAHK53PqcLC+TyYTdu3ejXbt2FermbjKZijyXyzpeylZ27doFpVJZ6G9XnE6dOsFsNuPZZ5/Ftm3bShxrCwDbtm1D165dER8fjylTpmDLli349NNPCxXCZXm/utfQoUOhUqnw22+/YfXq1VCpVJgwYQJefPFFNG3aFCtXrsRvv/2G7OxsdO3aFefOnbMe269fP5w4cQLffvstoqKiMHv2bLRp06bUMeNUw0jcokZUZbp16yZ8fX0LdWH44IMPBADx119/Wbf9szvP7du3hZOTk+jXr1+h88XHxwuNRiNeeukl67biug5269ZNdOvWzfqzpQtRixYthNFotG7/448/BACxbNmyUu+HpQvLihUrhMFgELm5uWLfvn2iQYMGQqFQiNOnTxe6zr1dlTp27Cj8/PxEdna2dZvRaBTNmzcXQUFB1i4R5e1iU9bzWjJ999139z1nkyZNRO3atYtsN5lMwmAwWG/3dhvJz88XTz/9tAAgAAiFQiHatGkjxowZI1JTU4uca9GiRQKAmDNnjhCioIuVq6ur6Nq1a5F98QBdBy1Zk5KSrN1gLNe83/29l6Wb64oVK4QQ5e86OHz4cAFAXLhwodB+ZrO50N/03selEML69yzu9s9uhhYP2nXwnwwGg+jevbtwd3e/b1ejf7Lcv2vXrgkAYsOGDdbfWZ6z3377baFj3nrrLaHVaq2P3S1btggAYtq0aYX2+/rrr23adbBbt24CgDh+/Lh1W3p6ulAoFMLJyalQN7BTp04JAGL69OmlXvvll18WSqWy0DljYmIEAPHxxx8X2nfZsmUCgHj11Vet2958803h6uoqrl27Vmjf77//XgAQMTExhe5jWV7bmjRpItq0aSMMBkOhcz7xxBMiICDA+rxu3ry5ePrpp0u9f2U9ly26Dt77unvw4EHRuHFj0bRp00JdAJcvX17sc/yf/P39RXh4uPXn8nQdTE5OFgDECy+8UGRfo9FY6Pl8b1c3y+O9uFtYWFiJWR+k62Bxtm3bJuRyuXj//ffvu6/ZbBZvvvmmkMvlAoCQyWQiPDxcvP/++0W63YaFhYmwsLBC3bL/qazvV5bn5+DBgwsdHx8fL5RKpXj33XcLbc/Ozha1a9cWAwcOFEIUdMMGIKZOnXrf+0g1F1u0yGEMGzYMaWlp2LhxIwDAaDRi8eLF6Nq1a6FBzP90+PBh5OXlFelKExwcjJ49e2Lnzp0VytO/f/9CrWgtW7YEcP+ufxaDBg2CSqWydvkxmUxYvXq19Tz/lJOTg6NHj+Jf//pXoa51CoUCr7zyChISEnDx4sVy34/KOm9JRo4cCZVKZb3d2zqj0Wiwbt06nDt3Dj/88ANeeOEF3Lx5E19//TXCw8OL5Jg3bx6cnJzwwgsvACjoYvX8889j//79NpvdLiYmxpo1ICDA2irx5ptvlvtc4m7rUUnfklfUhg0bCv1NixskP3DgQBw7dqzIrTwtjhUlhMCwYcOwf/9+LFq0qEwD31NTUzF8+HAEBwdDqVRCpVIhJCQEAIrt8vvPVr6WLVsiPz8fqampAApaTYCCGUrv9dJLL1XoPpUmICAAERER1p+9vb3h5+eH1q1bF+oGFh4eDqD014zPPvsMS5YswQ8//FDonHv37gVQ8O96r3/9619QKgvPk7V582b06NEDgYGBhVpALK15lnNZ3O+17dKlS7hw4YL1b3nvOfv164ekpCTrc7V9+/bYsmULRo0ahT179hRppS7PuWzh3tfdLl26ICsrC7///js8PT3LfS4hhM2fywAQERFR6Pk8efLkIvvs2LGjyHP5fjPA2srJkycxcOBAdOzYERMnTrzv/jKZDHPmzEFcXBxmzZqFIUOGwGAw4IcffkCzZs2sj7+//voLly9fxrBhw6DVaos9V0Xer5577rlCP2/btg1GoxGDBw8u9HjTarXo1q0b9uzZA6DgeRsWFobvvvsOU6ZMQXR0NMxmc3n+VFQDsNAih/Gvf/0LHh4e1rEOkZGRSElJsc5YVxJLF5XiumcEBgYW6sJSHj4+PoV+1mg0AHDf7m4W33zzDY4dO4aTJ08iPj4ecXFxePrpp0vc//bt2xBClHg/AFTovlTWeevWrYubN28WGS/1wQcfWD8YlNRlJjw8HO+99x4WL15s7UKSnp6Ozz77zLrPpUuXsG/fPvTv3x9CCGRkZCAjIwP/+te/AOC+M2GVVVhYGI4dO4Y//vgDq1atQqtWrTBx4kQsX7682Pubk5NT4rks4wYthYblA3FJXX6MRmOhD81169YFUPSDeffu3a1/0yeeeKLYc9WqVQvt2rUrcvP29i7l3j84IQRef/11LF68GAsXLsRTTz1132PMZjN69+6NtWvX4qOPPsLOnTvxxx9/WMcJFfccu9/zMT09HUqlssh+tWvXrtD9Kk1xf1O1Wl1ku2VcTn5+frHnGTduHL766it8/fXXRZYmsDwn/zkesLj7mJKSgk2bNhX68K5SqaxdEf857u1+f0tLN64PP/ywyDktM8Nazjl9+nR8/PHHWL9+PXr06AFvb288/fTT1i9CynMuW7C87u7duxdjxoxBSkoKnn76aeu4HeDv55mlW2FxcnJykJaWVuhLA6VSWepzGYB1rJOvry+cnJyKLbKXLl2KY8eOWb9ULE6rVq2KPJdLW97CVqKjo9GrVy80bNgQkZGR1sdGWYSEhOA///kP5s2bh9jYWKxYsQL5+fn43//+B6BgRlUA1rHAxanI+9U/97U85h566KEij7kVK1ZYH28ymQw7d+5Enz598O2336Jt27aoVasWRowYUWQJDaq5OL07OQwnJye8+OKLmDt3LpKSkjB//ny4ublZB0iXxPKhISkpqcjvbty4AV9f30rJez/169e3DsQuCy8vL8jl8hLvB4AK3ZfKOm+vXr2wfft2REZGWosfoKDIsHw4KWkA+L1kMhnef/99jB8/HmfPnrVunz9/PoQQWL16dbHrUP3666/46quvSh27VxZardb67/TQQw+hR48eaNasGd577z3rVO733t9NmzZZW9juJYTAxo0b4e3tbW2ZsHxITkxMLPbaiYmJhT5I9+rVC5988gk2btyI3r17W7d7enpaM/7zQ7KULEXWggULMG/evDJP0nH27FmcPn0aCxcuxKuvvmrdbhnHWBE+Pj4wGo1IT08v9DdKTk6u8Dkr07hx4zB27FiMHTsWn3zySZHfW+5DSkpKoeUgLPfxXr6+vmjZsiW+/vrrYq9V3skWLK8Ho0ePxrPPPlvsPpZlH1xcXDBu3DiMGzcOKSkp1tatAQMG4MKFC+U6ly3c+7r7yCOPwMnJCZ9++ilmzJiBDz/8EEBBi5KXlxc2btyIiRMnFttqtXHjRpjNZvTq1cu6zd/fH8eOHSu2pcvyHLc8nxUKBXr27Int27cjKSmpUDHQtGlTAKiUdRAfRHR0NB577DGEhIRg+/btxbacl8fAgQMxceJE6+u6ZcxraZNrVOT96p//Fpbfr1692tpKXpKQkBDrhCd//fUXVq5cibFjx0Kv12POnDmlHks1A1u0yKEMGzYMJpMJ3333HSIjI/HCCy/A2dm51GM6deoEJycnLF68uND2hIQE7Nq1C48++mhlRrYZFxcXdOjQAWvXri30jb7ZbMbixYsRFBRkHZRcnta18py3PF5//XX4+/vjo48+KvZNsTgl7Xfjxg1kZWVZPxCaTCb8+uuvCAsLw+7du4vcPvjgAyQlJWHLli3lzn0/Pj4+mDRpElJSUjBjxgzr9tdffx1+fn4YPXq0tbvavb799ltcuHABH330kfVb7YYNGyIkJASrVq0qMinFzZs3sXv3bjz22GPWbe3atUPv3r0xd+5c7N+/3+b3zZaEEHjjjTewYMEC/PTTTxgyZEiZj7V8MPrnt+U//fRThfNYZre0rIlmsXTp0gqfs7J8+eWXGDt2LD799FN88cUXxe5jmXXyn4P/V69eXWgmQQB44okncPbsWYSFhRXbqlneQqtx48Zo2LAhTp8+Xez52rVrBzc3tyLH+fv747XXXsOLL76IixcvIjc3t1znKm+vgbL46KOP0KBBA0yaNMnaSqFWq/G///0P58+fx3fffVfkmNTUVIwePRr+/v54/fXXrdsfe+wxZGVlFZlJEgBWrlwJuVxeaB200aNHw2QyYfjw4RWeibSqnDp1Co899hiCgoIQFRUFLy+vMh9b0uv6nTt3cP36devjr1GjRggLC8P8+fMLtTDeyxbvV3369IFSqcTly5dLfMwVp1GjRvj000/RokULnDx5six3nWoAtmiRQ2nXrh1atmyJqVOnWsd93I+npyc+++wzfPLJJxg8eDBefPFFpKenY9y4cdBqtSV+kKmOJk6ciF69eqFHjx748MMPoVarMWvWLJw9exbLli2zfkC1dCH5+eef4ebmBq1Wi9DQ0BJbO8p63vLw9PTE+vXrMWDAALRq1arQgsXp6enYt28fkpOT0blzZ+sx//d//4eMjAw899xzaN68ORQKBS5cuIAffvgBcrkcH3/8MQBgy5YtuHHjBr755ptCU+9bNG/eHD/++CPmzZtXYle6BzF48GBMmTIF33//Pd5++224u7vD09MTa9euxRNPPIGIiAj873//Q6tWrZCVlYUVK1ZgyZIlGDRokLWbjMX333+PgQMH4tFHH8Ubb7yB2rVrIzY2FpMmTYJarS7UXRIAFi9ejD59+uCxxx7Da6+9hj59+sDPzw9ZWVk4c+YMduzYUeyizikpKcVO0e3u7m79Bh2AtXUwLi4OQMG025ZWu3tbJu9nxIgRmDdvHoYOHYoWLVoUurZGo0GbNm1KPLZJkyYICwvDqFGjIISAt7c3Nm3aVOEZ3gCgd+/eeOSRR/DRRx8hJycH7dq1w8GDB4ss7Cy1yZMn4/PPP8fjjz+O/v37F/k3sywD0axZM7z44ouYPHmytXUkJiYGkydPhoeHR6Eps8ePH4+oqCh07twZI0aMQOPGjZGfn4+rV68iMjISc+bMKbW7VnF++ukn9O3bF3369MFrr72GOnXq4NatWzh//jxOnjxpnfmzQ4cOeOKJJ9CyZUt4eXnh/Pnz+O2339CpUyfrl2RlPVd5X9fKwjID3cCBAzFt2jR8+umnAAqWsDh9+rT1v4MGDSq0YHF2djY2b95cqFXn5ZdfxqxZszBw4ECMGjUKDz30EPLy8hAZGYm5c+fi3XffRf369a37d+nSBTNnzsS7776Ltm3b4v/+7//QrFkza4vNmjVrAKDY5/OJEyeKbVFq2rSpdf9z585ZZ9BLTk5Gbm6u9fndtGnTQs/70ly8eNH6hc/XX3+N2NjYQmNgw8LCSp0t9+uvv8bBgwcxaNAgtG7dGk5OTrhy5Qp+/PFHpKenFypmZ86ciQEDBqBjx454//33UbduXcTHx2Pbtm3WL0ke9P2qXr16GD9+PMaMGYO4uDg8/vjj8PLyQkpKCv744w9rK+yZM2fwzjvv4Pnnn0fDhg2hVquxa9cunDlzBqNGjSrT345qgKqff4NIWtOmTRMARNOmTYv9fUmLiP7yyy+iZcuWQq1WCw8PD/HUU09ZZ9uyKM+sg8XNvIcyzF52v5nm/nmdf876tn//ftGzZ0/h4uIinJycRMeOHYtdrHnq1KkiNDRUKBSKMs0eV5bzlmfWQYvk5GQxevRo0bJlS+Hi4iJUKpUIDAwUAwYMEIsWLSo009i2bdvE0KFDRdOmTYWHh4dQKpUiICBAPPvss+Lw4cPW/Z5++mmhVquLnYnQ4oUXXhBKpdK6eDBstGCxxe+//y4AiHHjxhXaHh8fL95++21Rv35962PtkUceEYsXLy5xocwdO3aI3r17C09PT+t9/ve//y1iY2OL3T8/P1/MmDFDPPzww9ZjvL29RdeuXcU333wj0tPTC+2PUmYd7NKlS5n3LY+QkJASz1OW2c/OnTsnevXqJdzc3ISXl5d4/vnnRXx8fJHnWEkLuBb3OpCRkSGGDh0qPD09hbOzs+jVq5e4cOGCzWcdLO4xExISIvr3719k+z8fl5ZZC8vyb5Cfny9Gjhwp/Pz8hFarFR07dhSHDx8WHh4eRWaDu3nzphgxYoQIDQ0VKpVKeHt7i4iICDFmzBhx586dQvexrK9tp0+fFgMHDhR+fn5CpVKJ2rVri549exaarW/UqFGiXbt2wsvLS2g0GlG/fn3x/vvvi7S0tHKfS4jyv65Z3O91t0OHDsLLy0tkZGRYt5nNZrFkyRLRvXt34enpKdRqtQgNDRX/+c9/iszgaJGVlSU++ugj66Lmzs7Ool27dmLOnDklPv9PnTolhgwZIkJDQ4VGoxFarVY0aNBADB48WOzcubPQvqXNOghAREVFlWnf+z3e72V5nJd0u9+/wZEjR8Tbb78tWrVqJby9vYVCoRC1atUSjz/+uIiMjCyy/+HDh0Xfvn2Fh4eH0Gg0IiwsrMjjuSzvV5bcx44dKzbX+vXrRY8ePYS7u7vQaDQiJCRE/Otf/xI7duwQQhQsHv7aa6+JJk2aCBcXF+Hq6ipatmwpfvjhhyIzu1LNJROiChdBISIiomrr0KFD6NKlC5YsWVIpMyoSETkSFlpEREQOKCoqCocPH0ZERAScnJxw+vRpTJo0ydrFraQpsomIqGw4RouIqJxMJlORySfuJZPJHni2wprKbDbfdy2Zf67jRJXD3d0d27dvx9SpU5GdnQ1fX1/07dsXEydOdJgiSwhR4pTqFgqFolLWu6oJ/jlxyj/J5fJC4/2IHA0f/URE5RQWFlZk/ZR7b/YyE6UUhg4dWurfzjKjIlW+Dh064MCBA7h16xYMBgOSkpKwcOHCEtenq4l+/fXX+z4e/7kgMxW4evXqff9248ePlzomkaTYdZCIqJz+/PPPEqcPBgA3Nzebrt1Tk1y9evW+C8iWZ304ogeRnp5e6sLCQMF09MVNN+/o9Ho9zpw5U+o+gYGB5Z7+n6gmYaFFRERERERkY+w6SEREREREZGMccXwfZrMZN27cgJubGwfDEhERERE5MCEEsrOzERgYeN/JXlho3ceNGzcQHBwsdQwiIiIiIqomrl+/jqCgoFL3YaF1H5YBsNevX4e7u7vEaYiIiIiISCpZWVkIDg4u0yQ5LLTuw9Jd0N3dnYUWERERERGVaUgRJ8MgIiIiIiKyMRZaRERERERENsZCi4iIiIiIyMZYaBEREREREdkYCy0iIiIiIiIbY6FFRERERERkYyy0iIiIiIiIbIyFFhERERERkY2x0CIiIiIiIrIxFlpEREREREQ2xkKLiIiIiIjIxlhoERERERER2RgLLSIiIiIiIhtjoUVERERERGRjLLSIiIiIiIhsjIUWERERERGRjbHQIiIiIiIisjGl1AGIiIiIqHrbsGEDtm7dav3ZyckJo0aNgp+fn4SpiKo3FlpEREREVKp169bh6tWrgEIFmM2AMOHEiRPo27ev1NGIqi12HSQiIiKiUt26dQsmJy9kt30FuQ0fs24jopKx0CIiIiKiEhkMBmRlZUGonADA+l8WWkSlY6FFRERERCW6ffs2ABQptNLT0yXLRGQPWGgRERERUYksLVdC5VzwX6UWkMmRlpYmZSyiao+FFhERERGV6ObNmwAAs7qg0IJMBrPKmYUW0X2w0CIiIiKiElkKLaFysW4zq51xMy0NZrNZqlhE1R4LLSIiIiIq0d8tWn8XWkLtApPRiIyMDIlSEVV/LLSIiIiIqESpqakACoorC0vrluV3RFQUCy0iIiIiKlFycjIgk1tnGwQAs8YVAJCSkiJVLKJqj4UWEREREZUoOTkZZrUrIJNZt1kKreTkZKliEVV7LLSIiIiIqFh6vR7p6enWwspCqFloEd0PCy0iIiIiKpala6BZXbjQMmvcAABJSUlVnonIXrDQIiIiIqJi3bhxAwAgtG6Ff6FQQSi1LLSISsFCi4iIiIiKlZiYCAAwa9yL/M6scUNiYiJMJlNVxyKyCyy0iIiIiKhY1kJLW0yhpXWH0WhEWlpaVccisgsstIiIiIioWKW3aBVsS0hIqNJMRPaChRYRERERFev69esF62cpVEV+Z2nlYqFFVDwWWkRERERUhF6vx42kJJi0HsX+3nx3e3x8fFXGIrIbLLSIiIiIqIjExEQIsxlmrWexv2ehRVQ6FlpEREREVISlgDKX0KIFhQpmtQsLLaIS2FWhtW/fPgwYMACBgYGQyWRYv359qfuvXbsWvXr1Qq1ateDu7o5OnTph27ZtVROWiIiIyI5du3YNAGB2KqHQQkERlpKSgtzc3KqKRWQ37KrQysnJQatWrfDjjz+Waf99+/ahV69eiIyMxIkTJ9CjRw8MGDAA0dHRlZyUiIiIyL5duXIFAGB28ipxH8vv2KpFVJRS6gDl0bdvX/Tt27fM+0+dOrXQzxMmTMCGDRuwadMmtGnTpthjdDoddDqd9eesrKwKZSUiIiKyZ1evXoVQqCFUziXuYym0rly5giZNmlRVNCK7YFctWg/KbDYjOzsb3t7eJe4zceJEeHh4WG/BwcFVmJCIiIhIekajEfHXr8Pk5AnIZCXuZ3LyBPB36xcR/c2hCq3JkycjJycHAwcOLHGf0aNHIzMz03q7fv16FSYkIiIikl5CQgJMRmOp3QaBwi1aRFSYXXUdfBDLli3D2LFjsWHDBvj5+ZW4n0ajgUajqcJkRERERNXL5cuXAZQ+PgtAwcyDGjdcvhxXBamI7ItDtGitWLECw4YNw8qVK/HYY49JHYeIiIioWrMWWs4lD7ewMDl54datdGRkZFRyKiL7UuMLrWXLluG1117D0qVL0b9/f6njEBEREVV7lkLL5HT/QstSjFmOIaICdlVo3blzB6dOncKpU6cAFPQHPnXqlHVK0dGjR2Pw4MHW/ZctW4bBgwdj8uTJ6NixI5KTk5GcnIzMzEwp4hMRERHZhcuXL8OsdgGU6vvua3ZioUVUHLsqtI4fP442bdpYp2YfOXIk2rRpg88//xwAkJSUVGgdh59++glGoxFvv/02AgICrLf//ve/kuQnIiIiqu4yMjKQlpYGk7NPmfY33W3RunTpUmXGIrI7djUZRvfu3SGEKPH3CxcuLPTznj17KjcQERERUQ0TGxsLoGzjswBAaNwgFGrrcURUwK5atIiIiIiocv1daJWtRQsyGUzO3rh27Rp0Ol0lJiOyLyy0iIiIiMjKUmiVtesgUND6ZTabuZ4W0T1YaBERERGRVWxsLIRSA6F2KfMxlqKM3QeJ/sZCi4iIiIgAADk5OUhISCgonGSyMh9n6Wb4119/VVY0IrvDQouIiIiIAPw9c6DJ2bdcx5mdPAG5goUW0T1YaBERERERgL9bpMwuZR+fBQCQyWFy8sbly5dhMBgqIRmR/WGhRUREREQAgIsXLwIo30QYFiYXHxiNRly9etXGqYjsEwstIiIiIgJQ0KIlFGoIjVu5jzXf7W5oKdaIHB0LLSIiIiJCbm4url+/Xu6JMCxMLpx5kOheLLSIiIiICJcuXYIQAmaX8k2EYWHWenFCDKJ7sNAiIiIiImuBVJHxWQAAuRwmJy9cunQJRqPRhsmI7BMLLSIiIiKydvkzVbBFCyiYFt5gMODatWu2ikVkt1hoEREREdEDTYRhYZkWnt0HiVhoERERETm8/Px8XL12DSZn7wpNhGFh6XbIQouIhRYRERGRw4uLi4Mwm2Gu6Pisu8xOXoBMzkKLCCy0iIiIiByedXzWAxZakCtgcvLE5cuXYTKZbJCMyH6x0CIiIiJycJcuXQKAB27RspwjPz8fiYmJD3wuInvGQouIiIjIwcXGxgJyBcxOHg98LpOzN4C/izciR8VCi4iIiMiBGY1GxMXFwXR3fNWDsrSKWbojEjkqFlpEREREDiwxMRF6vR4mJ2+bnM9ynri4OJucj8hesdAiIiIicmCXL18GAJidbVNoQamGWe1qPS+Ro2KhRUREROTALC1PZicvm53T7OyFtLQ0ZGVl2eycRPaGhRYRERGRA7MUWiZbtWgBBeO9wO6D5NhYaBERERE5sLgrVyBUzoBSY7NzmjlOi4iFFhEREZGjysvLQ0pyMkxOnjY9r/nu+eLj4216XiJ7wkKLiIiIyEFdv34dQgiYtZ42Pa9Z6w5AhqtXr9r0vET2hIUWERERkYO6du0agL9boGxGroRZ42Y9P5EjYqFFRERE5KAqrdACYHLyxO3btznzIDksFlpEREREDiohIQGApaufbYm757Rcg8jRsNAiIiIiclCJiYmAQgWhdLL5uc0a97+vQeSAWGgREREROSAhBK4nJMCkcQNkMpuf38wWLXJwLLSIiIiIHNDt27eRn5dnbXmyNbZokaNjoUVERETkgJKSkgAAZo1bpZxfqF0AmRzJycmVcn6i6o6FFhEREZEDSklJAQAIjWvlXEAmg1ntwkKLHBYLLSIiIiIHZCm0zOpKKrTunjs9PR0Gg6HSrkFUXbHQIiIiInJAlpamSmvRAmDWuEIIgdTU1Eq7BlF1xUKLiIiIyAGlpaUBAMwql0q7hlC7FLoWkSNhoUVERETkgNLT0wG5ElCoKu0aQuX897WIHAwLLSIiIiIHlJaWBrPKqVLW0LIQqoKFkFlokSNioUVERETkYMxmM27fvg3z3RanSrsOW7TIgbHQIiIiInIwWVlZMJlM1hanymI5/+3btyv1OkTVEQstIiIiIgeTlZUFABBKbaVex3L+zMzMSr0OUXVkV4XWvn37MGDAAAQGBkImk2H9+vX3PWbv3r2IiIiAVqtF/fr1MWfOnMoPSkRERFSNWQofodRU7oUUSkCuYKFFDsmuCq2cnBy0atUKP/74Y5n2v3LlCvr164euXbsiOjoan3zyCUaMGIE1a9ZUclIiIiKi6uvvFq1KLrQAmJVa6/WIHIlS6gDl0bdvX/Tt27fM+8+ZMwd169bF1KlTAQDh4eE4fvw4vv/+ezz33HPFHqPT6aDT6aw/84WBiIiIapqKFFray3sgz8+EWeuB/LDuZT5OKDT8PEUOya5atMrr8OHD6N27d6Ftffr0wfHjx2EwGIo9ZuLEifDw8LDegoODqyIqERERUZXJzc0t+B+FuszHyPMzochNhzy/fN0AhUKF3NxcCCHKdRyRvavRhVZycjL8/f0LbfP394fRaCxxhfLRo0cjMzPTert+/XpVRCUiIiKqMpZCS1TiYsVWChVMJhP0en3lX4uoGrGrroMVIfvHInyWb1P+ud1Co9FAo6n8/spEREREUrEWWvLKL7QsxVxubi4/Y5FDqdEtWrVr10ZycnKhbampqVAqlfDx8ZEoFREREZG08vLyCv6nClq0LMVcTk5OpV+LqDqp0YVWp06dEBUVVWjb9u3b0a5dO6hUVdBUTkRERFQN5efnAwCEvAo6N929BrsOkqOxq0Lrzp07OHXqFE6dOgWgYPr2U6dOIT4+HkDB+KrBgwdb9x8+fDiuXbuGkSNH4vz585g/fz7mzZuHDz/8UIr4RERERNWCteiRKyr9WuLuNVhokaOxqzFax48fR48ePaw/jxw5EgDw6quvYuHChUhKSrIWXQAQGhqKyMhIvP/++5g5cyYCAwMxffr0Eqd2JyIiInIElqVsRBUUWmChRQ7Krgqt7t27lzo16MKFC4ts69atG06ePFmJqYiIiIjsi7XokVVdoXXvOqVEjsCuug4SERER0YMzGo0F/yOr/I+C4m4xZ70mkYNgoUVERETkYEwmU0GRVcJyNzZ1t5gzmUyVfy2iaoSFFhEREZGDMRqNVVNkAdbrsEWLHA0LLSIiIiIHY23Rqgps0SIHxUKLiIiIyMGYzWYAVdOiJe5eh4UWORoWWkREREQOxmw2Q1Rx10EiR8NCi4iIiIgqXWlL9BDVRCy0iIiIiBxMVXYdtFyn4JpEjoOFFhEREZGDYesSUeVjoUVERETkiDhGi6hSsdAiIiIiIiKyMRZaRERERERENsZCi4iIiIgqHceFkaNhoUVERETkYKQoelhokaNhoUVERETkYAqKnqqdpIKFFjkaFlpEREREDqZqix7OOkiOiYUWERERkQOq6vYltmiRo2GhRURERORgzGZzla+jZTabq+Z6RNUECy0iIiIiB8NCi6jysdAiIiIicjBGkwlV9TFQ3L2OyWSqkusRVRcstIiIiIgcjMlkgqjiFi0WWuRoWGgRERERORij0QjIquhj4N3rGI3GqrkeUTXBQouIiIjIwej1ekCuqJqL3b2OXq+vmusRVRMstIiIiIgcjEGvh5BVTaFluQ4LLXI0LLSIiIiIHIjRaCwYL8UWLaJKxUKLiIiIyIFYC56qatGSKwEAOp2uSq5HVF2w0CIiIiJyILm5uQAAoVBXzQUVqkLXJXIULLSIiIiIHEhOTg4AQNwtgCqbYKFFDoqFFhEREZED+btFq2oKLcgUgExuLfCIHAULLSIiIiIHYi14qqrroEwGoVCx0CKHw0KLiIiIyIFkZmYCAIRKW2XXNCu1yMjIrLLrEVUHLLSIiIiIHMjt27cBAEJZdYWWUGqRmZkBs9lcZdckkhoLLSIiIiIHkpGRAQAwq5yq7JpC5QSTyYQ7d+5U2TWJpMZCi4iIiMiB3Lp1C0DVt2gBf7emETkCFlpEREREDuTmzZsAAKF2rrJrWq5luTaRI2ChRURERORAUlJSIFROgFxZZdc0q10BAMnJyVV2TSKpsdAiIiIichBCCCSnpMCsdqna62pYaJHjYaFFRERE5CAyMzOh1+msLUxVxXK9lJSUKr0ukZRYaBERERE5iMTERACA0LhV6XWF2hmQya3XJ3IELLSIiIiIHMS1a9cAACatR9VeWCaHSeuOa9euQQhRtdcmkggLLSIiIiIHYSm0zE6eVX5ts9YTOTk51unliWo6FlpEREREDsJaaGk9q/zaluIuPj6+yq9NJAW7K7RmzZqF0NBQaLVaREREYP/+/aXuv2TJErRq1QrOzs4ICAjAkCFDkJ6eXkVpiYiIiKqPuLi4gvFSSnWVX9tS3MXFxVX5tYmkYFeF1ooVK/Dee+9hzJgxiI6ORteuXdG3b98Svxk5cOAABg8ejGHDhiEmJgarVq3CsWPH8Prrr1dxciIiIiJpZWRkIDU1FSZnH0mub3IpuO5ff/0lyfWJqppdFVpTpkzBsGHD8PrrryM8PBxTp05FcHAwZs+eXez+R44cQb169TBixAiEhobi4Ycfxptvvonjx4+XeA2dToesrKxCNyIiIiJ7ZylwTM6+klxfaNwhFGpcvHhRkusTVTW7KbT0ej1OnDiB3r17F9reu3dvHDp0qNhjOnfujISEBERGRkIIgZSUFKxevRr9+/cv8ToTJ06Eh4eH9RYcHGzT+0FEREQkBUuBY3KRptCCTAaTsw+uXYtHXl6eNBmIqpDdFFppaWkwmUzw9/cvtN3f37/EVcY7d+6MJUuWYNCgQVCr1ahduzY8PT0xY8aMEq8zevRoZGZmWm/Xr1+36f0gIiIiksKFCxcAAGYXaboOFlzbF0KY2X2QHILdFFoWMpms0M9CiCLbLM6dO4cRI0bg888/x4kTJ7B161ZcuXIFw4cPL/H8Go0G7u7uhW5ERERE9sxsNuPMmTMwa9wgVM6S5TC5+gEAzpw5I1kGoqqilDpAWfn6+kKhUBRpvUpNTS3SymUxceJEdOnSBf/73/8AAC1btoSLiwu6du2Kr776CgEBAZWem4iIiEhqV69eRXZ2Nky+DSXNYXQr+MzGQoscgd20aKnVakRERCAqKqrQ9qioKHTu3LnYY3JzcyGXF76LCoUCALgqORERETkMS2FjdKstbRClFiYnL/z5558wGo3SZiGqZHZTaAHAyJEj8csvv2D+/Pk4f/483n//fcTHx1u7Ao4ePRqDBw+27j9gwACsXbsWs2fPRlxcHA4ePIgRI0agffv2CAwMlOpuEBEREVWp06dPAwBMUhdadzPk5+dznBbVeHbTdRAABg0ahPT0dIwfPx5JSUlo3rw5IiMjERISAgBISkoqtKbWa6+9huzsbPz444/44IMP4OnpiZ49e+Kbb76R6i4QERERVSmTyYTjx4/DrHGFULtKHQcmtwAg9TyOHz+Opk2bSh2HqNLIBPvQlSorKwseHh7IzMzkxBhERERkd2JiYvD2229DX6sJdPWKH25RFs4xG6DITYfJ2Qe5zZ6qeCCjHm6nlqJZ03DMnDmz4uchkkB5agO76jpIREREROXzxx9/AACMHkESJ7lLqYbR1Q/nzp1Hdna21GmIKg0LLSIiIqIa7OjRo4BMDpN79Zlt2eRRB0KYcfz4camjEFUaFlpERERENVR6ejouXLhQMNugQiV1HCujRzAA4ODBgxInIao8LLSIiIiIaqgDBw4AAIxeIRInKczs5AWzxg2HDh2CwWCQOg5RpWChRURERFRD7d27FwBg9KxehRZkMhi96iE3NxcnT56UOg1RpWChRURERFQDZWZm4tSpUzC5+kGonaWOU4Thbivbvn37JE5CVDlYaBERERHVQPv374fZbLYWNNWN2aUWhNoZ+/bvZ/dBqpFYaBERERHVQDt27AAAGL3rS5ykBDIZDF71kZ2VhWPHjkmdhsjmWGgRERER1TCpqak4ffo0jG61IdQuUscpkcGnoAi0FIVENQkLLSIiIqIaZteuXRBCwOgTJnWUUpmdfWDWeuDAgYPIzc2VOg6RTbHQIiIiIqpBhBDYvn07IJPD4FVP6jilk8lg8AmDXq/D/v37pU5DZFMstIiIiIhqkNjYWMTFxcHgWRdQaqSOc18GnwYAgC1btkichMi2WGgRERER1SCRkZEAAEOtRhInKRuhcYXRPRCnTp1CYmKi1HGIbIaFFhEREVENodPpELVjB4TaGSb3QKnjlJnBtyEAYOvWrRInIbIdFlpERERENcSBAweQc+cO9D4NAZn9fMwzeoVAKNXYsmULjEaj1HGIbMJ+noFEREREVKqNGzcC+LuFyG7IlTB4hyEtLQ1//PGH1GmIbIKFFhEREVENcO3atYK1s9zrQGjdpY5TboZaTQD8XSwS2TsWWkREREQ1gLU1y6+JxEkqxuzsBaOrP44ePYqkpCSp4xA9MBZaRERERHYuPz8fW7dtg1A5w+gZLHWcCjP4NYEQAps3b5Y6CtEDY6FFREREZOd27txZMAlGrUZ2NQnGPxVMiqHB5s2bodfrpY5D9EDs95lIRERERBBCYN26dYBMbh3nZLfkSuh9GyMzMxN79uyROg3RA2GhRURERGTHzp49i0uXLsHgFQKhdpY6zgMrGGMmKygeiewYCy0iIiIiO2YpSAx+TSVOYhtC4wqDZ12cP38eFy5ckDoOUYWx0CIiIiKyUzdv3sTevXthcvaGydVP6jg2Y/APBwCsWbNG4iREFcdCi4iIiMhObdiwASaTCXq/poBMJnUcmzG5BcDk5IVdu3cjPT1d6jhEFcJCi4iIiMgO6XQ6bNy4CUKlhdGnvtRxbEsmg8G/KUxGIxcwJrvFQouIiIjIDu3cuRNZWZnQ+zYG5Eqp49icwTsMQqnBhg0bONU72SUWWkRERER2RgiBVatXF0zp7hcudZzKoVBCX6sxMjIysGvXLqnTEJUbCy0iIiIiOxMdHY0rcXEweIfWiCndS2LwCwdkcqxatQpCCKnjEJULCy0iIiIiO7Nq1SoAgN6/mcRJKpdQu8DgVQ+XL1/GqVOnpI5DVC41r0MvEdnEnj17EB0dXezvVCoVXnjhBfj6+lZxKiIiSkhIwOHDh2F09YfZpea/Duv9m0F1Kw6rV69GmzZtpI5DVGYstIioiNzcXEyYMBF6va7EfYQQePfdd6swFRERAcDq1asBAIYa3pplYXatBZOrHw4dOoSEhAQEBQVJHYmoTNh1kIiK2L9/P/R6HXS1W+BOi+cK35o/B6Fywq5du2A0GqWOSkTkULKzs7FlyxaYNW4wetWVOk6V0fs3gxCCCxiTXWGhRURFbN26FQBg8GsCofUofHPygMErFLdv38axY8ckTkpE5Fg2b94MnU53d4Fix/kYZ/QKgVC7YsuWLcjOzpY6DlGZOM4zlIjK5Nq1a4iOjobRPRBC41bsPoZajQAAGzZsqMpoREQOzWg0Ys3atYBCBUOthlLHqVoyOXT+TZGfn4/ff/9d6jREZcJCi4gKWbt2LYCC1qySmJ29YXT1x9GjR3H9+vWqikZE5ND27t2LtJs3ofdtBCjUUsepcgbfRoBChTVr1rDrOtkFFlpEZJWeno7IyEiYNe4wepbe999Qu6C//LJly6ooHRGR4xJC3J3SXQa9f1Op40hDqYbetxFu3ryJ/fv3S52G6L5YaBGR1cqVK2EwGKAPaHHfvv9GzxCYtZ7Ytn07kpOTqyghEZFjiomJwYULF2DwCimxW7cj0PuFA/h7HTGi6oyFFhEBAFJTU7F23TqYNa4w+DS4/wEyGXSBrWAyGrFgwYLKD0hE5MAshYWjTOleEqF1h8EzBOfOnUNMTIzUcYhKxUKLiAAACxYsgEGvhy6wLSBXlOkYo3d9mJx9sH37dly+fLmSExIROaakpCTs27cfJhdfmFz9pI4jOUPtgmLTsp4YUXXFQouIEBMTgy1btsDk7A2jT/2yHyiTQRf8EIQQmDZtGoQQlReSiMhBrVu3DkKYofdvBshkUseRnMnVHyZnH+zduxcpKSlSxyEqkd0VWrNmzUJoaCi0Wi0iIiLuOxhSp9NhzJgxCAkJgUajQVhYGObPn19FaYmqP6PRiKlTpwIA8kM6l3tdFpN7IAxe9XDmzBlERUVVQkIiIseVm5uLzb//DqFyhtErVOo41YNMBr1/M5jNZqxfv17qNEQlsqtCa8WKFXjvvfcwZswYREdHo2vXrujbty/i4+NLPGbgwIHYuXMn5s2bh4sXL2LZsmVo0qTkaauJHM2qVasQGxsLvW9DmCvYJUUX3B5QqDBjxgzcunXLxgmJiBzXtm3bkJuTUzAJhNyuPrZVKqN3KITKCRs3bUJeXp7UcYiKZVfP2ClTpmDYsGF4/fXXER4ejqlTpyI4OBizZ88udv+tW7di7969iIyMxGOPPYZ69eqhffv26Ny5cxUnJ6qerl27hvnz50OonQuKpQoSGlfkBz2E7Oxs/PDDD+xCSERkA2azGatXrwHkChhqNZY6TvUiV0DvF46cO3ewfft2qdMQFctuCi29Xo8TJ06gd+/ehbb37t0bhw4dKvaYjRs3ol27dvj2229Rp04dNGrUCB9++GGp33zodDpkZWUVuhHVRHq9Hl9++SUMBgPyQjoDSs0Dnc9QqzGMbgHYv38/tmzZYqOURESO6+jRo0hMTIDeOwxCpZU6TrVjqNUYkCuwevVqmM1mqeMQFWE3hVZaWhpMJhP8/f0Lbff39y9xDZ+4uDgcOHAAZ8+exbp16zB16lSsXr0ab7/9donXmThxIjw8PKy34OBgm94Pouril19+waVLl6Cv1QSm+yxOXCYyGfJDuwJKDaZNm1Zql14iIrq/NWvWAOCU7iURKicYvOvj+vXrOH78uNRxiIqwm0LLQvaP2XaEEEW2WZjNZshkMixZsgTt27dHv379MGXKFCxcuLDEVq3Ro0cjMzPTert+/brN7wOR1Pbv34+VK1fCrPV8oC6D/yQ0rsgL6QKdTocvvhiL/Px8m52biMiRXL16FcePH4fRPQBmZy+p41Rbev+mAP4uSomqE7sptHx9faFQKIq0XqWmphZp5bIICAhAnTp14OHhYd0WHh4OIQQSEhKKPUaj0cDd3b3QjagmSUhIwMSJEwGFEnkNegAKpU3Pb/SuB71fU1y5EocpU6ZwvBYRUQWsXbsWAAqmdKcSmZ19YHSrjaNHj7InBVU7dlNoqdVqREREFJk+OioqqsTJLbp06YIbN27gzp071m1//fUX5HI5goKCKjUvUXWUm5uLTz/9FLm5ucgL6QKzU+V8S6oLfggmFz9s377d+mGBiIjKJjs7G9u2bYNZ4waTBz+v3I/Br6BVi+83VN3YTaEFACNHjsQvv/yC+fPn4/z583j//fcRHx+P4cOHAyjo9jd48GDr/i+99BJ8fHwwZMgQnDt3Dvv27cP//vc/DB06FE5OTlLdDSJJmM1mfP3117h69Sr0/s1g9AmrvIvJFchr0BNC7YyZM2fixIkTlXctIqIa5vfff4dOpyuY0r2caxs6IqNXXQi1K7Zu21boy3UiqdnVs3fQoEGYOnUqxo8fj9atW2Pfvn2IjIxESEgIACApKalQs7GrqyuioqKQkZGBdu3a4eWXX8aAAQMwffp0qe4CkWR++eUXHDx4EEb3OtAFP1Tp1xNqZ+SG9YQZMnzxxRfs0kFEVAYmkwnr1q0D5EoYfBtJHcc+yOTQ+YUjPy8PW7dulToNkZVMcABFqbKysuDh4YHMzEyO1yK7FRkZiW+//RZmrQdywp944Kncy0OZfhlOcXsREBiI2bNmwdPTs8quTURkb/bv34/PPvsMer9w6EI6SR2nEOeYDVDkpsPk7IPcZk9JHacwow5up1cgsLYfFi9eDDkXd6ZKUp7agI9Cohru+PHjmDx5MoRKi9yGvaq0yAIAo08YdIFtkHTjBsaMGQOdTlel1ycisieWcUYGv3CJk9gZpQZ6nzDcuHEDR44ckToNEQAWWkQ1WmxsLD777DOYBJDb4DEIrTStsvrA1jD4hCEmJgZff/01TCaTJDmIiKqzuLg4REdHw+heB2YnT6nj2B3D3ane161bJ3ESogIstIhqqKSkJHz88cfIy8tDXv1uMLv6SRdGJkN+vYdhdA/Evn378OOPP3LadyKif/h7SvemEiexT2YnLxjdAnDs2DFcu3ZN6jhED1Zo6fV6XLx4EUaj0VZ5iMgGMjIy8NFHH+HWrVvIr9sRRq96UkeyzkRocvbGunXrsHTpUqkTERFVG1lZWdi+PYpTuj8gtmpRdVKhQis3NxfDhg2Ds7MzmjVrZp1NbMSIEZg0aZJNAxJR+eTl5eGTTz7B9evXoQtoaX3TqRYUauQ17A2hccXcuXOxZcsWqRMREVULkZGR0Ot10Ps1BWQyqePYLaNnMMxqV2zdupVTvZPkKlRojR49GqdPn8aePXug1Wqt2x977DGsWLHCZuGIqHyMRiPGjh2Lc+fOweDbEPo6EVJHKkKonZHTsA+g1OK7777D4cOHpY5ERCQp65TuCiUMvg2ljmPfZHLo/cKRn5/PL/NIchUqtNavX48ff/wRDz/8MGT3fOvStGlTXL582WbhiKjshBD47rvvcPToURg9gpFfr0u1/VZUOHkgp2EvmGVyfPHFWMTExEgdiYhIMocOHUJKSgr0Pg0BpVrqOHbPUKsRIFdi3bp1MJvNUschB1ahQuvmzZvw8ys6sD4nJ6dQ4UVEVefnn3/Gtm3bYHLxQ15YD0BWvee6MbvWQm5YT+gNBowaNYoDl4nIYXFKdxu7Z6r3o0ePSp2GHFiFPok99NBD+P33360/W4qruXPnolOn6rW4HpEjWL16NZYtWwaz1hO5jXoBCqXUkcrE5BGEvHoPIzs7Gx9++CFu3rwpdSQioirFKd0rh8GvYHyypYglkkKFPo1NnDgRjz/+OM6dOwej0Yhp06YhJiYGhw8fxt69e22dkYhKsXv37oLp0tUuyG3Uu8oXJH5QRt8GyDfk4WbCMXz00ceYMWM6XF1dpY5FRFQl1qxZAwDQ+7M1y5bMzoWneg8JCZE6EjmgCrVode7cGYcOHUJubi7CwsKwfft2+Pv74/Dhw4iIqH6D74lqqtOnT+Prr78GFGrk3p3Nzx4ZAlpA798MV67E4bPPPoNer5c6EhFRpcvIyMD2qCiYNe4weQRLHafGscy6aylmiapauQstg8GAIUOGwNnZGb/++ivOnj2Lc+fOYfHixWjRokVlZCSiYly7dg2ffDIGRpNAboNHYXb2kjrSA9EFt4fBqx6io6Px7bffckFjIqrxfv/9dxj0+oIFijnG3eaMnsEwa9ywbds2ZGdnSx2HHFC5Cy2VSsVF4Igkdvv2bXz88cfIybmDvNCHYXIPkDrSg5PJkF//ERhd/bFjxw4sXLhQ6kRERJXGaDRi3fr1gELNKd0ry92p3nU6XaG5BYiqSoW6Dj7zzDNYv369jaMQUVnodDqMGfMpkpOToavTFkafMKkj2Y5cifwGj8Ksdcevv/6K7du3S52IiKhS7Nu3D2k3b0Lv2xBQqKSOU2MZfBsBChXWrl0Lo9EodRxyMBWaDKNBgwb48ssvcejQIURERMDFxaXQ70eMGGGTcERUmGWtrHPnYmDwaQB9QCupI9mcUGmR27AXXM9vxrfffos6deqgWbNmUsciIrKpVatWAQD0nNK9cinV0Ps0RGrqORw4cADdu3eXOhE5EJmowECI0NDQkk8okyEuLu6BQlUnWVlZ8PDwQGZmJtzd3aWOQw5uyZIlmDt3Loyu/shr/DggV0gdqdIospLg/Nc2eHq44+effy527T4iInsUExODt99+GwbPEOQ3fFTqOGXmHLMBitx0mJx9kNvsKanjlJksPwuuf65Gs2bNMHPmTKnjkJ0rT21QoRatK1euVCgYEVXc0aNH8csvv0BoXJHfoGeNLrIAwOQegPy6HZFx7RA+/fRTzJgxAxqNfU1dT0RUHEtrlqE2W+urgtC6w+BZFzExMTh37hyaNm0qdSRyEBUao3UvIQRnByOqZImJiRg//ksImQK5YY9CqJykjlQlDH5NoK/VCH/99RemTJnC1xoisnvJycnYu3cfTM4+MLn6Sx3HYRj8C4paS5FLVBUqXGgtWrQILVq0gJOTE5ycnNCyZUv89ttvtsxGRCiY/OLzzz8vmGGwXheYXXykjlSldHU7weRSC9u2bcPmzZuljkNE9EDWrFkDIczQ127OKd2rkMmtNkzOPti7dy+SkpKkjkMOokKF1pQpU/Cf//wH/fr1w8qVK7FixQo8/vjjGD58OH744QdbZyRyaNOmTcPly5eh9wuXbIZB7eU9cI7ZAO3lPVV/cbkCeQ16Qii1mDZtGi5evFj1GYiIbCA7OxubNm+GULvA6FXyeHeqBDIZ9LWbw2w2cwFjqjIVKrRmzJiB2bNn45tvvsGTTz6Jp556Ct9++y1mzZqF6dOn2zojkcPavn07IiMjYXLxhS64vWQ55PmZUOSmQ56fKcn1hdoFefW7wWg0Yty4ccjJyZEkBxHRg9i8eTPy8/Kg828KyB949AaVk9ErFELtis2//84FjKlKVOhZnpSUhM6dOxfZ3rlzZzbHEtnI9evXMXnKFEChRl5Yjxo/+cX9mDzqQBfQCjdu3OB4LSKyOwaDAavXrClYoLhWY6njOCa5HDr/psjPy8OmTZukTkMOoEKFVoMGDbBy5coi21esWIGGDbm6OdGDMhgMGD9+PHT5+cir1wVC4yZ1pGpBX6cNjK7+2LlzJ7Zu3Sp1HCKiMtuxYwfS09Kg920EKNRSx3FYhlqNAYUaq1evhl6vlzoO1XAVmt593LhxGDRoEPbt24cuXbpAJpPhwIED2LlzZ7EFGBGVz/z58xEbGwt9rUYwerMfv5VMjvz63eB6bj2mTZuOFi1aICgoSOpURESlMpvNWLZsOSCTQ88p3aWlUEHn1wS3ks5g+/bteOKJJ6RORDVYhVq0nnvuORw9ehS+vr5Yv3491q5dC19fX/zxxx945plnbJ2RyKGcOnUKy5cvh1nrAV1wB6njVDtC44q8kM7Iz8/D119/DaPRKHUkIqJSHTp0CPHx16D3aQChdpE6jsMz+DcD5AosW7YMJpNJ6jhUg1WoRQsAIiIisHjxYltmIXJ4d+7cwYQJEyAgQ179boBCJXWkasnoXR+GjAScP38eS5cuxeDBg6WORERULCEEli5dCgDQ124hcRoCAKFygt6nIRITL2D//v3o3r271JGohqpQi1ZkZCS2bdtWZPu2bduwZcuWBw5F5KhmzJiB1NRU6AJbw+ziK3Wcai2/bkcItSt+/fVXXLhwQeo4RETFOn36NM6dOweDVwiEk4fUcegufe3mAGRYsmQJJ1eiSlOhQmvUqFHFNrUKITBq1KgHDkXkiPbv349t27bB5FIL+oCWUsep/pRq5IV2hclkwoQJE6HT6aRORERUxG+//QYA0Ae0kjgJ3Uto3WHwDkVsbCz++OMPqeNQDVWhQis2NhZNmzYtsr1Jkya4dOnSA4cicjS3bt3C999/D8iVyKv/CCDj+iplYXIPgN6/GeLjr+GXX36ROg4RUSExMTE4ceIEjB5B7KVQDekDC4rfRYsWsVWLKkWFPs15eHggLi6uyPZLly7BxYWDPInKQwiB77//HpmZmcgPagehZdeS8tAFRcCs9cSqVasQHR0tdRwiIitLa5aOrVnVktnJCwaveoiJicGpU6ekjkM1UIUKrSeffBLvvfceLl++bN126dIlfPDBB3jyySdtFo7IEURGRuLQoUMwugfC4BcudRz7c08r4IQJE3Dnzh2pExER4a+//sKRI0dgdAuA2c1f6jhUAkuXzl9//VXiJFQTVajQ+u677+Di4oImTZogNDQUoaGhaNKkCXx8fAq6PxFRmSQkJGD6jBmAUo380K6ATCZ1JLtkdvGFLrA1bt68ialTp0odh4gICxcuBADoA1tLmoNKZ3bxgdEzGKdOnWKrFtlchaZ39/DwwKFDhxAVFYXTp0/DyckJrVq1QteuXW2dj6jGMhqN+Prrr6HLz0deWHeurfKA9AEtocxMwI4dO9CxY0c89thjUkciIgd14cKFgp4KbrVhcg+QOg7dhy6wDZQZ17FgwQJMmzZN6jhUg5SrRevo0aPW6dtlMhl69+4NPz8/fP/993juuefwf//3f5z5i6iMFixYgPPnz8Pg0wBG7/pSx7F/MjnyQh8BFCpMnjwZN27ckDoRETmov1uz2kgbhMrE7OILg2ddnD59mmN9yabKVWiNHTsWZ86csf78559/4o033kCvXr0watQobNq0CRMnTrR5SKKa5vjx41i6dCnMWnfkh3SSOk6NIbTuyAvpjLy8PIwbNx4Gg0HqSETkYM6fP28dm8XWLPth6eK5YMECzkBINlOuQuvUqVN49NFHrT8vX74c7du3x9y5czFy5EhMnz4dK1eutHlIopokNTUVX375JQRkyKvfHVCopI5Uoxh9wqD3bYiLFy9gzpw5UschIgczb948AIC+Dluz7ImlVevMmTM4duyY1HGohihXoXX79m34+/89c87evXvx+OOPW39+6KGHcP36ddulI6phDAYDxo4dWzCVe92OXFelkujqdoLJyRtr1qzBzp07pY5DRA4iOjoax48fh9EjCCa32lLHoXLS14kAAPzyyy9s1SKbKFeh5e/vjytXrgAA9Ho9Tp48iU6d/u72lJ2dDZWK384TFUcIgenTp+PcuXMw+DSAoVZjqSPVXAol8hr0BBRqfPPNt4iNjZU6ERHVcEII68LpujptJU5DFWF29oLBOwx//fUX9u/fL3UcqgHKVWg9/vjjGDVqFPbv34/Ro0fD2dm50EyDZ86cQVhYmM1DEtUE69atw6ZNm2By9kF+SGdO5V7JhNYdufW7Qa/XYfToT5Ceni51JCKqwY4ePYqYmBgYvOqxt4Id09VpA8jkmDdvHkwmk9RxyM6Vq9D66quvoFAo0K1bN8ydOxdz586FWq22/n7+/Pno3bu3zUMS2bvDhw/jxx9/hFA5I6/hY4CiQisrUDmZPIORH/QQ0tJu4pNPxiAvL0/qSERUA5lMJvz0888AZNCzNcuuCa079L4Nce3aNWzfvl3qOGTnyvVpr1atWti/fz8yMzPh6uoKhUJR6PerVq2Cq6urTQMS2bvz589j7NixMEOO3AaPcr2sKmao3Rzy/ExcvHgB48aNw1dffQWlkoUuEdnOjh07cCUuDnrfRjA7eUodhx6QPrAN1OmXMW/efPTs2RMajUbqSGSnytWiZeHh4VGkyAIAb2/vQi1cRI7u2rVr+PjjUdDp9cgN6wGzay2pIzkemQy6ep1h9AjCkSNH8P3338NsNkudiohqCJ1OVzDToFzJmQZrCKF2hs6/GdLSbmLt2rVSxyE7VqFCS0qzZs1CaGgotFotIiIiyjxY8eDBg1AqlWjdunXlBiS6KyEhAe+//z6ysjKRV+9hmDyDpY7kuGRy5IX1gMmlFrZu3Ypp06ZxRikison169cjNTUVOv+mNbLHgvPZdXCJXgaX6GWQ594CAMhzb8Elehmcz66TOF3l0Qe0gFBqsXjxEmRlZUkdh+yUXRVaK1aswHvvvYcxY8YgOjoaXbt2Rd++fREfH1/qcZmZmRg8eHChNcCIKtONGzcwcuRI3Lp1C/l1O8Lo21DqSKRQIbdRb5icfbBhw4aCMXMstojoAWRlZeG3334DlBroa7eQOk6lkBnyITfmQW7MgwwFr5kyiIKfDfkSp6tECjV0Aa2Qk3MHixcvljoN2Sm7KrSmTJmCYcOG4fXXX0d4eDimTp2K4OBgzJ49u9Tj3nzzTbz00kuFpqInqizXrl3Du+++i9TUVOQHt4fBv6nUkchCqUFu4z7WNbamTJnCboREVGGLFi3CnTt3kB/QGlByHE9NY/BrArPGHWvWrkViYqLUccgO2U2hpdfrceLEiSKzGvbu3RuHDh0q8bgFCxbg8uXL+OKLL8p0HZ1Oh6ysrEI3orKKjY3FiBEjkJ6ejvy6HWGo3VzqSPRPSi1ymzwOk4svNm3ahIkTJ8JoNEqdiojsTEJCAtatWw+zxh0GvyZSx6HKIFdAF9QOJqMRP//8s9RpyA7ZTaGVlpYGk8kEf3//Qtv9/f2RnJxc7DGxsbEYNWoUlixZUuZZxiZOnAgPDw/rLTiY42qobI4dO4Z33x2BzMws5NV7mC1Z1ZlSi9xGj8Po6o+oqCiMGjUKubm5UqciIjvy888/w2QyQhfcDpAXnSCMagajVwiMrv7Yu3cv/vzzT6njkJ2xm0LLQvaPRV6FEEW2AQVrWrz00ksYN24cGjVqVObzjx49GpmZmdbb9evXHzgz1Xxbt27FqFGjkK/XI69BTxhrlf0xRxJRqpHXqA8MnnVx/PhxjBgxAmlpaVKnIiI7cObMGezbtw9GV38YPUOkjkOVSSaDLvghAMDMmTPZ3ZzKxW4KLV9fXygUiiKtV6mpqUVauQAgOzsbx48fxzvvvAOlUgmlUonx48fj9OnTUCqV2LVrV7HX0Wg0cHd3L3QjKonJZMKcOXMwadIkmGQq5DTuC6MX33TthkKJ/AY9ofdrgkuXLuHNN9/EhQsXpE5FRNWY2WzGjBkzAAC6uh2AYr7spZrF7OoHg3d9XLhwATt27JA6DtkRuym01Go1IiIiEBUVVWh7VFQUOnfuXGR/d3d3/Pnnnzh16pT1Nnz4cDRu3BinTp1Chw4dqio61VDZ2dn45JNPsHz5cpi1nrgT/gTMrn5Sx6Lyksmhq9sJ+cEdkJ5+C++++y62b98udSoiqqa2bt2K2NhYGHwbwuziK3UcqiK6oHaAXImffv4ZeXl5UschO1G2gUvVxMiRI/HKK6+gXbt26NSpE37++WfEx8dj+PDhAAq6/SUmJmLRokWQy+Vo3rzwRAR+fn7QarVFthOVV2xsLD7//HMkJSXB6BGMvLBugIKLddstmQyG2s1gdvKEc9xuTJgwAefOncNbb73FRdiJyCo3Nxc/z50LKJTQ1YmQOg5VIaFxha52C6TfiMayZcswdOhQqSORHbCbFi0AGDRoEKZOnYrx48ejdevW2LdvHyIjIxESUtBVKykp6b5rahE9CCEENm7ciLfeegtJSUnQBbZGXsNHWWTVECaPOrgT/iRMzt5Yv3493n33XSQlJUkdi4iqicWLFyPj9m3oareCUDtLHYeqmL52Cwi1C5YtX17iRGxE95IJrthZqqysLHh4eCAzM5PjtRxcdnY2Jk+ejD179kAotcir3w0mjzpSx6oSzjEboMhNh8nZB7nNnpI6TuUzG6G5dgTqtL/g7OKCD0aO5ILnRA4uISEBr732GvQKLXKaPwvI7apTUIW5RC+D3Fh8Vzmz0gk5bV6s4kTSUqZfhlPcXnTr1g3jxo2TOg5JoDy1gV21aBFJJTo6GkOGDMWePXtgdPVHTtMnHabIckhyJXShDyMv9BHk5uvx5ZdfYsKECcjJyZE6GRFJZObMmTAajdAFd3CYIouKMnrXt073Hh0dLXUcquZYaBGVIj8/H7NmzcLIkSORlp4OXZ0I5DXpC6FxlToaVQGjbwPcafoUTC61sH37dgwZOhQnT56UOhYRVbGjR4/i8OHDMLoHwuhZV+o4JCWZDLqQjgBkmDZ9Ohe8p1Kx0CIqwZkzZzBs2DCsXLkSJo07csKfgD6wFSDj08aRCK07csP7QxfYBqmpNzFy5EhMmTKFCxwTOQiDwVAwnbtMxuncCQBgdvaBvlYjXL1yBRs3bpQ6DlVj/MRI9A85OTmYPn06/vvf/yIx8QZ0tVsgp9lTnMbXkcnk0Ndpg5zwATA5e2Pjxo147bXXcOTIEamTEVElW716NRISEqD3awqzk5fUcaia0NeJAJQazJs3HxkZGVLHoWqKhRbRXUII7Nu3D4MHD8batWth0nogJ7w/9MEPsT8+AQDMLj7IDR9Q0Lp1Mw2jRo3C2LFjkZaWJnU0IqoEN2/exK+LFkGonKALbCN1HKpGhEqL/DptkZNzB3PnzpU6DlVTLLSIANy4cQNjxozB559/jvTbGdDVaYucpk9xAWIqSq4oaN1q9jSMrv7Ys2ePtThnX32imuWnn35Cfl4e8oPaAUou40GFGWo1hsnZG5GRkbhw4YLUcagaYqFFDi0/Px/z58/Hq6++ikOHDsHoHog7zZ6BPrA1IFdIHY+qMbOTJ/Ka9ENevYeRqzdh+vTpeOON/8OpU6ekjkZENnD69Gns2LEDJpdaMPo0kDoOVUcyOXR1O0EIgalTp8JsNkudiKoZFlrkkIQQ2L17N1555RUsWrQIepkaeWE9kNeoD4SW66VRGclkMNZqhDvNn4O+VmNcuRKH9957D+PGjUNKSorU6YiogoxGI6ZOnQYAyA/pxAkwqEQmN38YfMJw4cIFbNmyReo4VM1w4Ak5nJiYGMyaNQsxMTGAXAFdQCvoA1oCCpXU0chOCZUWunpdYKjVGNprR7B7924cOHgQA59/Hi+99BJcXFykjkhE5bBhwwZcuRIHfa3GnAiJ7ksX9BBUGfH46aef0bVr1/suYkuOgy1a5DCSkpIwfvx4vP3224iJiYHBK7Sgm2BQBIsssgmziy9yw/sjr3436KHGkiVL8PLLL2Pjxo0cv0VkJ27duoV58+ZBKDXQBUVIHYfsgFA7Iz+wDbKyMjF//nyp41A1wkKLarzbt29jxowZ+Pcrr2DXrl0wudRCTpP+yG/Qg90EyfZkMhh9wnCnxbPQBUUgIzsHU6ZMwWuvvYY9e/ZACCF1QiIqxU8//YTc3Fzo6kQASq3UcchOGPyawuzkiQ0bNiI2NlbqOFRNsNCiGisnJwcLFizAiy+9hDVr1sCgdEZeWHfkhj8Bs5u/1PGoppMroQ9ohTst/gW9XzgSEm9g7NixGD58OE6cOCF1OiIqxtmzZ7Ft2zaYnH1hqNVI6jhkT+Ry5NftBCHMnBiDrDhGi2qcvLw8rFu3DsuWL0d2VhaEyhm6kM4w+DYC5PxugaqWUDlBF9IJev9m0CRG4+LFi/jggw/Qpk0bDBkyBC1btpQ6IhEBMJlMmDp1KgDLBBh8v6DyMbkHwOBdHzExMdi+fTsef/xxqSORxFhoUY2h0+mwceNGLFmyBBkZGRBKDfRBEdD7NQMUfKiTtITWHflh3aAPaA5N4klER0cjOjoaDz30EIYMGYKmTZtKHZHIoW3cuBGXLl2C3rcRzK61pI5DdkoX3B6qzOuYM2cOunTpAjc3N6kjkYT46ZPsXn5+PjZt2oRly5bh1q1bgEINXZ220Ps3BRRcYJKqF7OzD/Ia9oL8zk1obpzEsWPHcOzYMXTo0AGDBw9Gs2bNpI5I5HAyMjLwyy/zAKUG+qB2UschOybUzsgPaI2MhGNYuHAh3n33XakjkYRYaJHdys3NxcaNG7F8+XJkZGQUFFgBraCv3RxQaqSOR1Qqs2st5DXqA0V2CtQ3TuLo0aM4evQo2rVrh8GDB7NLIVEV+vnnn5GTcwf5IZ0gVJwAgx6Mwb8p1Gl/Ye3adejXrx/CwsKkjkQSYaFFdic7Oxvr16/HqlWrkZWVCSjV0AW2KWjBYoFFdsbk5o+8xn3vFlyncPz4cRw/fhytW7fGv//9b0REREDGxVKJKs25c+cQGRkJk7MPDLUaSx2HagK5AvkhneB8cSumTZuGadOm8XXcQbHQIrtx69YtrF69GuvWrUNeXl7BGKw6baH3awoo2UWQ7FtBwdUH8jup0Nw4jVOnTuHUqVNo3LgJ/v3vl9GlSxfIOZkLkU0VmgCjbkdOgEE2Y3IPhMGrHs6cOYOdO3fisccekzoSSYCFFlV7N27cwMqVK/F7ZCQMen3BLILB7Qu+eeRCw1TDmF39kNeoF+S56VDfOIOLFy/gs88+Q0hICF588UU8+uijUKn4uCeyhS1btuCvv/6CwacBl/0gmyuYGCMBs2bNQufOneHs7Cx1JKpiLLSo2oqNjcWyZcuwe/ceCGGGWeMGfUg7GHwbAnKF1PGIKpXZ2Qf5DXpAl98W6qQ/cS3+EiZNmoRffpmHgQOfxxNPPME3baIHkJWVhZ9+/rlgfG8wJ8Ag2xMaV+gCWuJW4kksWrQIw4cPlzoSVTEWWlStCCFw8uRJLF++HMeOHQMAmJx9oK/dAkbveuzWQQ5HaD2gC30Y+jptoE6OQVraRcyaNQu/LlqEZ55+Gs8++yy8vb2ljklkdxYsWIDsrCzkB7eHUPFLC6oc+trNoUq7hFWrVqN///4IDg6WOhJVIRZaVC0YjUbs2bMHy5evwKVLsQXb3AOhr90CJvdAgINIycEJtQt0ddtDF9gK6tQLEKnnsHjxYqxYsQJ9+vTBwIEDUbduXaljEtmFuLg4bNiwAWatJwx+XMOOKpFcify67SGP3YGZM2di0qRJUieiKsRCiySVm5uL33//HatWrUJqaiogk8HgXR/62s1hdvGVOh5R9aPUQB/YCvrazaBKuwRzSgw2b96MzZs3o0uXLhg0aBBatGjBGa6ISiCEwIwZM2A2m5FftwPASWaokpk8gmF0r4MjR47g8OHD6NSpk9SRqIqw0CJJpKamYu3atdi4aRNyc3IAhRJ6/2bQ+zeF0HAVdaL7kith8GsCQ63GUGbEQ5X8Jw4ePIiDBw+iSZMmGDRoELp27Qqlki/zRPfau3cvoqOjYfCsC5NHHanjkCOQyaCr2wHKmPWY8eOPiIiIgFrN2ZIdAd+BqUrFxsZi5cqV2LVrF0wmE4TKGfo6EdD7NeEaWEQVIZPB6BUCo1cI5HdSoU4+iwsXLmLcuHHwr10b/3ruOfTv358TZxAB0Ol0mDV7NiCTQxfcXuo45EDMTp7Q+zXFjcSzWLt2LV544QWpI1EVYKFFlc5sNuOPP/7AihUrEB0dDQAwOXlBX7s5jN71OYMgkY2YXf2Q36AndPlZUKfEICU1FjNnzsSChQvx5IABePbZZ+Hn5yd1TCLJrFy5EqkpKdDVbgmhdZc6DjkYXWBrqG5dwq+//orevXtzIiMHwEKLKo1Op0NUVBRWrlyF+PhrAACjex3oazfnBBdElUho3aEL6QRdnbZ3J844j+XLl2PVqlXo2bMnBg4ciIYNG0odk6hKpaWlYfGSJRAqJ+gDW0kdhxyRUg1dYFvIrh3CvHnz8L///U/qRFTJWGiRzWVmZmLDhg1Yu3YtMjIyAJkcBt+G0Ps3g9mZ394QVRnrxBnNobwVB3XyWURFRSEqKgpt27bFoEGD0L59e06cQQ5h7ty50OXnI7/ew1zsniRjqNUIqtTziIyMxNNPP80vvWo4FlpkM4mJiVi1ahUiI7dAr9dBKDXQB7SEwa8phJrjQ4gkI1fA6NsQRp8GUGTdgDr5LE6ePImTJ08iNDQUgwYNwqOPPgqVih8+qWa6cOECtm3bBpOzD4y+/GBLEpLJoavbEYqLWzBz5kz88MMP/LKrBmOhRQ/swoULWL58Ofbu3QchzDBr3KCv2wYG34b81pCoOpHJYPKogzyPOpDn3oI6+SyuXI3DpEmT8PPPP+P555/HgAED4OrqKnVSIpsRQmDWrFkAAF3dDuy2TpIzuQfA4FkXp06dwqFDh9ClSxepI1ElYaFFFSKEwB9//IHly5f/PcGFiy/0tVvA6BUCyLguCVF1Znb2Rn79R6ALioAq5Rxu3byIn376Cb/99hueeuopPPfcc/D15Vp2ZP8OHDiAM2fOwOAZApNbbanjEAEAdMEPQZWZgNmzZ6NDhw5ciqOG4r8qlYvJZMKePXuwZMkSxMXFAQCMHkHQ125R8AbGbwprDOez6yAz5AMAZMaC/8pzb8ElehmESovc5s9IGY9sRKhdoA9+CPrAVlClXoRIjcGyZcuwatUq9O7dGy+99BKCgoKkjklUIUajEXPmzLk7nXs7qeMQWQmtB/S1miAh4Rw2btyIZ599VupIVAlYaFGZ6PV6bN++HUuXLcONxERAJoPBJwz62i04wUUNJTPkQ27MK7wNAjJjHswSZaJKpFDDENACBv+mUKZfhib5LCIjI7Fly1b06NEdL7/8MsLCwqROSVQuGzduRGJiIvT+TSG0HlLHISpEH9ga6vRLWLBwIXr37s1u2zUQCy0qlU6nw6ZNm7Bs+XKkp6UBcgX0fuHQ124OoXGTOh4R2ZpcAWOtRjD6NoQy4xrUN85g165d2LVrFzp27IjBgwejadOmUqckuq/c3Fz8+uuvgEINXWBrqeMQFSFUWuQHtAISjmH58uV4/fXXpY5ENsZCi4plKbCWLF2K27duAQoVdLVbwFC7GYSKMwgS1XgyGYxe9WD0DCmYqTDpNI4cOYIjR46gQ4cOePXVV1lwUbW2YsUKZGZmQlcnAlBqpY5DVCyDfzg0qeewcuUqPPPMM/Dx8ZE6EtkQCy0qRK/XY9OmTVi8ZMnfBVZga+j9mwFKjdTxiKiq3TNToSI7Geobp3D06FEcPXoUHTp0wJAhQ9CkSROpUxIVcuvWLSxfsQJC5Vzw/kVUXcmVyA9sA9nVA1i4cCE++OADqRORDbHQIgAFk1xERUVh/vz5SE1NZYFFREWY3Gojr/HjRQqubt26YdiwYahbt67UEYkAAIsWLYIuPx+6el0ABT/qUPVm9G0Ac8pZ/P777xg4cCCCg4OljkQ2wjm4HZwQAgcPHsSwYcMwadIkpKalQ1e7BbJbDoS+TlsWWURUhKXgym3SDyZXP+zduxevvfYavv/+e6SlpUkdjxxcUlISNm3eDLPWo2A9R6LqTiZHfp12MJvNWLhwodRpyIb4NY8Di4uLw4wZMwrWwZLJoK/VGPrA1hBqF6mjEZEdMLnVRm6T/lBkXIc28Tg2b96MqB078Mq//43nn38eGg2/qKGq99tvv8FkNEJXtw3XdCS7YfIMhsnFF7t27cLLL7+M+vXrSx2JbICvQA4oKysLU6dOxbBhryM6OhoGz7q40+xZ6Op1YZFFROUjk8HkVRc5zZ5GXr2HkW+S4ZdffsGrr76G/fv3QwghdUJyIAkJCdi6dStMTl4weodKHYeo7GQy6Oq0hRCCrVo1CFu0HIgQArt27cK0adORlZUJs9YT+XXbw+TBxUiJ6AHJ5DDWaoQ73vWgvnEaySkx+Oyzz9CxY0eMHDkSfn5+UickB7Bw4UKYzeaCru8ymdRxiMrF5F4HRld/7Nu3DxcvXkTjxo2ljkQPiC1aDiI1NRWjR4/Gl19+iaycHOQHt0dOs6dZZBGRbSnU0Ac/hDvNn4XRvQ6OHDmCwa++ivXr18Ns5lLXVHni4+Oxc+dOmJx9YPTkxCxkh2Sygi8JUDChC9k/uyu0Zs2ahdDQUGi1WkRERGD//v0l7rt27Vr06tULtWrVgru7Ozp16oRt27ZVYdrqYceOHXj11Vdx5MgRGN3r4E6zZ2Go3RyQ290/PxHZCaF1R16j3sgLfQT5BjOmTp2KkSNH4ubNm1JHoxpqyZIlEEJAH9iarVk2NmvWrGJvZHsm9wAY3Wrj4MGDuHTpktRx6AHZ1SftFStW4L333sOYMWMQHR2Nrl27om/fvoiPjy92/3379qFXr16IjIzEiRMn0KNHDwwYMKBg8gcHkJ+fj2+//RZfffUV8vQm5IV2RV6j3hAaV6mjEZEjkMlg9G2AO82fhcGrHk6dOoVhw17H0aNHpU5GNUxSUhKioqIKxmaxNYvsnD6gFYCCLw/IvsmEHY1U7tChA9q2bYvZs2dbt4WHh+Ppp5/GxIkTy3SOZs2aYdCgQfj888/LtH9WVhY8PDyQmZkJd3f3CuWWQlJSEkaPHo2rV6/C5OyLvLDuEFr7yU/Sc4leBrkxr9jfmZVOyGnzYhUnIrsmBFQ3L0J7/ShgNmHw4MEYMmQIZGx5IBuYPHkyNm3ahLyw7jB6c7Y2W+J7gQSEgPP5zVDmpmHhwoUICQmROhHdozy1gd20aOn1epw4cQK9e/cutL137944dOhQmc5hNpuRnZ0Nb2/vEvfR6XTIysoqdLM3Fy9exH/eegtXr16F3r8pcsP7s8giImnJZDD4NUFO+BMwa92xaNEiTJo0CQaDQepkZOfS09OxZcsWmLUeMHrVkzoO0YOTyaALbAUhBJYuXSp1GnoAdlNopaWlwWQywd/fv9B2f39/JCcnl+kckydPRk5ODgYOHFjiPhMnToSHh4f1Zm+rc584cQIj/vtfZNzOQH5IJ+jqdgTkCqljEREBAMzOPsgJfwImVz9s27YNo0aNQn5+vtSxyI6tXbsWRqMRutotuG4W1Rgmj2CYnLywY+dOLgRvx+zuFemf3UyEEGXqerJs2TKMHTsWK1asKHWa4dGjRyMzM9N6u379+gNnrioXLlzAJ2PGQKc3ILfBozD4hUsdiYioKKUWuY0fh8ErBCdOnMC4ceNgNBqlTkV2KDc3F+s3bIBQOcHoEyZ1HCLbkcmg928Gk9GItWvXSp2GKshuCi1fX18oFIoirVepqalFWrn+acWKFRg2bBhWrlyJxx57rNR9NRoN3N3dC93sQUJCAj766GPodDrkhvWAyYuDgYmoGpMrkV+/B4weQTh8+DCmTJnCxY2p3LZu3YqcO3eg9wtn7w2qcYw+YRAqJ2zYuBG5ublSx6EKsJtCS61WIyIiAlFRUYW2R0VFoXPnziUet2zZMrz22mtYunQp+vfvX9kxJWE0GjF27FhkZWUiL6QLTJxxiYjsgVyOvLAeMLnUQmRkpEMuv0EVZzKZsGrVKkCuhN6vidRxiGxProDeryly7tzB1q1bpU5DFWA3hRYAjBw5Er/88gvmz5+P8+fP4/3330d8fDyGDx8OoKDb3+DBg637L1u2DIMHD8bkyZPRsWNHJCcnIzk5GZmZmVLdhUqxePFiXLp0CfpajWCs1UjqOEREZadQIS+sB6BQY/qMGUhNTZU6EdmJ48ePIykpCXqfMECplToOUaXQ+zUG5AqsX7+Brf52yK4KrUGDBmHq1KkYP348WrdujX379iEyMtI67WVSUlKhNbV++uknGI1GvP322wgICLDe/vvf/0p1F2wuNTUVvy1eDKFxhS64g9RxiIjKTWhckVe3A3JzcjB37lyp45Cd2LBhAwDAwNYsqsmUWhi86iE+/hpOnz4tdRoqJ6XUAcrrrbfewltvvVXs7xYuXFjo5z179lR+IImtW7cOJqMR+cFtAIVK6jhERBVi9GkAU/JZ7Nq1C2+88UapkxYRpaSk4PDhIzC5+MHs7CN1HKJKpfcLhyr9MjZs2IDWrVtLHYfKwa5atKgwo9GIjZs2QaicuUAjEdk3mQz62s1hMpnw+++/S52GqrnNmzdDCDPHZpFDMLvUgsnJG/v278etW7ekjkPlwELLjl26dAk5d+7A4FWXsy0Rkd0zetUDZDKcOnVK6ihUjZnNZmzdug1QqGH0rid1HKLKJ5PB4NcYJqMRO3fulDoNlQMLLTsWExMDADC5lj69PRGRXVCoYHLyxrlz57iuFpXozz//xM2bqdB71wPkdjcCgqhCDN6hgExeZPZtqt5YaNmx9PR0AIBZYx9rfRER3Y9Z4w6DwYA7d+5IHYWqKcsHTaNPA4mTEFUhpRYGjyD89ddfuHbtmtRpqIxYaNmxvLy8gv9R8Bs9Iqoh7r6eWV/fiO6h1+uxe88eCLULe3OQwzH6FIzH37Fjh8RJqKxYaNkxtVpd8D8mdrEhohri7uuZ9fWN6B4nT55Ezp070HvXB2QyqeMQVSmjZ11AocLu3buljkJlxKYQO+bvX/Btnlx/B2bUkjgN1USzZs0qdvvwER9UcRJyFHL9HahUKnh5eUkdhaqhQ4cOAQCMXiESJyGSgFwJg3sdJCRcRUJCAoKCgqRORPfBFi07FhwcDACQ53KqTyKqAYQZivwMBAUFQS7n2xMVJoTAocOHIZRamF18pY5DJAmjZ8Fnv8OHD0uchMqCLVp2rFmzZpDL5VBkJ0sdhWqokhYHh9KpaoOQQ5DnpAMmA1q1aiV1FKqGLl26hLSbNwsmwZCxECfHZPIoaMU6fPgwnn/+eYnT0P3wlcqOOTs7Izw8HMqcm4AxX+o4REQPRJl5HQDQpk0biZNQdfTHH38A+PsbfSJHJFROMLnUwunTpzlpkB1goWXnunXrBggzVLc51ScR2TEhoLp1BRqNBu3bt5c6DVVDZ8+eBQCY3GpLnIRIWka3AJhMJly4cEHqKHQfLLTsXPfu3SGTyaBMvyx1FCKiCpPnpkOen4kuXbrAyYldU6kwIQTOnj0Ls8YdQsXHBzk2k5sfACAmJkbiJHQ/LLTsnJ+fH9q1awdldjJk+ZlSxyEiqhDVzYsAgL59+0qchKqj69evIzs7GyZXP6mjEEnO7FLwPLC08lL1xUKrBujfvz8AQJ16UeIkREQVYDJAfSsO/v7+iIiIkDoNVUOWb+5ZaBEBQqWFWeuOmJgYCCGkjkOlYKFVA3Tp0gVeXl5QpV8CzFy8mIjsiyr9MmAyYMCAAZzWnYoVHx8PADA5e0uchKh6MDl5Izs7GxkZGVJHoVLwHa0GUKlU6N+/P2TGfCg5KQYR2RnVzYtQKBTsNkglSkhIAACYte4SJyGqHizPBctzg6onFlo1hKX7oOrmXxInISIqO3lOOhS56ejSpQt8fHykjkPVVEJCAoRCDSg0UkchqhbMGhZa9oCFVg0REBCAtm3bQpmdBJkuW+o4RERlokqLBQD069dP4iRUXQkhkJh4o+AbfJlM6jhE1YK426KVmJgocRIqDQutGqRPnz4AANWtOImTEBGVgTBDdfsKvLy88NBDD0mdhqqp3Nxc6PU6mFXOUkchqjYsz4dbt25JnIRKw0KrBunSpQuUSiWUt65IHYWI6L4U2SmQGfLQrVs3KBQKqeNQNZWXl1fwPwqVtEGIqpO7zwfr84OqJRZaNYirqyvatWsHRe4tyPQ5UschIiqVMuM6AOCRRx6ROAlVZ7m5uQAAIWehRWQhWGjZBRZaNUy7du0AAIqsGxInISIqnSIrERqNBs2bN5c6ClVjf7doKaUNQlSdyBQAZCy0qjkWWjVM27ZtARR0ySEiqraMOijybqNFixZQq9VSp6FqzGgsWB9S8CML0d9kMkAuh8lkkjoJlYKvWjVMSEgINBoNFLnpUkchIiqRIrdgAHeTJk0kTkLVnaurKwBAZtZLnISoGjEbAbMJLi4uUiehUrDQqmEUCgUaNGgARd5tQJiljkNEVCz53UKrQYMGEieh6s5aaBlZaBFZyEwGAH8/P6h6YqFVAwUFBQHCDJk+V+ooRETFkt9d7y8oKEjiJFTdWQstEwstIqu7Xzyw0KreWGjVQLVr1wbw9wcZIqLqxvL6FBAQIHESqu7UajXUajVkxnypoxBVG3JjwSQYbm5uEieh0rDQqoF8fHwAADIDZ6IhoupJZsiDVqvl+AK6L5lMhrp160KRlwEIIXUcompBnpcBAKhbt660QahULLRqIC8vLwAstIio+pIZ86yvVUT3ExYWBpiNkLGnBhGAv8e5hoWFSZyESsNCqwayFlrsZkFE1ZTcqIOnp6fUMchOWD5MKvJuSZyEqHqQ592CQqlki1Y1x0KrBvLw8ADAQouIqimTATAbra9VRPdTv359AIA8h0uXEEGYocy7jZC6daFSqaROQ6VgoVUDWcZoyQ2cdZCIqh/Z3dcmy2sV0f00bdoUKpUKyswEqaMQSU6RnQKYDGjTpo3UUeg+WGjVQM7OznBxdYVMd0fqKERERcj1OQAAf39/iZOQvXB2dkZERAQUuel8byOHp8y4BgB4+OGHJU5C98NCq4YKqlMHCl0WYOaixURUvcjzbgMA6tSpI3ESsieWD5XKjHiJkxBJSAgob8fD1dUNLVq0kDoN3QcLrRqqcePGgNkEef5tqaMQERWiyEkDcPd1iqiMOnfuDJlMBuXta1JHIZKMPPcW5Po76Ny5E5RKpdRx6D5YaNVQzZs3BwAoMxMlTkJEdA9hhjIrCR4enmzRonLx9vZG69atocxOsraKEjkaVep5AECPHj0kTkJlwUKrhurcuXPBwOH0y1JHISKyUmQlQWbIRY8e3SGTyaSOQ3bm+eefBwCoUmIkTkJU9WSGPKhvXUZQUBA6dOggdRwqAxZaNZSrqys6d+4MRd5tKNiqRUTVhPruB+RevXpJnITsUceOHREUFAR1+mXIDHlSxyGqUqrUC4DZhOeffx5yOT/C2wP+K9VggwcPhkwmg+b6H4DgpBhEJC1FZiKUmQl46KGH0KxZM6njkB2Sy+UFrVpmU8GHTiJHYTZCffM83Nzd0adPH6nTUBmx0KrBwsLC0K9fPyjybkN945TUcYjIgckM+XC6dggymRz/+c9/pI5DdqxPnz7w8PCAJuWsdU02oppOnXwWMkM+nnn6aWi1WqnjUBmx0Krh/u///g8BAQHQ3DgF5a2rUschIkdkNkF7eRdkumwMGfIa6tevL3UismNarRZvvPEGYDJAk3BC6jhElU6muwNN0hl4e3vjhRdekDoOlQMLrRrOw8MDEyZMgJOTE5yu7IXiNtcfIaIqZDZCe3kPlNnJ6NGjB1555RWpE1EN0LdvXzRs2BCqtFjI79yUOg5RpdIkHAPMRgwfPhzOzs5Sx6FysLtCa9asWQgNDYVWq0VERAT2799f6v579+5FREQEtFot6tevjzlz5lRR0uojNDQUX375JTRqFZwv7bRODUpEVJlkhnw4X9gKVcY1RERE4OOPP+ZMg2QTCoUCI0aMAABo4w8DQkiciKhyKLKTobp1Bc2aNeMkQnbIrgqtFStW4L333sOYMWMQHR2Nrl27om/fvoiPL76V5sqVK+jXrx+6du2K6OhofPLJJxgxYgTWrFlTxcml165dO8yYPh1eXl7QXjsMzdWDgMkgdSwiqqEU2SlwPr8JipxU9OnTB5MmTeK4ArKpFi1aoFevXlDkpHG6d6qZTAZorx6ETCbDu+++yy+q7JBdFVpTpkzBsGHD8PrrryM8PBxTp05FcHAwZs+eXez+c+bMQd26dTF16lSEh4fj9ddfx9ChQ/H9999XcfLqoVGjRpg1ayYaNGgA9c2LcI1ZB0VWktSxiKgmMRuhif8Dzhd+h0KfgyFDhmDUqFFQqVRSJ6Ma6O2334a3tze0Ccchz0mTOg6RTWnjj0Cen4kXX3wRTZo0kToOVYDdFFp6vR4nTpxA7969C23v3bs3Dh06VOwxhw8fLrJ/nz59cPz4cRgMxbfm6HQ6ZGVlFbrVJAEBAZg9ezZeffVVKI15cL64BZorByDTc+YmInoAQkCREQ+XmA1Qp5xFcN26mDnzR7z66qv8FpYqjaenJ8aMGQMZBJzi9rKnBtUYyvQ4qNJi0aRJEwwdOlTqOFRBdlNopaWlwWQywd/fv9B2f39/JCcnF3tMcnJysfsbjUakpRX/zdfEiRPh4eFhvQUHB9vmDlQjKpUKQ4YMwezZs1G/fn2o0/6C65+roU44Dhj1UscjIjsjz06B04VIOMfugFKfjYEDB+KXuXPRtGlTqaORA4iIiMALL7wAeX4mNPFHpI5D9MBkumw4XTsEJycnfPbZZ1AqlVJHogqym0LL4p/fjAohSv22tLj9i9tuMXr0aGRmZlpv169ff8DE1VejRo0wd+5cfPzxx/D19oIm6Qxc/1wFddJpwKiTOh4RVXPyO6nQxu6Ay4XfobyTgkceeQQLFy7EW2+9BY1GI3U8ciDDhg1D48ZNoE6LhfLmX1LHIao4kxFOl3YDJj3ef/991KlTR+pE9ADspkT29fWFQqEo0nqVmppapNXKonbt2sXur1Qq4ePjU+wxGo3GoT4gKBQK9O3bFz179sS6deuwePFi3Ek4AU3Saeh9GkHv3xRC6y51TCKqLoQZytvxUKecheJOKgCgZcuWePPNN9GsWTOJw5GjUiqVGDv2C7z55nDg2iHkalxhcg+UOhZR+QgB7ZW9UOSmYcCAAUWGv5D9sZsWLbVajYiICERFRRXaHhUVhc6dOxd7TKdOnYrsv337drRr144Ds/9Bo9HghRdewIoVK/D222/D39cH6tRzcP1zDbSXdkKRdYPT5zoYodLCrHQq9iZUnD3O4RjzoUqOgcufa+B0eReUOTfRpUsXTJ8+HdOmTWORRZILCAjAhAlfQ6VUwPnyLsjzMqSOVCPwvaDqaBKOQ3X7Gtq1a4f//ve/UschG5AJYT+fnlesWIFXXnkFc+bMQadOnfDzzz9j7ty5iImJQUhICEaPHo3ExEQsWrQIQMH07s2bN8ebb76JN954A4cPH8bw4cOxbNkyPPfcc2W6ZlZWFjw8PJCZmQl3d8dp2TEajdi/fz9WrFiBCxcuAADMGjcYfBvC4NMAQuMqcUIiqnTCDEXWDahuxkKVcQ0QZqjVGvTr1xfPPfdcjRzDSvZv586d+PLLL2HWuCE3/AkIlZPUkYjuS3XzIrRXDyIkJAQzZ86Eqys/Z1VX5akN7KbrIAAMGjQI6enpGD9+PJKSktC8eXNERkYiJCQEAJCUlFRoTa3Q0FBERkbi/fffx8yZMxEYGIjp06eXuchyZEqlEj169ED37t1x7tw5REZGYueuXchPPAlN4kkY3evA4NsQRs+6gMKuHkZEdB+y/Eyo0i9DnRYLmT4HABBavz769+uHXr16wcPDQ+KERCV79NFHkZiYiPnz58MpdgdyGz8OKNiLhaovRcZ1aK8dgqenJyZNmsQiqwaxqxYtKThqi1ZxcnNzsXfvXmzZsgVnzpwp2ChXwuAZDKN3fRg96gByFl1E9kimy4bq1hUob12BIjcdAODi4oLHHnsMffv2RePGjTlNO9kNIQS+++47REZGwujqj7xGvVlsUbWkyEyAc+wOaDRq/DBlCmdrtQPlqQ1YaN0HC63iXb9+HVFRUdi1axcSEhIKNirUMHjWhcE7tGAQslwhbUgiKpVMnwPlrStQ3boCRc5NAIBCqUSH9u3Rs2dPdO3a1aEmB6KaxWQyYeLEidixYweMbgHIa9iLPTCoWlFk3YBzbBTUSiW+/fYbtG7dWupIVAYstGyIhVbphBC4dOkSdu/ejV27diM5OangFwoVDO5BMHrVhdEjCFDywxqR5ISAPO8WlBnXobx9zdpypVAoEBERgR49euDhhx+Gm5ubxEGJbMNoNOKrr77Cnj17YHQPRF7Dx9jzgqoFRVYSnGOjoFLKMWniREREREgdicqIhZYNsdAqOyEELl68iN27d+PAgYNITLzb0iWTw+jmD6NnCIyedTmRBlFVMpuhuJMM5e14KDPjIdfdAVAwDrNt27Z45JFH0LVrV467ohrLaDRi3Lhx2L9/P4wedZDX4FEWWyQpRXYynGO3QykDJkyYgPbt20sdicqBhZYNsdCqGCEE4uPjceDAARw8eBDnz5+3LhZtcvKC0SMIJo8gmFz9AbndrDJAZBdk+lwoMhOgzEyAMvsGZEY9AMDF1RWdOnbEww8/jPbt28PZ2VnipERVw2Aw4IsvvsChQ4cKxmw1fIw9LUgSiox4OF/eDYVMhi+/HF/iEkVUfbHQsiEWWraRnp6Ow4cP4+DBgzh58iR0Ol3BLxRqGNwDYPIIgtEjCELtIm1QInskzFDcuWktrixdAgEgMDAQnTp1wsMPP4wWLVpAqeQ3+eSYDAYDJk2ahJ07d8Lk7I28Rr0hVPyygaqOMi0WTlcPQKPR4OuvvkK7du2kjkQVwELLhlho2Z5Op8OZM2dw9OhRHDly5O/JNFDQ2mXyqAOjex2Y3PzZvYOoBDLdHSizEqHITIQyOwkyY8GXFyqVCq1bt0bHjh3RoUMHBAUFSZyUqPowm82YMWMG1q1bB7PGHbmNekNo+d5OlU+V/Ce014/Bzd0d337zDcLDw6WORBXEQsuGWGhVvhs3buDo0aM4evQoTp6Mhl5/t7VLroDR1b+g6PIIhNnJG+D00uSoTHoospKhzEqEMusG5PmZ1l8FBASgQ4cO6NixI1q3bg2tVithUKLqTQiBRYsWYcGCBRAqJ+Q26g2zs4/UsaimEgLqhBPQJJ+Br28tTJ78vXX9V7JPLLRsiIVW1dLr9Th79iyOHz+OY8eOITY21vo7oXKC0S0QRo9AmNwCOKkG1WxmMxQ5N6HIugFF1g0oc24CwgwAcHZ2RkREBNq1a4d27dqhTp06Eoclsj8bNmzA1KlTIeRK5NbvDpNnsNSRqKYxG6G9cgCqW3EIrlsXk7//Hn5+flKnogfEQsuGWGhJKyMjAydOnMCxY8dw7NgxpKf/PfbErHWH0T0QJvdAGN0COLCZ7JsQkOdlFBRVWTegvJMMmAwAALlcjvDwcDz00EP/396dR1VV7/0Df5/5HIaDzCACDiiICioIagNazmYTeVNySp+evOWcVs6iOWSZQ9cmb6WrEn0qTSszM8cQFQXCCcUBJ3BEzmHmDN/fH8T5ReB8dDO8X2udtS57/Byu7c177+/+bERGRiIkJITPWhHZwa5du/DOO3NRVlaGkoBomLz5sliyD5mpGLrM36EovIKwsDDMmTOH3V3rCAYtO2LQqjkqOhkePHgQBw8eRGpqKoqKiv6aK4PF0R1m54aw6H35fBfVCrLSgr+CVU55d0BTsW1eQGAgIiMiEBERgfDwcDg58Q4u0YOQkZGBKVOmIDc3F2VeLVEaEA3I2A2X7p28+AYcMn+DrLQAPXv2xBtvvAG1Wi11WWQnDFp2xKBVc5nNZpw4ccIWvA4fPgyz2Vw+U66A2dELFr0vzPqGsDp68MRJkpOZiqHIz4HCmFP+nFVpvm2eh4cHIv4KVu3bt4eHh4eElRLVL1euXMHkyZNx6tSp8ndtNesKKPiHMd09heEiHE5tByxleOWVVxAXFwcZny+vUxi07IhBq/YoKSnBoUOHkJKSgoMHDyIzM9P27i4o1OUvTXYuH2po1TVgYw168CwmKPIvQWnMhsKYA0Vxrm2Wo5MT2rdrh/bt26N9+/YICAjgyZhIQkVFRZgzZw6SkpJg1TZAUfMnIbQc6kV3SAioLh+B9kIyVCoVpk6Zgi5dukhdFT0ADFp2xKBVexmNRqSlpSElJQUpKSk4d+6cbV55Yw1f2zNebKxBdmG1QlF45a8GFjmVGlio1RqEh4fZglVQUBAUCoXEBRPR31ksFqxYsQJr1qwBFGoUNY1hkwy6PYsZ2qxEqHJPwd3dHe+88w7bt9dhDFp2xKBVd1y9ehWpqam2oYbXrl2zzbNqKhprlIcvNtagOyIE5MU3/n8Di/xLgLV8+GpFA4uKoYChoaEco09US/z+++94992FKCsrRalfe5T5hnMUBFVLVpoP3cltUBRdR+vWrREfHw93d74uoC5j0LIjBq26SQiB8+fP24YZpqSmorCgwDbf4uBR3kZe7weLkxcg550HKicrKywPVhUvCv5bA4smTZrYglV4eDgcHR0lrJSI7kdmZiamTZ+Oy5cuwdQgECVNHwcUKqnLohpEYcyGw6kdgLkEzzzzDEaNGgWViv9G6joGLTti0KofLBYLMjMzbXe70tPT/9ZYQ1n+fJfe76/nu1x5ZbM+sT1ndRFKQzbkJXm2WR6enugQGYmIiAi0a9eOVzGJ6hiDwYD4+HikpKTAqm2A4qAnyp/xpfpNCKguHYb24gEoFQqMHz8effv2lboqekgYtOyIQat+KikpQXp6Og4cOIADBw7g9OnTtnlC5QCTix8sLo04zLAu+ms4oNJwAQrDRSgLLtues9LqdGjXti06dOiAiIgINrAgqgfMZjNWrFiBtWvXAgoVihs/ArNbU6nLIqmYy6DN2g3VjbNw9/DA7Ph4tGrVSuqq6CFi0LIjBi0CgOvXr+PgwYM4cOAAkpOTcePGjb/myGBx8oTZpRHMer+/2sjzD+9ax1xa3hnQcAEqw0XITOXvZ5PJZAgODkZUVBQiIyMRGhrKFwUT1VM7d+7EggULUFxcjDLvUJQ26sBh5fWMvCgXulPbIC8xon379pg+fTpcXV2lLoseMgYtO2LQon+yWq04deoU9u/fj/379+Pw4cOwWCwAAKHUwuziB3ODAJj1foCSzQ9qJCEgL8mDMu88FHnnoSy4AqD8UOjq6oqoqChERUUhIiICDRo0kLRUIqo5zp8/j+kzZiDrzBlYnLxQ3KwrhJrPYtYHymsnoTu7B7CaMWjQILz88svsHFtPMWjZEYMW3U5BQQFSU1Oxf/9+JO3di2tXr5bPkMnLn+1yCYC5gT+Elv9+JGW1lD9rlXceSsN528uC5XI5WrdujejoaERFRaFZs2aQy/lyayKqXnFxMT744AP89ttvECotipt2gUXfUOqy6EGxmqE5tw/qq8fh6OiEqVOnoHPnzlJXRRJi0LIjBi26G0IInDp1CklJSdizZw8yMjJsL022al1gahAAs2tjDjF8WMxlUBrOQ3njLFTGi4DFBKD8ZcEdo6PRuXNndOjQgf9tE9FdEUJg48aN+PDDD2E2m1HasB3KGoYDMl6kqUtkJUboTm2Houg6goKCMGfOHPj6+kpdFkmMQcuOGLTofuTm5mLfvn1ISkrC/uRklBSXtwIXakeYGgTC7BoIi7M3T852JDMVQ5l3DsobZ6E0ZtsaWfj7+6Nz587o3LkzWrVqxWetiOi+ZWRkYOasWbh86RLM+oYoaRoDodJJXRbZgTI3C7qsPwBLGZ5++mm8/vrr0GjY/IoYtOyKQYvspbS0FAcPHsTu3bvxxx9/ID+/fOiaUGrL73S5N4XF2Yeh6x7ITMVQ5p6B8kYWlPmXUfG8VXBwMB5//HE8+uijCAwMlLZIIqqT8vPzsWDBAiQmJkKoHcqHEjr7SF0W3SurBZoLB6C+fAQarRaTJk5Et27dpK6KahAGLTti0KIHwWw2Iz09Hbt27cKuXbuRm3sdwF+t492awOTeDFYHdw4vvBWLqXxIYO6pv+5cCchkMrRp0waPPfYYHnvsMfj48I8dInrwhBD49ttv8emnn8JitaLULwJlPm14DK9lZKUF5UMFC6+icePGiI+P50U6qoJBy44YtOhBs1qtOHz4MLZt24Zt27fDaDCUT9fqYXJrCpN7EBtpVBDW8hbs109BlXcesJa/VDo0NBTdunVDTEwMXxpMRJI5fPgwZs2Kx7VrV2F28Udx08f5rsVaQpF3Hg5ndgHmUvTq1Qvjxo2DVquVuiyqgRi07IhBix4ms9mMgwcPYuvWrdi9ezdKSkrKpzv7wuTZAmbXQEBe/54tkpUYobp2AuprJ23vuAoMDET37t3xxBNPoGFDdvwiopohLy8P8+bNw/79+yE0Tihq2hVWJ0+py6KbEVaoL6RAcykdKrUa48eNQ58+faSuimowBi07YtAiqZSUlCAxMRE///wzUlJSAABCqYHJrRlMni1gdXCTuMIHzGqB8kYWVFdPQJmfAwBwdnZGjx490Lt3bzRr1gwyDsshohrIarVi9erV+PzzLyAAlPhHweTVkkMJaxhZWRG0p3dAmX8JjRo1Qnx8PJo1ayZ1WVTDMWjZEYMW1QTZ2dnYtGkTfvnlF1y/Xv48l9nZF2U+rWBx8a9TJ2+ZqRiqKxlQX82AzFTepTEiIgJ9+/bFI488wq5PRFRrpKamIn72bOTduAGTa2OUNHkUUPBF9jWBwpgN3emdkJmK0bVrV0yaNAkODg5Sl0W1AIOWHTFoUU1iNpuxf/9+rF+/HsnJyQAAq0aPMu9QmDyaAwqVxBXeO3lRLtSXj0B1/RQgrHB2dka/fv3Qr18/vreEiGqt69evY86cOUhLS4NVq0dxsyfq/oiEmkwIqHP+hOZiCpRKJUaNGoVnnnmGIyTojjFo2RGDFtVUWVlZ+P7777H5119hKiuDUGpQ5t0aZd4ta9UVU3nhNWgupkJpOA8ACAgIRP/+L6B79+58EJmI6gSz2YyVK1fi66+/BuRKFAd2htkjSOqy6h9zKXSnd0FpOA8vb2/Mjo9HSEiI1FVRLcOgZUcMWlTTGQwGbNy4Ed9++x2MRkOtCVz/DFht27ZFXFwcIiMjIZfzXWJEVPfs2bMHc+fOQ2FhAco8Q1AaEA3IFVKXVS/IC6/B4dR2yErzER0djalTp/LvOronDFp2xKBFtUVRURF++OEHJKxZg3yjEUKpQWnDdjB5hdSolyDLSvOhOb8fqhtnAQDt2rXD0KFD0bZtW2kLIyJ6CLKzszFjxgycPHkSFkcPFDd7AkLjJHVZdZrq6glozyVBJqx4+eWXMWjQIF7Qo3vGoGVHDFpU2xQVFWH9+vVYvToBhYUFsOpcURIQDYte4hboFlP5uPjLRwCrBWFhYRg+fDgDFhHVO6WlpVi6dCk2bdoEKDUoatoFFhc/qcuqe6wWaM4mQX3tBJz1esyYPh0dOnSQuiqq5Ri07IhBi2qrvLw8fPHFF/jxx58ghBUWnZukQ1TkZQWQmYrh5eWF1157DTExMXz4mIjqtU2bNmHx4sUwmcwo8Y+Eybt1neoiKyVZWSF0J7dBUXgVwcEhmD07Ht7e3lKXRXUAg5YdMWhRbZeZmYmPP/4YR44ckbQOjVaL2Oefx4ABA9iinYjoLxkZGZg6bRquX7sGk1tTlDR+FFDUvxfT25Mi/xJ0p7ZDZipG7969MW7cOJ53yG4YtOyIQYuIiIgepNzcXMyaNQvp6emwOLihOOhJCI2z1GXVPkJAdTUD2nP7oJDLMHr0aLZuJ7u7m2zAJwGJiIiIJOTm5oYPPvgAzz33HBRFuXA6uhEKY7bUZdUuVgs0WYnQnk1CAxc9Fi9ejGeffZYhiyTFoEVEREQkMaVSibFjx+Ktt96CEhY4nNgC1dXjUpdVO5hLoDvxK9TXTiA4OASfffYZwsLCpK6KiEGLiIiIqKbo3bs3lixZAhe9M7RZidCc2wcIq9Rl1Vjy4jw4Hv0JyvxL6Nq1K5YtWwovLy+pyyICwKBFREREVKO0bt0an3zyCRo3bgz15SPQZf4OWExSl1XjKAwX4XjsJ8hLjRg6dChmzJjBphdUozBoEREREdUwvr6+WL58OaKjo6E0nIfjsZ8gKy2QuqwaQ3UlAw6ZW6CSC0yfPh0vv/wyn8eiGodBi4iIiKgGcnR0xNy5cxEbGwt58Q04ZvwMedENqcuSlhBQXzgI7dk9aODigiVLluDJJ5+UuiqiatWaoHXjxg0MHjwYLi4ucHFxweDBg5GXl3fT5U0mE9566y20adMGjo6OaNiwIYYMGYLsbHbxISIiotpBqVRi9OjRGD16NOSmIjhm/AxF/iWpy5KGsEKTlQhNzp/w8/PDxx9/jFatWkldFdFN1ZqgFRcXh7S0NGzevBmbN29GWloaBg8efNPli4qKkJKSgunTpyMlJQXr1q3DiRMn8PTTTz/EqomIiIjuX2xsLKZPnw4FrHA48SuUN7KkLunhspihO/k71NdOICQkBMuXL4evr6/UVRHdUq14YfGxY8cQGhqKvXv3Ijo6GgCwd+9edOrUCRkZGQgODr6j7SQnJyMqKgpnz55FQEDAHa3DFxYTERFRTZGSkoKpU6eiuLgEJYEdYfJqKXVJD565BA4ntkJReAXR0dGYNWsWdDqd1FVRPVXnXliclJQEFxcXW8gCgI4dO8LFxQV79uy54+0YDAbIZDI0aNDgpsuUlpbCaDRW+hARERHVBO3bt8eyZcvQwLUBtGeToM5Jl7qkB0pmKoZjxi9QFF5Bz549MXfuXIYsqjVqRdC6dOlSte9E8PLywqVLdzZOuaSkBG+//Tbi4uJumT7nz59vew7MxcUF/v7+91w3ERERkb01b94cHy1fDi9vb2guHIA6O03qkh4IWVkRHDJ+gbz4Bl544QW8/fbbUCqVUpdFdMckDVqzZs2CTCa75efAgQMAUG3LTiHEHbXyNJlMGDBgAKxWKz766KNbLjt58mQYDAbb5/z58/f25YiIiIgekIYNG2LZ0qXw9fWF5mIK1BdTgJr/NMgdk5UVwuH4L5CX5GHgwIF4/fXX2b6dah1JLwuMGjUKAwYMuOUyjRs3Rnp6Oi5fvlxl3tWrV+Ht7X3L9U0mE/71r3/hzJkz2LZt223HUmo0Gr7sjoiIiGo8Hx8fLF26FOPHj8fFi2mAsKLMLwKo5YFEVloAh+ObIS81YvDgwRg+fDhDFtVKkgYtDw8PeHh43Ha5Tp06wWAwYP/+/YiKigIA7Nu3DwaDAZ07d77pehUhKzMzE9u3b4e7u7vdaiciIiKSmpeXV3nYmjAB58+VP69V1ihS4qrunaysEI7Hf4GsNB/Dhw/HkCFDpC6J6J7Vime0WrZsiV69euGVV17B3r17sXfvXrzyyit46qmnKnUcDAkJwfr16wEAZrMZL7zwAg4cOIBvvvkGFosFly5dwqVLl1BWVibVVyEiIiKyKw8PDyxdsgT+AQHQ5KRDlXNI6pLujbkUDid+haw0HyNGjGDIolqvVgQtAPjmm2/Qpk0b9OjRAz169EBYWBi++uqrSsscP34cBoMBAHDhwgVs3LgRFy5cQNu2beHr62v73E2nQiIiIqKazs3NDYvefx+enp7QXkiG8uoJqUu6OxYTHE5sgbw4Dy+++CIGDRokdUVE961WvEdLSnyPFhEREdUW586dw+jRo2EwGFHcrCvMbo2lLun2rBboMn+D0piNPn36YNKkSXwmi2qsOvceLSIiIiK6vYCAALz33nvQ6bTQnd4JhTFH6pJuTQhoT++E0piNxx9/HBMmTGDIojqDQYuIiIioDmnRogXmz58PlVIOh1PbICsxSl3STakvpkB1Iwvt2rXDtGnT+J4sqlMYtIiIiIjqmLZt22LSpEnlDSYyfwPMNa8RmPL6KWhy/kSjRo0we/ZsqNVqqUsisisGLSIiIqI6qEePHhg4cCDkJQboTm8HhFXqkmzkBVehy/oDjo5OmD9/PpydnaUuicjuGLSIiIiI6qj/+Z//QefOnaE0XITmfLLU5QAof1eWw8nfIYdAfPws+Pv7S10S0QPBoEVERERURykUCkybNg2NmzSB+vIRKHOzpC1IWKE9vRMyUxFef/11REbW3pcrE90OgxYRERFRHebg4IDZ8fHQaDTQnf0DstICyWpRZ/8JZf4ldO3aFc8//7xkdRA9DAxaRERERHVcQEAAxo0bB5jLoD29U5LntRT5l6DJToO3jw/eeOMNtnGnOo9Bi4iIiKge6NWrF5588kkoCy5DnZ32cHduLoXu9E7I5TLMmD4dTk5OD3f/RBJg0CIiIiKqB2QyGSZMmAAfH19osv+EvODqQ9u39mwSZGWFGDFiBFq1avXQ9kskJQYtIiIionrC0dERU6ZMBiCgPZsIWB/8EEKF4QJUuafRqlUrDBw48IHvj6imYNAiIiIiqkfCwsLQr18/KIpyob58+MHuzGKC7uweKBRKTJw4EXI5//Sk+oP/2omIiIjqmf/93/+Fq6sbNNmpkJUYH9h+NBdTISstQFzcQDRp0uSB7YeoJmLQIiIiIqpnnJ2dMXbsGMBqgfZs0gPZh7woF+rLR9CoUSMMGjTogeyDqCZj0CIiIiKqh2JiYtChQwcojRehMFy0+/Y1Fw4AEBg3bhw0Go3dt09U0zFoEREREdVDMpkMI0eOhEwmKw9FQtht2wpjDpSGC4iMjERkZKTdtktUmzBoEREREdVTzZo1Q48ePaAoug5l7mn7bFQIaM4nQyaT4dVXX7XPNolqIaXUBRARERGRdIYPH45t27ZBnE2C9fKR+9+g1QpFcS66de+O5s2b3//2iGopBi0iIiKieszb2xvDhg3D119/A2EttMs2XXx8MGLECLtsi6i2kglhxwG5dZDRaISLiwsMBgP0er3U5RARERERkUTuJhvwGS0iIiIiIiI7Y9AiIiIiIiKyMwYtIiIiIiIiO2PQIiIiIiIisjMGLSIiIiIiIjtj0CIiIiIiIrIzBi0iIiIiIiI7Y9AiIiIiIiKyMwYtIiIiIiIiO2PQIiIiIiIisjMGLSIiIiIiIjtj0CIiIiIiIrIzBi0iIiIiIiI7Y9AiIiIiIiKyMwYtIiIiIiIiO2PQIiIiIiIisjMGLSIiIiIiIjtj0CIiIiIiIrIzpdQF1HRCCACA0WiUuBIiIiIiIpJSRSaoyAi3wqB1G/n5+QAAf39/iSshIiIiIqKaID8/Hy4uLrdcRibuJI7VY1arFdnZ2XB2doZMJpO6HCJJGI1G+Pv74/z589Dr9VKXQ0REEuC5gKj8TlZ+fj4aNmwIufzWT2HxjtZtyOVyNGrUSOoyiGoEvV7PkysRUT3HcwHVd7e7k1WBzTCIiIiIiIjsjEGLiIiIiIjIzhi0iOi2NBoNZs6cCY1GI3UpREQkEZ4LiO4Om2EQERERERHZGe9oERERERER2RmDFhERERERkZ0xaBEREREREdkZgxZRLZKVlQWZTIa0tDSpSyEiqlW6dOmCcePGAQAaN26MJUuWSFoPEdV9DFpEtYi/vz9ycnLQunXr2y5bEcoqPi4uLujYsSN+/PHHKssWFxdj5syZCA4OhkajgYeHB1544QUcOXKk0nLDhg3Ds88+W2X9tLQ0yGQyZGVl2aYJIbBixQp06tQJer0eTk5OaNWqFcaOHYuTJ0/alps1a1alOis+ISEhtmXWrVuHnj17wsPD466DZm5uLkaPHo3g4GA4ODggICAAY8aMgcFguONtEBH907p169C9e3d4enpCr9ejU6dO+PXXX6Uu64FYuXIlGjRocFfrdOnSxXY8V6vVaNasGSZPnozS0tIqy/7000/o0qULnJ2d4eDggA4dOmDlypWVltmxYwdkMhny8vKqrN+2bVvMmjWr0rTU1FS8+OKL8PX1hUajQWBgIJ566in8+OOPqOgD98/z5N8/e/fuBQDk5OQgLi4OwcHBkMvltrB+p1asWIHHHnsMrq6ucHV1Rbdu3bB///672gbVXgxaRLWIQqGAj48PlErlHa+zdetW5OTkYN++fYiKikJsbCwOHz5sm19aWopu3brhiy++wJw5c3DixAls2rQJFosF0dHRtpPN3RBCIC4uDmPGjEGfPn2wZcsWpKenY9myZdDpdHjnnXcqLd+qVSvk5ORU+vzxxx+2+YWFhXjkkUewYMGCu64lOzsb2dnZeP/993Ho0CGsXLkSmzdvxogRI+56W0REFXbt2oXu3btj06ZNOHjwILp27Yp+/fohNTVV6tJqjFdeeQU5OTk4efIkFi5ciOXLl1cJRB9++CGeeeYZdO7cGfv27UN6ejoGDBiAkSNHYuLEife03w0bNqBjx44oKCjAqlWrcPToUXz77bd49tlnMW3atCoX2irOk3//REREACg/R3p6emLq1KkIDw+/61p27NiBgQMHYvv27UhKSkJAQAB69OiBixcv3tN3o1pGEJFdGY1GERcXJxwcHISPj4/44IMPRExMjBg7dqwQQojly5eLoKAgodFohJeXl4iNjbWt+8svv4hHHnlEuLi4CDc3N9G3b19x8uRJ2/wzZ84IACI1NfW2dVS3rNFoFADEsmXLbNMWLFggZDKZSEtLq7S+xWIRkZGRIjQ0VFitViGEEEOHDhXPPPNMlX2lpqYKAOLMmTNCCCESEhIEALFhw4Zqa6vYnhBCzJw5U4SHh9/2+9zsO92L//u//xNqtVqYTKb72g4R1R5/Pw4HBgaKxYsX2+YBEJ988ono27ev0Ol0IiQkROzZs0dkZmaKmJgY4eDgIDp27FjpeFyd0NBQER8fb/vZZDKJ0aNH247pb775phgyZEil46jVahXvvvuuaNKkidBqtSIsLEx8++23tvnbt28XAMTWrVtFRESE0Ol0olOnTiIjI6PSvjdu3Cjat28vNBqNaNKkiZg1a1alY9zMmTOFv7+/UKvVwtfXV4wePdo2r7S0VEyaNEk0bNhQODg4iKioKLF9+/ZK+//7Z+bMmXf1+67w/PPPi/bt29t+PnfunFCpVGLChAlV1l+2bJkAIPbu3Vupjhs3blRZNjw83FZTQUGBcHd3F88999xNa6s4B93tOaW673S3zGazcHZ2FqtWrbqv7VDtwDtaRHY2YcIEJCYmYuPGjfjtt9+we/dupKSkAAAOHDiAMWPGYPbs2Th+/Dg2b96Mxx9/3LZuYWEhJkyYgOTkZPz++++Qy+V47rnnYLVa77suk8mEFStWAABUKpVt+urVq9G9e/cqV+rkcjnGjx+Po0eP4s8//7yrfSUkJCA4OBhPP/10tfNlMtldVm9fBoMBer3+ru4MElHdNmfOHAwZMgRpaWkICQlBXFwcXn31VUyePBkHDhwAAIwaNeqm61utVuTn58PNzc027d1338U333yDL7/8EomJiTAajfjhhx8qrTdt2jR8+eWX+Pjjj3HkyBGMHz8egwYNws6dOystN3XqVCxatAgHDhyAUqnE8OHDbfN+/fVXDBo0CGPGjMHRo0fx6aefYuXKlZg7dy4A4LvvvsPixYvx6aefIjMzEz/88APatGljW//ll19GYmIi1qxZg/T0dPTv3x+9evVCZmYmOnfujCVLlkCv19vu9tzLnaY///wTiYmJlc4/3333HUwmU7Xbe/XVV+Hk5ISEhIS72s+WLVtw/fp1vPnmmzddRspzUFFREUwmU6V/J1SHSZ30iOoSo9EoVCpVpauReXl5wsHBQYwdO1Z8//33Qq/XC6PReEfbu3LligAgDh06JIS4tztaOp1OODo6CrlcLgCIxo0bi+vXr9uW02q1N71Cl5KSIgCItWvXCiHu/I5WSEiIePrppystM3bsWOHo6CgcHR2Fn5+fbfrMmTOFXC63zav4jBgx4qbf6X7uaF27dk0EBASIqVOn3vM2iKj2ud0drWnTptl+TkpKEgDE559/bpuWkJAgtFrtTbe/cOFC4ebmJi5fvmyb5u3tLd577z3bz2azWQQEBNiOowUFBUKr1Yo9e/ZU2taIESPEwIEDhRCV72hV+PnnnwUAUVxcLIQQ4rHHHhPz5s2rtI2vvvpK+Pr6CiGEWLRokWjRooUoKyurUvfJkyeFTCYTFy9erDT9ySefFJMnTxZCCPHll18KFxeXm3736sTExAiVSiUcHR2FWq0WAIRcLhffffedbZmRI0fecrthYWGid+/eQog7v6O1YMECAUDk5uba5u/fv7/S+eXHH38UQlQ9T/79Yzabq/1O93tH67XXXhPNmjWz/X9HdRsv5xLZ0enTp2EymRAVFWWb5uLiguDgYABA9+7dERgYiKZNm6JXr17o1asXnnvuOTg4OAAATp06henTp2Pv3r24du2a7U7WuXPn7qgBRnXWrl2LkJAQnDhxAuPGjcMnn3xyx1fSxF8PDN/L1b9/rjN16lSMGjUK69atw7x58yrNCw4OxsaNGytNc3Z2vut93o7RaETfvn0RGhqKmTNn2n37RFR7hYWF2f63t7c3AFS66+Pt7Y2SkhIYjUbo9fpK6yYkJGDWrFnYsGEDvLy8AJTfOb98+XKl84FCoUBERITt2H706FGUlJSge/fulbZXVlaGdu3a3bQ+X19fAMCVK1cQEBCAgwcPIjk52XYHCwAsFgtKSkpQVFSE/v37Y8mSJbZzT58+fdCvXz8olUqkpKRACIEWLVpU2l9paSnc3d3v8LdXvZdeeglTp06F0WjEu+++C71ej9jY2DteXwhhl7tPYWFhtiZKzZs3h9lsrjR/7dq1aNmyZaVpCoXivvf7TwsXLkRCQgJ27NgBrVZr9+1TzcOgRWRHNwsmFdOdnZ2RkpKCHTt2YMuWLZgxYwZmzZqF5ORkNGjQAP369YO/vz9WrFiBhg0bwmq1onXr1igrK7vnmvz9/dG8eXM0b94cTk5OiI2NxdGjR21/DLRo0QJHjx6tdt2MjAwA5ScmANDr9Th79myV5Sq6QLm4uNiWr1i3gqenJzw9PW37/Tu1Wo2goKB7+4J3KD8/H7169YKTkxPWr19fafgKEdHfjwkVx/Dqpv1zKPfatWsxYsQIfPvtt+jWrVuV7d7sfPD3bf3888/w8/OrtJxGo7ltfRXrW61WxMfH4/nnn6+yf61WC39/fxw/fhy//fYbtm7ditdeew3vvfcedu7cCavVCoVCgYMHD1YJF05OTlW2dzdcXFxsx/avv/4arVq1wueff25rRtSiRQsYDAZkZ2ejYcOGldYtKyvD6dOn8cQTTwCALdwaDIYqHRDz8vIqnX8A4Pjx4+jYsSOA8t/lrc4x/v7+D/wc9P7772PevHnYunVrpdBMdRuf0SKyo2bNmkGlUlVq3Wo0GpGZmWn7WalUolu3bli4cCHS09ORlZWFbdu24fr16zh27BimTZuGJ598Ei1btsSNGzfsWl9MTAxat25d6arngAEDsHXr1irPYVmtVixevBihoaG257dCQkJw+PBhlJSUVFo2OTkZnp6ecHV1BQAMHDgQx48fx4YNG+xa/70yGo3o0aMH1Go1Nm7cyCuJRGQXCQkJGDZsGFavXo2+fftWmufi4gJvb+9K5wOLxVKpK2FoaCg0Gg3OnTuHoKCgSh9/f/87rqN9+/Y4fvx4lW0EBQVBLi//U0+n0+Hpp5/GsmXLsGPHDiQlJeHQoUNo164dLBYLrly5UmVdHx8fAOUXwywWy/38qqBSqTBlyhRMmzYNRUVFAIDY2FgolUosWrSoyvKffPIJCgsLMXDgQADlAUoulyM5ObnScjk5Obh48aJt5EiPHj3g5uaGd999977qtaf33nsPc+bMwebNmxEZGSl1OfQQ8Y4WkR05Oztj6NChmDRpEtzc3ODl5YWZM2dCLpdDJpPhp59+wunTp/H444/D1dUVmzZtgtVqRXBwMFxdXeHu7o7PPvsMvr6+OHfuHN5++2271/jGG2+gf//+ePPNN+Hn54fx48djw4YN6NevHxYtWoTo6GhcvnwZ8+bNw7Fjx7B161bb1dOXXnoJc+bMweDBg/HWW2/B1dUVSUlJmD9/PiZPnmzbx4ABA7Bu3ToMGDAAkydPRs+ePeHt7Y2zZ89i7dq1Va6ams1mXLp0qdI0mUxmG76Tm5uLc+fOITs7G0D5lUoA8PHxsf0hcDP5+fno0aMHioqK8PXXX8NoNMJoNAIov8v2IIaHEFHdl5CQgCFDhmDp0qXo2LGj7Rim0+lsd1dGjx6N+fPnIygoCCEhIfjwww9x48YN2zHV2dkZEydOxPjx42G1WvHoo4/CaDRiz549cHJywtChQ++olhkzZuCpp56Cv78/+vfvD7lcjvT0dBw6dAjvvPMOVq5caXtlh4ODA7766ivodDoEBgbC3d0dL730EoYMGYJFixahXbt2uHbtGrZt24Y2bdqgT58+aNy4MQoKCvD7778jPDwcDg4OtiHvdyMuLg5TpkzBRx99hIkTJyIgIAALFy7ExIkTodVqMXjwYKhUKmzYsAFTpkzBG2+8gejoaNvv6tVXX8Ubb7wBpVKJ8PBwZGdnY+rUqWjZsiV69OgBoPwu3H//+1+8+OKL6Nu3L8aMGYPmzZujoKAAmzdvBlB1WOD169ernIMaNGhguyhXMeywoKAAV69eRVpaGtRqNUJDQ2/7nRcuXIjp06dj9erVaNy4sW0/Tk5O933HkGoBKR8QI6qLqmvvHhUVJd5++22xe/duERMTI1xdXYVOpxNhYWG2RhNCCPHbb7+Jli1bCo1GI8LCwsSOHTsEALF+/XohxP23dxeivK1tcHCw+Pe//22bVlhYKKZNmyaCgoKESqUSbm5uIjY21taE4+8yMzNFbGys8PPzE46OjqJNmzbiP//5j7BYLJWWs1gs4pNPPhHR0dG2h6GbNm0qXnnlFXH06FHbcjNnzqzSOhiA0Gg0tmW+/PLLape5kxbD1bUmrvhUNO8gorrvds0wKo6zQlR//PxnM4aYmJhqjytDhw61rWMymcSoUaOEXq8Xrq6u4q233hL9+/cXAwYMsC1jtVrF0qVLRXBwsFCpVMLT01P07NlT7Ny5s9r9ClG1AZEQQmzevFl07txZ6HQ6odfrRVRUlPjss8+EEEKsX79eREdHC71eLxwdHUXHjh0rNdcoKysTM2bMEI0bNxYqlUr4+PiI5557TqSnp9uWGTlypHB3d7+v9u5CCDF37lzh6ekp8vPzbdM2bNggHnvsMeHo6Ci0Wq2IiIgQX3zxRZV1S0pKxOzZs0XLli2FTqcTgYGBYtiwYSInJ6fKssnJyeKFF14QXl5eQqlUCnd3d9GzZ0+xZs2aKu3dq/skJCTYtlXd/MDAwNv+DoQo/7d2r+cvqv1kQvxtsDAR2V1hYSH8/PywaNEiviSXiKges1qtaNmyJf71r39hzpw5UpdDRA8Yhw4S2VlqaioyMjIQFRUFg8GA2bNnAwCeeeYZiSsjIqKH6ezZs9iyZQtiYmJQWlqK//znPzhz5gzi4uKkLo2IHgI2wyB6AN5//32Eh4ejW7duKCwsxO7du+Hh4WHXfYwcOdI2xvufn5EjR9p1XzXZN998c9PfQ6tWraQuj4jqMblcjpUrV6JDhw545JFHcOjQIWzdurVKK/HaZvfu3Tc97ta3545u9XvYvXu31OWRxDh0kKiWunLliq2pwz/p9fpq26jXRfn5+bh8+XK181QqFQIDAx9yRUREdVtxcTEuXrx40/kPulV6TXLy5MmbzvPz84NOp3uI1VBNw6BFRERERERkZxw6SEREREREZGcMWkRERERERHbGoEVERERERGRnDFpERERERER2xqBFRERkZzKZDD/88IPUZRARkYQYtIiIqE4aNmwYZDJZte+Ve+211yCTyTBs2LA72taOHTsgk8mQl5d3R8vn5OSgd+/ed1EtERHVNQxaRERUZ/n7+2PNmjUoLi62TSspKUFCQgICAgLsvr+ysjIAgI+PDzQajd23T0REtQeDFhER1Vnt27dHQEAA1q1bZ5u2bt06+Pv7o127drZpQggsXLgQTZs2hU6nQ3h4OL777jsAQFZWFrp27QoAcHV1rXQnrEuXLhg1ahQmTJgADw8PdO/eHUDVoYMXLlzAgAED4ObmBkdHR0RGRmLfvn0P+NsTEZGUlFIXQERE9CC9/PLL+PLLL/HSSy8BAL744gsMHz4cO3bssC0zbdo0rFu3Dh9//DGaN2+OXbt2YdCgQfD09MSjjz6K77//HrGxsTh+/Dj0ej10Op1t3VWrVuHf//43EhMTIYSosv+CggLExMTAz88PGzduhI+PD1JSUmC1Wh/4dyciIukwaBERUZ02ePBgTJ48GVlZWZDJZEhMTMSaNWtsQauwsBAffPABtm3bhk6dOgEAmjZtij/++AOffvopYmJi4ObmBgDw8vJCgwYNKm0/KCgICxcuvOn+V69ejatXryI5Odm2naCgIPt/USIiqlEYtIiIqE7z8PBA3759sWrVKggh0LdvX3h4eNjmHz16FCUlJbZhfxXKysoqDS+8mcjIyFvOT0tLQ7t27Wwhi4iI6gcGLSIiqvOGDx+OUaNGAQCWL19eaV7FEL6ff/4Zfn5+lebdSUMLR0fHW87/+zBDIiKqPxi0iIiozuvVq5etI2DPnj0rzQsNDYVGo8G5c+cQExNT7fpqtRoAYLFY7nrfYWFh+O9//4vc3Fze1SIiqkfYdZCIiOo8hUKBY8eO4dixY1AoFJXmOTs7Y+LEiRg/fjxWrVqFU6dOITU1FcuXL8eqVasAAIGBgZDJZPjpp59w9epVFBQU3PG+Bw4cCB8fHzz77LNITEzE6dOn8f333yMpKcmu35GIiGoWBi0iIqoX9Ho99Hp9tfPmzJmDGTNmYP78+WjZsiV69uyJH3/8EU2aNAEA+Pn5IT4+Hm+//Ta8vb1twxDvhFqtxpYtW+Dl5YU+ffqgTZs2WLBgQZXAR0REdYtMVNeLloiIiIiIiO4Z72gRERERERHZGYMWERERERGRnTFoERERERER2RmDFhERERERkZ0xaBEREREREdkZgxYREREREZGdMWgRERERERHZGYMWERERERGRnTFoERERERER2RmDFhERERERkZ0xaBEREREREdnZ/wNRSsC/ElbwPAAAAABJRU5ErkJggg==",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Reshape the DataFrame to long format\n",
    "df_long = pd.melt(df_output, id_vars=['gt_name_2'], value_vars=['gsai_ROUGE1_2', 'llm2geneset_ROUGE1_2'],\n",
    "                  var_name='Metric', value_name='Score')\n",
    "\n",
    "# Create the violin plot\n",
    "plt.figure(figsize=(10, 6))\n",
    "sns.violinplot(x='Metric', y='Score', data=df_long)\n",
    "plt.title('Violin Plot of GSAI_ROUGE1_2 and llm2geneset_ROUGE1_2 Scores')\n",
    "plt.xlabel('Metric')\n",
    "plt.ylabel('Score')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "587ba604-8505-41bb-88c7-2cde01f6325d",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
